Cannabis

磁力链接/BT种子名称

Cannabis

磁力链接/BT种子简介

种子哈希：044d76ddecaa26baf0b734ede43b15c3d3931a79
文件大小： 31.63G
已经下载：1951次
下载速度：极快
收录时间：2017-08-08
最近下载：2024-12-10

移花宫入口

移花宫.com邀月.com怜星.com花无缺.comyhgbt.icuyhgbt.top

磁力链接下载

magnet:?xt=urn:btih:044D76DDECAA26BAF0B734EDE43B15C3D3931A79
推荐使用PIKPAK网盘下载资源，10TB超大空间，不限制资源，无限次数离线下载，视频在线观看

下载BT种子文件

磁力链接 迅雷下载 PIKPAK在线播放 91视频 含羞草 欲漫涩 逼哩逼哩 成人快手 51品茶 抖阴破解版 暗网禁地 91短视频 TikTok成人版 PornHub 草榴社区 乱伦社区

最近搜索

文件列表

  • (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.pdf 776.4 kB
  • (-)D9THC as an hypnotic - An Experimental Study of Three Dose Levels.pdf 535.3 kB
  • (THC) attenuates weight loss in an activity-based model of anorexia nervosa.pdf 67.1 kB
  • (The receptors) The cannabinoid receptors.pdf 6.0 MB
  • 19,19-Dimethylheptyl-D-8-tetrahydrocannabinol-11-oic Acid - A Novel, Orally Effective Cannabinoid with Analgesic and Anti-inflammatory Properties.pdf 211.6 kB
  • 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.pdf 105.7 kB
  • 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-a production in murine macrophages, and in mice.pdf 66.4 kB
  • 3-(10,10-Dimethylbutyl)-1-deoxy-D8-THC and Related Compounds- Synthesis of Selective Ligands for the CB2 Receptor.pdf 236.3 kB
  • A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.pdf 657.2 kB
  • A cannabis reader - global issues and local experiences - Perspectives on cannabis controversies, treatment and regulation in Europe.pdf 4.2 MB
  • A capture-recapture derived method to estimate cannabis production in industrialized countries.pdf 160.5 kB
  • A CASE OF CANNABINOID HYPEREMESIS SYNDROME CAUSED BY SYNTHETIC CANNABINOIDS.pdf 73.5 kB
  • A case of cannabinoid rotation in a young woman with chronic cystitis.pdf 38.3 kB
  • A Comparative Analysis of Material (GCMS-of-Cannabinoids 1979).pdf 427.4 kB
  • A comparison of D9-THC and anandamide induced c-fos expression in the rat forebrain.pdf 1.9 MB
  • A contribution to the improvement of accuracy in the quantitation of THC.pdf 75.3 kB
  • A Contribution to the Pharmacology of cannabis Indica.pdf 254.5 kB
  • A cotwin-control analysis of drug use and abuse-dependence risk associated with early-onset cannabis use.pdf 204.7 kB
  • A Cyclotrimerization Route to Cannabinoids.pdf 166.0 kB
  • A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea.pdf 214.2 kB
  • A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.pdf 717.5 kB
  • A drug discovery case history THC and CBD.pdf 339.1 kB
  • A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene.pdf 114.4 kB
  • A FUNCTIONAL MRI STUDY OF THE EFFECTS OF D9THC AND CANNABIDIOL EFFECTS IN HUMANS.pdf 60.0 kB
  • A further comparison of Cannabis users and non-users.pdf 5.4 MB
  • A genome-wide association study of DSM-IV cannabis dependence.pdf 229.7 kB
  • A Gut Gone to Pot - A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid.pdf 1.2 MB
  • A historical overview of chemical research on cannabinoids.pdf 190.7 kB
  • A hunger for cannabinoids.pdf 98.3 kB
  • A longitudinal study of cannabis use and mental health from adolescence to early adulthood.pdf 164.4 kB
  • A longitudinal study of the effects of adolescent cannabis use on high school completion.pdf 126.4 kB
  • A mechanical investigation of the retting process in dew-retted hemp (Cannabis sativa).pdf 394.9 kB
  • A more reliable evaluation of hemp THC levels is necessary and possible.pdf 167.7 kB
  • A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.pdf 337.0 kB
  • A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China.pdf 2.3 MB
  • A new tetrahydrocannabinolic acid.pdf 113.2 kB
  • A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro.pdf 190.3 kB
  • A novel methodology for the synthesis of 1-desoxy-D8-tetrahydrocannabinol (THC) analogues.pdf 236.1 kB
  • A novel methodology for the synthesis of 1-desoxy-D8THC analogues.pdf 245.4 kB
  • A Novel Probe for the Cannabinoid Receptor.pdf 737.5 kB
  • A Novel Synthetic, Nonpsychoactive Cannabinoid Acid (HU-320) With Antiinflammatory Properties in Murine Collagen-Induced Arthritis.pdf 361.9 kB
  • A PCR marker Linked to a THCA synthase Polymorphism is a Reliable Tool to Discriminate Potentially THC-Rich Plants of Cannabis sativa L.pdf 405.3 kB
  • A phase I study to assess the effect of food on the single dose bioavailability of the THC-CBD oromucosal spray.pdf 195.7 kB
  • A phase I study to assess the single and multiple dose pharmacokinetics of THC-CBD oralmucosal spray.pdf 335.5 kB
  • A Phase I, Double Blind Study to Assess the Pharmacokinetic Profile of (CBME) Administered Sublingually in Variant Cannabinoid Ratios in Normal Healthy Male Volunteers.pdf 153.0 kB
  • A Pilot Clinical Study of D9THC in Patients with recurrent glioblastoma multiforme.pdf 277.2 kB
  • A preliminary DTI study showing no brain structural change associated with adolescent cannabis use.pdf 378.4 kB
  • A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention.pdf 284.9 kB
  • A preliminary investigation on the distribution of cannabinoids in man.pdf 177.1 kB
  • A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.pdf 434.9 kB
  • A prospective study on intrauterine cannabis exposure and fetal blood flow.pdf 169.6 kB
  • A putative G protein-coupled receptor involved in innate immune defense of Procambarus clarkii against bacterial infection.pdf 805.4 kB
  • A random walk through a cannabis field.pdf 421.4 kB
  • A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.pdf 369.4 kB
  • A rapid and sensitive method for the identification of D9THC in oral fluid by liquid chromatography–tandem mass spectrometry.pdf 345.4 kB
  • A real-time PCR assay for the relative quantification of the tetrahydrocannabinolic acid (THCA) synthase gene in herbal Cannabis samples.pdf 716.8 kB
  • A Red Herring - Marijuana Arrestees Do Not Become Violent Felons.pdf 950.4 kB
  • A REVIEW OF RECENT ADVANCES IN CANNABINOID RESEARCH AND THE 1994 INTERNATIONAL SYMPOSIUM ON CANNABIS AND THE CANNABINOIDS.pdf 656.2 kB
  • A review of the world cannabis situation.pdf 39.9 kB
  • A role for p53 in the regulation of lysosomal permeability by D9THC in rat cortical neurons – implications for neurodegeneration.pdf 465.0 kB
  • A role for p53 in the the B-amyloid-mediated regulation of the lysosomal system.pdf 561.2 kB
  • A single dose study of nabilone, a synthetic cannabinoid.pdf 540.6 kB
  • A single low dose of tetrahydrocannabinol induces long-term cognitive deficits.pdf 190.5 kB
  • A Species Comparison of the Toxicity of Nabilone, a New Synthetic Cannabinoid.pdf 1.1 MB
  • A Study of Cotyledon Asymmetry in Cannabis sativa L..pdf 2.5 MB
  • A submicron emulsion ocular vehicle for a D8THC - Effect on Intraocular pressure in Rabbits.pdf 2.9 MB
  • A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits.pdf 53.4 kB
  • A survey of the potency of Japanese illicit cannabis in fiscal year 2010.pdf 650.4 kB
  • A synthetic route to anandamide analogues carrying a substituent at the terminal carbon and an acetylene group in the end pentyl chain.pdf 243.9 kB
  • A tale of two cannabinoids - The therapeutic rationale for combining THC and CBD.pdf 163.7 kB
  • A vapourized D9THC delivery system part II - Comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.pdf 1.4 MB
  • A9-TETRAHYDROCANNABINOL CI'I-IC) MODULATES IL-1 BIOACTIVITY in human monocyte - macrophage cell lines.pdf 551.3 kB
  • AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity.pdf 2.0 MB
  • Abnormal brain activity in prefrontal brain regions in abstinent marijuana users.pdf 660.6 kB
  • Abstinence symptoms following oral THC administration to humans.pdf 134.4 kB
  • Abstinence symptoms following smoked marijuana in humans.pdf 151.0 kB
  • Abuse Potential of Dronabinol (Marinol).pdf 874.0 kB
  • Accepted ManuscriptENDOCANNABINOIDS, SPERM FUNCTIONS AND ENERGY METABOLISM.pdf 303.9 kB
  • ACCESSING 0.5 to 2.0 GRAMS CBD - FRACTIONATING THE PHYTOCANNABINOIDS BY THEIR VAPORIZATION POINTS.pdf 58.9 kB
  • Accumulation of Cannabinoids in Glandular Trichomes of Cannabis.pdf 390.9 kB
  • ACLU Racial Marijuana Report.pdf 6.0 MB
  • ACQUISITION OF TOLERANCE TO D-9-THC AS MEASURED BY THE RESPONSE OF A CELLULAR FUNCTION.pdf 280.0 kB
  • Action of Cannabidiol on the Anxiety and Other Effects produced by D9THC in normal subjects.pdf 706.1 kB
  • Action of Cannabidiol on the Anxiety and Other Effects Produced by THC in Normal Subjects.pdf 293.8 kB
  • Actions of cannabinoid receptor ligands on rat cultured sensory neurones- implications for antinociception.pdf 458.9 kB
  • Actions of delta-9-tetrahydrocannabinol in cannabis - Relation to use, abuse, dependence.pdf 75.6 kB
  • Actions of delta-9-tetrahydrocannabinol in cannabis- Relation to use, abuse, dependence.pdf 86.6 kB
  • Activation of cannabinoid receptor 2 inhibits experimental cystitis.pdf 783.5 kB
  • Activation of Cannabinoid Receptors Decreases the Area of Ischemic Myocardial Necrosis.pdf 287.5 kB
  • Activation of Epsilon Protein Kinase C-Mediated Anti-Apoptosis Is Involved in Rapid Tolerance Induced by Electroacupuncture Pretreatment Through Cannabinoid Receptor Type 1.pdf 2.7 MB
  • ACTIVATION OF TRANSIENT RECEPTOR POTENTIAL A1 CHANNELS BY MUSTARD OIL, TETRAHYDROCANNABINOL AND Ca2 REVEALS DIFFERENT FUNCTIONAL CHANNEL STATES.pdf 1.1 MB
  • Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1, PGC-1α pathway.pdf 1.0 MB
  • Activation through Cannabinoid Receptors 1 and 2 on dendric Cells Triggers NF-k B-Dependent Apoptosis- Novel Role for Endogeneous and Exogeneous Cannabinoids in Immunoregulation.pdf 802.0 kB
  • Activity-based anorexia in C57BL6 mice- Effects of the phytocannabinoid D9THC and the anandamide analogue, OMDM-2.pdf 851.7 kB
  • Acute administration of THC impairs spatial but not associative memory function in zebrafish.pdf 1.4 MB
  • Acute and Chronic Toxicity of Marijuana.pdf 604.1 kB
  • Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance.pdf 296.0 kB
  • Acute and Residual Effects of Marijuana in Humans.pdf 135.4 kB
  • Acute and subacute bronchial effects of oral cannabinoids.pdf 513.2 kB
  • Acute cannabis poisoning in a 10 month old infant ... Intoxication aiguë par cannabis chez un nourrisson de 10 mois.pdf 248.9 kB
  • Acute cardiovascular fatalities following cannabis use.pdf 104.5 kB
  • Acute D9THC blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice.pdf 2.6 MB
  • Acute D9THC exposure facilitates quinpirole-induced hyperlocomotion.pdf 296.7 kB
  • Acute effects of D9THC and standardized cannabis extract on the auditory evoked mismatch negativity.pdf 230.8 kB
  • Acute effects of THC on time perception in frequent and infrequent cannabis users.pdf 416.1 kB
  • Acute Effects of Two Tetrahydrocannabinols (D9THC and D8THC) on Water Intake in Water Deprived Rats - Implications for Behavioral Studies on Marijuana Compounds.pdf 448.4 kB
  • Acute or chronic effects of cannabinoids on spontaneous or pharmacologically induced yawning in rats.pdf 153.5 kB
  • Acute psychomotor, memory and subjective effects of MDMA and THC (co-) administration over time in healthy volunteers.pdf 65.8 kB
  • Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia.pdf 1.0 MB
  • Adolescent cannabis use increases risk for cocaine-induced paranoia.pdf 211.3 kB
  • Adolescent exposure to cannabis as a risk factor for psychiatric disorders.pdf 276.4 kB
  • Adolescent Marijuana Use from 2002 to 2008 - Higher in States with MMJ laws, cause still unclear.pdf 201.9 kB
  • Advantages of polypharmaceutical herbal Cannabis compared to single-ingredient, synthetic THC.pdf 92.7 kB
  • Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular effects of marijuana inhalation - what cardiologists need to know.pdf 269.5 kB
  • Adverse effects of cannabis and cannabinoids.pdf 145.6 kB
  • Adverse effects of cannabis on health - An update of the literature since 1996.pdf 265.5 kB
  • Adverse effects of cannabis.pdf 106.9 kB
  • Adverse effects of medical cannabinoids - a systematic review.pdf 410.0 kB
  • Adverse Health Consequences of Cannabis Use.pdf 850.1 kB
  • Adverse health effects of non-medical cannabis use.pdf 1.2 MB
  • Again on the Nature of Inheritance of Chemotype.pdf 42.6 kB
  • Agonistic Properties of Cannabidiol at 5-HT1a Receptors.pdf 195.3 kB
  • Agronomy of fibre hemp (Cannabis sati6a L.) in Europe.pdf 201.1 kB
  • Ajulemic acid - A novel cannabinoid produces analgesia without a ‘‘high’’.pdf 156.6 kB
  • ALCOHOL CONSUMPTION AND CANNABIS USE IN YOUNG ADULT CZECHS.pdf 30.3 kB
  • Alertness and electrocortical activity after (co-)administration of MDMA and THC in healthy volunteers.pdf 69.6 kB
  • ALKANES OF THE ESSENTIAL OIL OF CANNABIS SATIVA.pdf 229.6 kB
  • ALPHA EEG SPECTRUM DIFFERENCES FOLLOWING PHOTIC DRIVING IN NORMAL SUBJECTS AND SCHIZOPHRENIC PATIENTS.pdf 84.0 kB
  • Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent D9THC exposure in rats.pdf 3.4 MB
  • Alterations of theory of mind network activation in chronic cannabis users.pdf 1.0 MB
  • Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease.pdf 604.3 kB
  • Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice - implications for excitotoxicity.pdf 615.6 kB
  • Altered Regional Blood Volume in Chronic Cannabis Smokers.pdf 527.4 kB
  • Alternative reinforcer response cost impacts cocaine choice in humans.pdf 262.0 kB
  • Alternative Therapies for Overactive Bladder - Cannabis and Urge Incontinence.pdf 247.8 kB
  • AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.pdf 217.6 kB
  • American law and the species problem in Cannabis - science and semantics.pdf 189.2 kB
  • An analgesia circuit activated by cannabinoids.pdf 229.9 kB
  • An archaeological and historical account of Cannabis in China.pdf 2.9 MB
  • An Aromatic Microdomain at the Cannabinoid CB1 Receptor Constitutes an Agonist - Inverse Agonist Binding Region.pdf 632.2 kB
  • An Attributional Life Cycle Assessment of Hemcrete.pdf 1.9 MB
  • An Ecological Study of Naturalized Hemp (Cannabis sativa L.) in East-Central Illinois.pdf 765.9 kB
  • An EEG investigation on nabilone, a synthetic cannabinoid, in rabbits.pdf 489.3 kB
  • An efficient new cannabinoid antiemetic in pediatric oncology.pdf 445.8 kB
  • An effort to discover the preferred conformation of the potent AMG3 cannabinoid analog when reaching the active sites of the cannabinoid receptors.pdf 1.4 MB
  • AN END TO Marijuana Prohibition - The drive to legalize picks up.pdf 160.0 kB
  • An Ethno-Methodological Approach to Cannabis and Music Perception, with EEG Brain Mapping in a Naturalistic Setting.pdf 206.1 kB
  • An evaluation of the quality of medicinal grade Cannabis in the Netherlands.pdf 267.8 kB
  • An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions.pdf 307.6 kB
  • An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of THC-Induced Effects on Psychosis and Cognition.pdf 147.4 kB
  • An exploratory prospective study of marijuana use and mortality following acute myocardial infarction.pdf 287.5 kB
  • An improved brief measure of cannabis misuse- The Cannabis Use Disorders Identification Test-Revised (CUDIT-R).pdf 196.7 kB
  • AN IN VITRO INVESTIGATION OF THE EFFECTS OF RIMONABANT (A CANNABINOID CB1 RECEPTOR ANTAGONIST) ON CELL ADHESION AND INFLAMMATORY ASSOCIATED CYTOKINE PRODUCTION.pdf 5.5 MB
  • An Initial Evaluation of Nabilone in the Control of Radiotherapyinduced Nausea and Vomiting.pdf 195.8 kB
  • An introduction to the endocannabinoid system - from the early to the latest concepts.pdf 399.5 kB
  • An Introduction to the Medical Benefits of Cannabis.pdf 2.0 MB
  • An Optically Active Terpenic Synthon for D9 Cannabinoids - Synthesis of (-)-1 1-Hydroxy-D9T HC and Its l',l'-Dimethylheptyl Analogue.pdf 355.0 kB
  • An ultra-low dose of tetrahydrocannabinol provides cardioprotection.pdf 1.7 MB
  • Anaerobic digestion of industrial hemp–Effect of harvest time on methane energy yield per hectare.pdf 482.8 kB
  • ANALGESIC EFFECTS of l’,l’ DIMETHYLHEPTYL-D8THC - 1 l-OIC ACID (CT3) in MICE.pdf 600.7 kB
  • Analysis and toxicological evaluation of Cannabinoids in hemp food products - a review.pdf 170.2 kB
  • Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenis NMR.pdf 1.1 MB
  • Analysis of cannabis in oral fluid specimens by GC-MS with automatic SPE.pdf 259.3 kB
  • Analysis of synthetic cannabinoids in herbal blends by means of nano-liquid chromatography.pdf 749.1 kB
  • Analysis of THCA synthase gene expression in cannabis- A preliminary study by real-time quantitative PCR.pdf 318.6 kB
  • Analysis of the NMI01 Marker for a Population Database of Cannabis Seeds.pdf 190.8 kB
  • Analysis of the viruses of hemp (Cannabis sativa L.) with regard to the hemp aphid (Phorodon cannabis Pass.) as virus vector.pdf 1.3 MB
  • Analytical Characterization of Hemp (Cannabis sativa) Seed Oil from Different Agro-ecological Zones of Pakistan.pdf 97.8 kB
  • Analytical Characterization of Hempseed (Seed of Cannabis sativa L.) Oil from eight Regions in China.pdf 158.9 kB
  • Anandamide and D9THC directly inhibit cells of the immune system via CB2 receptors.pdf 337.3 kB
  • Anandamide in a Membrane Bilayer Properties of the Endocannabinoid Ligand The Conformation, Location, and Dynamic properties of the endocannabinoid ligand Anandamide in the membrane bilayer.pdf 911.9 kB
  • Anandamide synthesis is induced by arachidonate mobilizing agonists in cells in the immune system.pdf 274.1 kB
  • Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase.pdf 459.7 kB
  • Anther culture and callus induction in Cannabis sativa L..pdf 52.2 kB
  • Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease - role of CB1 and TRPV1 receptors.pdf 461.7 kB
  • Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.pdf 869.7 kB
  • Anti-inflammatory cannabinoids in diet.pdf 84.9 kB
  • Antibacterial Cannabinoids from Cannabis sativa - A Structure-Activity Study.pdf 85.3 kB
  • Antibiotic activity of various types of Cannabis resin.pdf 331.3 kB
  • Anticoagulant effects of a Cannabis extract in an obese rat model.pdf 251.4 kB
  • Antidepressant-like effect of D9THC and other cannabinoids isolated from Cannabis sativa L..pdf 950.2 kB
  • Antidepressant-like effects of D9THC and rimonabant in the olfactory bulbectomised rat model of depression.pdf 735.9 kB
  • Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.pdf 532.5 kB
  • Antiemetic efficacy of smoked marijuana - Subjective and behavioral effects on nausea induced by syrup of ipecac.pdf 374.5 kB
  • Antiemetics in patients receiving chemotherapy for cancer - A randomized comparison of D9THC and Prochlorperazine.pdf 724.4 kB
  • Antiemetics in patients receiving chemotherapy for cancer - A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.pdf 112.9 kB
  • Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats.pdf 1.5 MB
  • Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents.pdf 525.5 kB
  • Antiinflammatory action of endocannabinoids palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.pdf 218.8 kB
  • Antimicrobial Activity of Cannabis sativa L..pdf 49.3 kB
  • Antineoplastic Activity of Cannabinoids.pdf 677.0 kB
  • Antinociception and sedation following intracerebroventricular administration of D9THC in female vs. male rats.pdf 451.1 kB
  • Antinociceptive activity of D9THC non-ionic microemulsions.pdf 490.2 kB
  • Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.pdf 283.6 kB
  • Antisense oligodeoxynucleotides to the K-1 receptor block the antinociceptive effects of D9THC in the spinal cord.pdf 219.6 kB
  • Antisense Oligodeoxynucleotides to the Kappa Receptor Enhance D9THC-induced Antinociceptive Tolerance.pdf 96.8 kB
  • Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.pdf 645.8 kB
  • Antitumor Effects of CBD, a Nonpsychoactive cannabinoid on human glioma cell lines.pdf 209.3 kB
  • Anxiety does not affect the antinociceptive effect of D9-THC in mice- participation of cannabinoid and opioid receptors.pdf 224.9 kB
  • Application of Hempseed Oil in the Treatment of Ear, Nose and Throat (ENT) Disorders.pdf 614.7 kB
  • Application of two-dimensional gas chromatography combined with pixel-based chemometric processing for the chemical profiling of illicit drug samples.pdf 1.3 MB
  • Are cannabinoid drugs neurotoxic or neuroprotective.pdf 170.3 kB
  • Are cannabis prevalence estimates comparable across countries and regions- A cross-cultural validation using search engine query data.pdf 567.1 kB
  • Arterial Consequences of Recreational Drug Use.pdf 112.6 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/An exploratory prospective study of marijuana use and mortality following acute myocardial infarction.pdf 287.5 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.pdf 875.6 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis - a trigger for acute myocardial infarction - a case report.pdf 78.4 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis - a trigger for acute myocardial infarction. A case report.pdf 78.4 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis and myocardial infarction without angiographic stenosis in young patient- guilty or not guilty- A case report.pdf 321.4 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis and stroke - is there a link.pdf 332.4 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis arteritis - a new case report and a review of literature.pdf 86.9 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis arteritis - four new cases.pdf 209.8 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis Arteritis - Review of the Literature.pdf 61.7 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis arteritis [2].pdf 357.6 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis Arteritis Revisited - Ten New Case Reports.pdf 770.3 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis arteritis.pdf 334.9 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis related Stroke - Myth or Reality.pdf 641.4 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis use - signal of increasing risk of serious cardiovascular disorders.pdf 997.5 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis, possible cardiac deaths and the coroner in Ireland.pdf 135.0 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/CANNABIS-INDUCED BRAIN ISCHEMIA.pdf 63.8 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis-induced cerebral and myocardial infarction in a young woman.pdf 189.6 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man.pdf 249.9 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis-Related Myocardial Infarction and cardioembolic stroke.pdf 146.3 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cannabis-Related Stroke - Case Series and Review of Literature.pdf 351.6 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cardiac asystole following cannabis (marijuana) usage – Additional mechanism for sudden death.pdf 776.2 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Cardiovascular Pharmacology of Cannabinoids.pdf 332.2 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications - A Systematic Review.pdf 486.9 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Inconsistent coroner interpretations of cardiac death in the presence of Cannabis in urine.pdf 108.2 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Lethal Ischemic Stroke after Cisplatin-Based Chemotherapy for Testicular Carcinoma and Cannabis Inhalation.pdf 402.3 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Marijuana Abusers Are at increased risk for stroke - preliminary evidence from cerebrovascular perfusion data.pdf 374.2 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Marijuana use and long-term mortality among survivors of acute myocardial infarction.pdf 147.0 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Myocardial infarction and marijuana.pdf 1.0 MB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2.pdf 2.9 MB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Myocardial infarction during marijuana smoking in a young female.pdf 1.0 MB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Occipital stroke shortly after cannabis consumption.pdf 107.0 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Popliteal Artery Entrapment Associated with Cannabis Arteritis.pdf 623.0 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Pot Shots — Cannabis Arteritis of the Digits.pdf 193.8 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Presence of Cryofibrinogen in a Cannabis user with Digital Ischaemia.pdf 444.4 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Progressive cannabis-induced arteritis - a clinical thromboangiitis obliterans subgroup.pdf 85.8 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Recurrent stroke associated with cannabis use.pdf 126.4 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Recurrent transient ischemic attacks in a Cannabis smoker.pdf 179.3 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Residual effects of focal brain ischaemia upon cannabinoid CB1 receptor density and functionality in female rats.pdf 639.6 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Sexual Headache and Stroke in a Heavy Cannabis Smoker.pdf 1.0 MB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Stroke and transient ischaemic attacks in association with substance abuse in a young man.pdf 351.8 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Sudden unexpected death under acute influence of cannabis.pdf 338.8 kB
  • Arterial Disease, Heart attack, Stroke, Arteritis/Triggering Myocardial Infarction by Marijuana.pdf 155.4 kB
  • Artificial Neural Networks and the Study of the psychoactivity of cannabinoid compounds.pdf 448.2 kB
  • Assessment of cannabinoid induced gene changes - tolerance and neuroprotection.pdf 225.8 kB
  • Assessment of the role of CB receptors in cannabinoid anticonvulsant effects.pdf 100.2 kB
  • Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis.pdf 161.8 kB
  • Association Between Marijuana Exposure and Pulmonary Function Over 20 Years.pdf 1.9 MB
  • Association of cannabis use with opioid outcomes among opioid-dependent youth.pdf 462.9 kB
  • Association of Herbal Cannabis Use With Negative Psychosocial Parameters in Patients With Fibromyalgia.pdf 81.5 kB
  • Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.pdf 1.7 MB
  • ATMOSPHERIC TRANSPORTATION of marijuana pollen from North Africa to the Southwest of Europe.pdf 401.3 kB
  • Atrial fibrillation and marijuana smoking.pdf 148.7 kB
  • Attenuation of Cyclophosphamide-Induced Taste Aversions in Mice by Prochlorperazine, A9-Tetrahydrocannabinol, Nabilone and Levonantradol.pdf 813.8 kB
  • Auditory-Evoked Potentials and Selective attention - different ways of information processing in Cannabis users and controls.pdf 119.7 kB
  • B-Arrestin 2 Regulates Cannabinoid CB1 Receptor Signaling and Adaptation in a Central Nervous System Region–Dependent Manner.pdf 2.2 MB
  • Before the Grand Opening - Measuring Washington State’s Marijuana Market in the Last Year Before Legalized Commercial Sales.pdf 993.0 kB
  • Behavioral Analysis of Marijuana Effects on Food Intake in Humans.pdf 580.1 kB
  • Behavioral Effects of THC as a Function of Environment and Prior Drug Experience.pdf 362.7 kB
  • Behavioral, Biochemical, and Molecular Modeling evaluations of cannabinoid analogs.pdf 816.1 kB
  • Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.pdf 2.2 MB
  • Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation- Role of CB1-CB2 receptors.pdf 1.3 MB
  • Beyond THC - The New Generation of Cannabinoid Designer Drugs.pdf 2.0 MB
  • Bidirectional control of airway responsiveness by endogenous cannabinoids.pdf 284.0 kB
  • BINDING AND FUNCTIONAL STUDIES WITH THE PERIPHERAL AND NEURONAL CANNABINO1D RECEPTORS.pdf 137.2 kB
  • Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa).pdf 1.4 MB
  • Biochemical and immunohistochemical changes in D9THC-treated type 2 diabetic rats.pdf 1.5 MB
  • Biochemical differences in Cannabis sativa L. depending on sexual phenotype.pdf 243.7 kB
  • Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.pdf 580.9 kB
  • BIOLOGICAL ACTIVITY OF THE TETRAHYDROCANNABINOLS.pdf 2.3 MB
  • Biological control of Cannabis sativa.pdf 873.0 kB
  • Biological effects of THC and a lipophiliccannabis extract on normal and insulin resistant 3T3-L1 adipocytes.pdf 241.5 kB
  • Biologically Active Cannabinoids from High-Potency Cannabis sativa.pdf 372.2 kB
  • Biomarkers for the effects of cannabis and THC in healthy volunteers.pdf 1.0 MB
  • Biorefinery of Cannabis sativa using one- and two-step steam treatments for the production of high quality fibres.pdf 541.7 kB
  • Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L..pdf 224.9 kB
  • Biphasic Effects of Anandamide.pdf 228.7 kB
  • Bipolar disorder and co-occurring cannabis use disorders- Characteristics, co-morbidities and clinical correlates.pdf 231.2 kB
  • Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.pdf 715.8 kB
  • Blurred Boundaries - The Therapeutics and Politics of Medical Marijuana.pdf 206.2 kB
  • Boron Trifluoride Etherate on Silica-A Modified Lewis Acid Reagent (VII). Antitumor activity of CBG against human oral epitheloid carcinoma cells.pdf 599.9 kB
  • Botanical and Chemical Study of THC in samples of Cannabis sativa L. An experience in Venezuela.pdf 462.3 kB
  • BRAIN CB1 RECEPTOR EXPRESSION FOLLOWING LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION.pdf 2.3 MB
  • Brain imaging study of the acute effects of THC on attention and motor coordination in regular users of marijuana.pdf 390.7 kB
  • Brain imaging study of the acute effects of Δ9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana.pdf 390.5 kB
  • Brain imaging study on the effects of D9THC on orientation and motor coordination in regular users of marijuana.pdf 59.6 kB
  • Brain Neuroimaging in Cannabis Use - A Review.pdf 119.3 kB
  • Brain regional differences in CB1 receptor adaptation and regulation of transcription.pdf 210.2 kB
  • Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa.pdf 1.1 MB
  • Breeding, production, processing and use of specialty Cannabis.pdf 1.8 MB
  • Bronchodilator effect of D1THC administered by aerosol of asthmatic patients.pdf 518.7 kB
  • Bronchodilator effect of D1THC.pdf 404.2 kB
  • Building with Hemp and Lime.pdf 1.2 MB
  • Bullous lung disease due to marijuana.pdf 272.2 kB
  • Byssinosis in Hemp Mill Workers.pdf 621.1 kB
  • C3-Heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.pdf 651.1 kB
  • Can oral fluid cannabinoid testing monitor medication compliance and-or cannabis smoking during oral THC and oromucosal Sativex administration.pdf 1.0 MB
  • Cancer, Apoptosis, Anti-tumor/5‐Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non‐psychoactive cannabinoid.pdf 694.2 kB
  • Cancer, Apoptosis, Anti-tumor/A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma.pdf 3.2 MB
  • Cancer, Apoptosis, Anti-tumor/A comparison of the apoptotic effect of D9THC in the neonatal and adult rat cerebral cortex.pdf 843.9 kB
  • Cancer, Apoptosis, Anti-tumor/A high cannabinoid CB1 receptor immunoreactivity is accociated with disease severity and outcome in prostate cancer.pdf 619.4 kB
  • Cancer, Apoptosis, Anti-tumor/A Population-Based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma.pdf 194.8 kB
  • Cancer, Apoptosis, Anti-tumor/Amphiregulin Is a Factor for Resistance of Glioma Cells to Cannabinoids-Induced Apoptosis.pdf 804.3 kB
  • Cancer, Apoptosis, Anti-tumor/Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors- Evidence far a Protective Role of Cannabinoid Receptors.pdf 840.0 kB
  • Cancer, Apoptosis, Anti-tumor/Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1 - possible involvement of lipid rafts.pdf 332.5 kB
  • Cancer, Apoptosis, Anti-tumor/Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells.pdf 505.7 kB
  • Cancer, Apoptosis, Anti-tumor/Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.pdf 1.1 MB
  • Cancer, Apoptosis, Anti-tumor/Anandamide-induced cell death in primary neuronal cultures - role of calpain and caspase pathways.pdf 396.0 kB
  • Cancer, Apoptosis, Anti-tumor/Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.pdf 952.6 kB
  • Cancer, Apoptosis, Anti-tumor/Anti-Tumoral action of cannabinoids Involement of sustained ceramide accumulation and extracellular signal regulated kinase activation.pdf 383.1 kB
  • Cancer, Apoptosis, Anti-tumor/Anti-tumoral action of cannabinoids on hepatocellular carcinoma- role of AMPK-dependent activation of autophagy.pdf 2.1 MB
  • Cancer, Apoptosis, Anti-tumor/Antiemetic effects of D9THC in patients receiving cancer chemotherapy.pdf 532.7 kB
  • Cancer, Apoptosis, Anti-tumor/ANTINEOPLASTIC AND APOPTOTIC EFFECTS OF CANNABINOIDS. N-ACYLETHANOLAMINES - PROTECTORS OR KILLERS.pdf 371.6 kB
  • Cancer, Apoptosis, Anti-tumor/Antiproliferative Mechanism of a Cannabinoid Agonist by Cell Cycle Arrest in Human Gastric Cancer Cells.pdf 2.4 MB
  • Cancer, Apoptosis, Anti-tumor/Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.pdf 213.4 kB
  • Cancer, Apoptosis, Anti-tumor/Antitumor Effects of THC.pdf 224.4 kB
  • Cancer, Apoptosis, Anti-tumor/Antitumorigenic Effects of Cannabinoids beyond Apoptosis.pdf 606.7 kB
  • Cancer, Apoptosis, Anti-tumor/Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent.pdf 417.5 kB
  • Cancer, Apoptosis, Anti-tumor/Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN- Involvement of the transcription factor PPARγ.pdf 567.1 kB
  • Cancer, Apoptosis, Anti-tumor/Apoptosis signal-regulating kinase 1 is crucial for oxidative stress-induced but not for osmotic stress-induced hepatocyte cell death.pdf 561.3 kB
  • Cancer, Apoptosis, Anti-tumor/Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1.pdf 518.2 kB
  • Cancer, Apoptosis, Anti-tumor/ASK1-p38 MAPK-JNK signaling cascade mediates anandamide-induced PC12 cell death.pdf 311.3 kB
  • Cancer, Apoptosis, Anti-tumor/Cancer Therapy Vol 6, 103-116, 2008. The molecular bases of cannabinoid action in cancer (review article).pdf 809.5 kB
  • Cancer, Apoptosis, Anti-tumor/cancer.gov cancertopics pdq cam cannabis healthprofessional page1 (as of 11-21-13).pdf 796.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol Activated the Intrinsic Apoptotic Pathway in Murine Lymphocytes.pdf 1.1 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.pdf 302.9 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative, Nitrosative Stress, Inflammation, and Cell Death.pdf 401.8 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol enhances the inhibitory effects of Δ9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.pdf 413.2 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells.pdf 904.6 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.pdf 139.8 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.pdf 1.5 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol, a nonpsychotropic phytocannabinoid, induces apoptosis in cultured murine microglia.pdf 82.6 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol-induced apoptosis in human leukemia cells- A novel role of cannabidiol in the regulation of p22phox and Nox4 expression.pdf 902.6 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiol-Induced Apoptosis in Murine Microglial Cells Through Lipid Raft.pdf 1.0 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.pdf 884.2 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabimimetic fatty acid derivatives in cancer and inflammation.pdf 217.2 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL-oxysterol induced apoptosis.pdf 878.8 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid action induces autophagymediated cell death through stimulation of ER stress in human glioma cells.pdf 10.5 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism.pdf 272.3 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid receptor 1 mediates high glucose-induced apoptosis via endoplasmic reticulum stress in primary cultured rat mesangial cells.pdf 1.6 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α–Mediated Ceramide De novo Synthesis in Colon Cancer Cells.pdf 798.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells.pdf 333.4 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid receptor agonists are mitochondrial inhibitors – A unified hypothesis ... induce cell death.pdf 443.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid Receptor as a Novel Target for the Treatment of Prostate cancer.pdf 868.6 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.pdf 175.4 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid Receptor Signaling.pdf 234.5 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis.pdf 991.2 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.pdf 301.6 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids - potential anticancer agents.pdf 316.8 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids and cancer - causation, remediation, and palliation.pdf 294.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids and cancer - causation, remediation, and.pdf 303.2 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids and cancer - potential for colorectal cancer therapy.pdf 84.4 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids and cancer - pros and cons of an antitumour strategy.pdf 250.2 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids and Cancer.pdf 473.3 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids and cell fate.pdf 255.5 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids and omega-3-6 endocannabinoids as cell death and anticancer modulators.pdf 1.3 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids enhance human B-cell growth at low nanomolar concentrations.pdf 556.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids for Cancer Treatment - Progress and Promise.pdf 316.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids for Cancer Treatment- Progress and Promise.pdf 325.9 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids in intestinal inflammation and cancer.pdf 405.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids in the treatment of cancer.pdf 305.3 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids in the Treatment of Symptoms in cancer and AIDS, 2nd edition #93.pdf 69.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.pdf 577.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress- Related Genes.pdf 681.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.pdf 2.4 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids inhibit glioma cell invasion by Down-regulating Matrix Metalloproteinase-2 Expression.pdf 662.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.pdf 843.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.pdf 560.7 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.pdf 796.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids modulate cell survival in embryoid bodies.pdf 173.3 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidinositol 3-Kinase-Protein Kinase B Pathway.pdf 367.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.pdf 1.0 MB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5.pdf 234.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.pdf 410.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids, endocannabinoids, and cancer by Hermanson & Marnet 2011.pdf 349.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabinoids- A new hope for breast cancer therapy.pdf 830.5 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabis - Inhibition of Tumor Cell Migration - Patent Pending GW Pharma.pdf 71.7 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabis and cancer chemotherapy - A comparisom of oral D9THC and Prochlorperazine.pdf 951.8 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabis and tobacco smoke are not equally carcinogenic.pdf 194.8 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabis use and cancer of the head and neck - case-controlled study.pdf 73.1 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabis use and cancer.pdf 58.9 kB
  • Cancer, Apoptosis, Anti-tumor/Cannabis use and risk of lung cancer - a case–control study.pdf 203.0 kB
  • Cancer, Apoptosis, Anti-tumor/Cellular signal transduction by anandamide and 2-arachidonoylglycerol.pdf 168.3 kB
  • Cancer, Apoptosis, Anti-tumor/Comparison of Orally Administered Cannabis Extract and D9THCl in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome - A Multicenter, Phase III,.pdf 310.3 kB
  • Cancer, Apoptosis, Anti-tumor/Comparison of the Pharmacology and Signal Transduction of the Human Cannabinoid CB1 and CB2 Receptors.pdf 1.7 MB
  • Cancer, Apoptosis, Anti-tumor/Control of the cell survival or death decision by cannabinoids.pdf 188.5 kB
  • Cancer, Apoptosis, Anti-tumor/COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells.pdf 1.6 MB
  • Cancer, Apoptosis, Anti-tumor/Critical appraisal of the potential use of cannabinoids in cancer management.pdf 333.1 kB
  • Cancer, Apoptosis, Anti-tumor/Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion.pdf 593.9 kB
  • Cancer, Apoptosis, Anti-tumor/Cytotoxicity of synthetic cannabinoids found in “Spice” products - The role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line.pdf 516.6 kB
  • Cancer, Apoptosis, Anti-tumor/D9THC enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.pdf 527.9 kB
  • Cancer, Apoptosis, Anti-tumor/D9THC induces apoptosis in C6 glioma cells.pdf 240.0 kB
  • Cancer, Apoptosis, Anti-tumor/D9THC induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.pdf 414.6 kB
  • Cancer, Apoptosis, Anti-tumor/De-Petrocellis-et-al.2000.-Endocannabinoids and fatty acid amides in cancer inflammation and related disorders.pdf 244.6 kB
  • Cancer, Apoptosis, Anti-tumor/DELTA-9-TETRAHYDROCANNABINOL SUPPRESSES TUMOR NECROSIS FACTOR-A MATURATION AND SECRETION BUT NOT ITS TRANSCRIPTION IN MOUSE MACROPHAGES.pdf 1.5 MB
  • Cancer, Apoptosis, Anti-tumor/Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and D9THC in BV-2 microglial cells.pdf 1.5 MB
  • Cancer, Apoptosis, Anti-tumor/Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide.pdf 389.2 kB
  • Cancer, Apoptosis, Anti-tumor/Dissecting lipid raft facilitated cell signaling pathways in cancer.pdf 1.3 MB
  • Cancer, Apoptosis, Anti-tumor/Doubts about the role of Cannabis in causing lung cancer.pdf 116.2 kB
  • Cancer, Apoptosis, Anti-tumor/Effect of the Psychoactive Metabolite of Marijuana, D9THC, on the synthesis of Tumor Necrosis Factor by human large granular lymphocytes.pdf 451.0 kB
  • Cancer, Apoptosis, Anti-tumor/Effects of smoked Cannabis and Oral D9THC on Nausea and Emesis after cancer chemotherapy - A review of state clinical trials.pdf 111.5 kB
  • Cancer, Apoptosis, Anti-tumor/Effects on Cell Viability.pdf 168.6 kB
  • Cancer, Apoptosis, Anti-tumor/Endocannabinoid system modulation in cancer biology and therapy.pdf 386.4 kB
  • Cancer, Apoptosis, Anti-tumor/Endocannabinoids as emerging suppressors of angiogenesis and breast tumor growth and metastatic spreading.pdf 2.4 MB
  • Cancer, Apoptosis, Anti-tumor/Endocannabinoids in endocrine and related tumours.pdf 314.8 kB
  • Cancer, Apoptosis, Anti-tumor/Endocannabinoids in the immune system and cancer.pdf 285.1 kB
  • Cancer, Apoptosis, Anti-tumor/Epidemiologic review of marijuana use and cancer risk.pdf 140.9 kB
  • Cancer, Apoptosis, Anti-tumor/Friend or foe- Role of peroxisome proliferator-activated receptor-V in human bladder cancer.pdf 208.6 kB
  • Cancer, Apoptosis, Anti-tumor/Functionally selective cannabinoid receptor signalling- Therapeutic implications and opportunities.pdf 544.0 kB
  • Cancer, Apoptosis, Anti-tumor/Gemcitabine-cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.pdf 870.2 kB
  • Cancer, Apoptosis, Anti-tumor/High Concentrations of Cannabinoids Activate Apoptosis in Human U373MG Glioma Cells.pdf 236.6 kB
  • Cancer, Apoptosis, Anti-tumor/HOW CBD MAY CAUSE CANCER CELLS TO DIE IN BRAIN tumors.pdf 58.3 kB
  • Cancer, Apoptosis, Anti-tumor/Identification and characterization of cannabinoids that induce cell death through mitochondrial permeability transition in Cannabis leaf cells.pdf 1.3 MB
  • Cancer, Apoptosis, Anti-tumor/INFLUENCE OF PYSCHOACTIVE AND NONPSYCHOACTIVE CANNABINOIDS ON CELL PROLIFERATION AND MACROMOLECULAR BIOSYNTHESIS IN HUMAN CELLS.pdf 1.2 MB
  • Cancer, Apoptosis, Anti-tumor/Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1.pdf 688.1 kB
  • Cancer, Apoptosis, Anti-tumor/Inhibition of colon carcinogenesis by a standardized Cannabis sativaextract with high content of cannabidiol.pdf 1.4 MB
  • Cancer, Apoptosis, Anti-tumor/Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 cannabinoid receptor.pdf 436.2 kB
  • Cancer, Apoptosis, Anti-tumor/Inhibition of human tumor prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015- Involvement of CB2.pdf 598.8 kB
  • Cancer, Apoptosis, Anti-tumor/Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(þ)-Methanandamide and JWH-015 - Involvement of CB2.pdf 557.2 kB
  • Cancer, Apoptosis, Anti-tumor/Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.pdf 281.4 kB
  • Cancer, Apoptosis, Anti-tumor/Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.pdf 3.4 MB
  • Cancer, Apoptosis, Anti-tumor/Is marihuana [THC] anti-carcinogenic.pdf 72.5 kB
  • Cancer, Apoptosis, Anti-tumor/Linking ER Stress to Autophagy - Potential Implications for Cancer Therapy.pdf 1.4 MB
  • Cancer, Apoptosis, Anti-tumor/Marijuana as a potential respiratory tract carcinogen - A retrospective analysis of a community.pdf 316.5 kB
  • Cancer, Apoptosis, Anti-tumor/Marijuana Smoke and D9-Tetrahydrocannabinol Promote Necrotic Cell Death but Inhibit Fas-Mediated Apoptosis.pdf 115.8 kB
  • Cancer, Apoptosis, Anti-tumor/Marijuana use and cancer incidence (California, USA).pdf 55.5 kB
  • Cancer, Apoptosis, Anti-tumor/Marijuana Use and Increased Risk of Squamous Cell carcinoma of the head and neck.pdf 124.6 kB
  • Cancer, Apoptosis, Anti-tumor/Marijuana use and oral cancer - a review.pdf 407.2 kB
  • Cancer, Apoptosis, Anti-tumor/Marijuana Use and Risk of Oral Squamous Cell Carcinoma.pdf 96.6 kB
  • Cancer, Apoptosis, Anti-tumor/Mechanism of cannabinoid-induced apoptosis p8-regulated genes.pdf 3.4 MB
  • Cancer, Apoptosis, Anti-tumor/Metabolism of Anandamide by COX-2 Is Necessary for Endocannabinoid-Induced Cell Death in Tumorigenic Keratinocytes.pdf 284.7 kB
  • Cancer, Apoptosis, Anti-tumor/Mitochondrial membrane depolarization and caspase dependent apoptosis induced by Cannabis sativa.pdf 1.2 MB
  • Cancer, Apoptosis, Anti-tumor/Modulation of D9THC-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.pdf 910.2 kB
  • Cancer, Apoptosis, Anti-tumor/Non-THC cannabinoids inhibit prostate carcinoma growth.pdf 3.1 MB
  • Cancer, Apoptosis, Anti-tumor/Non‐THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo - pro‐apoptotic effects and underlying mechanisms.pdf 3.1 MB
  • Cancer, Apoptosis, Anti-tumor/NORML - Cannabinoids as Cancer Hope.pdf 155.5 kB
  • Cancer, Apoptosis, Anti-tumor/NORML - Cannabis Smoke and Cancer - Assessing the Risk.pdf 236.5 kB
  • Cancer, Apoptosis, Anti-tumor/O-1602, an atypical cannabinoid, inhibits tumor growth in colitis associated colon cancer through multiple mechanisms.pdf 1.6 MB
  • Cancer, Apoptosis, Anti-tumor/Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.pdf 357.1 kB
  • Cancer, Apoptosis, Anti-tumor/p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukemia cells.pdf 290.1 kB
  • Cancer, Apoptosis, Anti-tumor/Pathways mediating the effects of CBD on the reduction of breast cancer cell proliferation, invasion, and metastasis.pdf 1.7 MB
  • Cancer, Apoptosis, Anti-tumor/Pot for the prostate.pdf 230.0 kB
  • Cancer, Apoptosis, Anti-tumor/Potential use of cannabimimetics in the treatment of cancer.pdf 2.3 MB
  • Cancer, Apoptosis, Anti-tumor/Preparation and Characterization of D9THC loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.pdf 787.2 kB
  • Cancer, Apoptosis, Anti-tumor/Prevention and treatment of cancer cachexia - New insights into an old problem.pdf 382.8 kB
  • Cancer, Apoptosis, Anti-tumor/Reactive oxygen species and p38 phosphorylation regulate the protective effect of D9THC in the apoptotic response to NMDA.pdf 166.7 kB
  • Cancer, Apoptosis, Anti-tumor/Relative involvement of cannabinoid CB and CB receptors in the D9THC -induced inhibition of natural killer activity.pdf 220.9 kB
  • Cancer, Apoptosis, Anti-tumor/Risk of Lung Cancer and Past Use of Cannabis in Tunisia.pdf 49.4 kB
  • Cancer, Apoptosis, Anti-tumor/Role of PI3K-AKT-mTOR signaling in the cell cycle progression of human prostate cancer.pdf 434.3 kB
  • Cancer, Apoptosis, Anti-tumor/Saikosaponin-d Enhances the Anticancer Potency of TNF-𝛼 via Overcoming Its Undesirable Response of Activating NF-Kappa B signalling in cancer cells.pdf 3.7 MB
  • Cancer, Apoptosis, Anti-tumor/Spontaneous regression of septum pellucidum-forniceal pilocytic astrocytomas - possible role of Cannabis inhalation.pdf 609.1 kB
  • Cancer, Apoptosis, Anti-tumor/Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death.pdf 784.8 kB
  • Cancer, Apoptosis, Anti-tumor/Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by D9THC.pdf 384.8 kB
  • Cancer, Apoptosis, Anti-tumor/Structure-dependent inhibitory effects of synthetic cannabinoids against ... induced inflammation and skin tumour promotion in mice.pdf 531.2 kB
  • Cancer, Apoptosis, Anti-tumor/Suppression of Certain Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation.pdf 568.2 kB
  • Cancer, Apoptosis, Anti-tumor/Suppression of Nerve Growth Factor Trk Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation.pdf 561.6 kB
  • Cancer, Apoptosis, Anti-tumor/Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.pdf 1.3 MB
  • Cancer, Apoptosis, Anti-tumor/Targeting cannabinoid receptors to treat leukemia - Role of cross-talk between extrinsic and intrinsic pathways in THC-induced apoptosis of Jurkat cells.pdf 282.5 kB
  • Cancer, Apoptosis, Anti-tumor/Targeting endocannabinoids signaling in tumor-associated macrophages as treatment for glioblastoma multiforme.pdf 315.7 kB
  • Cancer, Apoptosis, Anti-tumor/Targeting the endocannabinoid system in cancer therapy - A call for further research.pdf 188.3 kB
  • Cancer, Apoptosis, Anti-tumor/TETRAHYDROCANNABINOL INCREASES C6 GLIOMA CELL DEATH PRODUCED BY OXIDATIVE STRESS.pdf 411.0 kB
  • Cancer, Apoptosis, Anti-tumor/Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation.pdf 51.5 kB
  • Cancer, Apoptosis, Anti-tumor/Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation.pdf 551.1 kB
  • Cancer, Apoptosis, Anti-tumor/THC inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.pdf 276.9 kB
  • Cancer, Apoptosis, Anti-tumor/The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism.pdf 402.2 kB
  • Cancer, Apoptosis, Anti-tumor/The cannabinoid D9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.pdf 311.7 kB
  • Cancer, Apoptosis, Anti-tumor/The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.pdf 769.0 kB
  • Cancer, Apoptosis, Anti-tumor/The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model.pdf 2.3 MB
  • Cancer, Apoptosis, Anti-tumor/The Dual Effects of THC on cholangiocarcinoma cells- Anti-invasion activity at low concentration and Apoptosis Induction at high concentration.pdf 499.1 kB
  • Cancer, Apoptosis, Anti-tumor/The endocannabinoid signaling system in cancer.pdf 1.5 MB
  • Cancer, Apoptosis, Anti-tumor/The endocannabinoid system and cancer - therapeutic implication.pdf 1.3 MB
  • Cancer, Apoptosis, Anti-tumor/The endocannabinoid system in cancer—Potential therapeutic target.pdf 476.6 kB
  • Cancer, Apoptosis, Anti-tumor/The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.pdf 309.5 kB
  • Cancer, Apoptosis, Anti-tumor/The endocannabinoid system- A new entry in remote cell death mechanisms.pdf 856.2 kB
  • Cancer, Apoptosis, Anti-tumor/The endocannabinoids system and cancer - therapeutic implication.pdf 1.2 MB
  • Cancer, Apoptosis, Anti-tumor/The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.pdf 268.2 kB
  • Cancer, Apoptosis, Anti-tumor/The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells.pdf 214.5 kB
  • Cancer, Apoptosis, Anti-tumor/The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas.pdf 1.5 MB
  • Cancer, Apoptosis, Anti-tumor/The intersection between cannabis and cancer in the United States.pdf 169.6 kB
  • Cancer, Apoptosis, Anti-tumor/The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells.pdf 391.6 kB
  • Cancer, Apoptosis, Anti-tumor/The role of cannabinoids in prostate cancer- Basic science perspective and potential clinical applications.pdf 310.5 kB
  • Cancer, Apoptosis, Anti-tumor/The role of COX-2 in intestinal inflammation and colorectal cancer.pdf 385.4 kB
  • Cancer, Apoptosis, Anti-tumor/The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.pdf 987.8 kB
  • Cancer, Apoptosis, Anti-tumor/The tumour suppressor protein, p53, is involved in the activation of the apoptotic cascade by D9THC in cultured cortical neurons.pdf 635.8 kB
  • Cancer, Apoptosis, Anti-tumor/Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients- systematic review and meta-analysis.pdf 241.5 kB
  • Cancer, Apoptosis, Anti-tumor/Towards the use of non-psychoactive cannabinoids for prostate cancer.pdf 152.3 kB
  • Cancer, Apoptosis, Anti-tumor/TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action.pdf 664.8 kB
  • Cancer, Apoptosis, Anti-tumor/Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer.pdf 407.2 kB
  • Cancer, Apoptosis, Anti-tumor/Update on the endocannabinoid system as an anticancer target.pdf 270.9 kB
  • Cancer, Apoptosis, Anti-tumor/Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.pdf 188.1 kB
  • Cancer, Apoptosis, Anti-tumor/WIN 55,212-2 Sensitizes Hepatocellular Carcinoma Cells to ... death receptor 5 axis.pdf 2.2 MB
  • Cancer, Apoptosis, Anti-tumor/Δ9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria.pdf 1.3 MB
  • Cannabidiol (CBD) ameliorates cognitive impairments associated with a model of chronic liver disease in mice.pdf 44.3 kB
  • Cannabidiol - an overview of some chemical and pharmacological aspects. Part I - chemical aspects.pdf 244.7 kB
  • Cannabidiol - from an inactive cannabinoid to a drug with a wide spectrum of action.pdf 682.3 kB
  • Cannabidiol - transdermal delivery and anti-inflammatory effect in a murine model.pdf 1.8 MB
  • Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells.pdf 817.4 kB
  • Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation.pdf 319.3 kB
  • Cannabidiol and Cannabinol in Man.pdf 374.6 kB
  • Cannabidiol and Cannabol, Constituents of Cannabis indica Resin.pdf 136.4 kB
  • Cannabidiol arrests onset of autoimmune diabetes in NOD mice.pdf 500.2 kB
  • Cannabidiol as a potential treatment for psychosis.pdf 769.4 kB
  • Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.pdf 485.6 kB
  • Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy.pdf 940.0 kB
  • Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.pdf 534.3 kB
  • Cannabidiol attenuates the appetitive effects of THC in humans smoking their chosen cannabis.pdf 362.5 kB
  • Cannabidiol decreases body weight gain in rats- Involvement of CB2 receptors.pdf 258.4 kB
  • Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo.pdf 1.3 MB
  • Cannabidiol e an Innovative Strategy for Graft Versus Host Disease Prevention e an Update of a Phase I-II Study.pdf 339.4 kB
  • Cannabidiol enhances consolidation of explicit fear extinction in humans.pdf 430.9 kB
  • Cannabidiol for neurodegenerative disorders- important new clinical applications for this phytocannabinoid.pdf 988.9 kB
  • Cannabidiol for the treatment of psychosis in Parkinson's disease.pdf 109.9 kB
  • Cannabidiol in dystonic movement disorders.pdf 83.0 kB
  • Cannabidiol in Humans—The Quest for Therapeutic Targets.pdf 313.6 kB
  • Cannabidiol in Medicine - A Review of its therapuetic potential in CNS disorders.pdf 84.0 kB
  • Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL-6 mice.pdf 2.3 MB
  • Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.pdf 1.1 MB
  • Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.pdf 290.6 kB
  • Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19 (38 pages).pdf 1.6 MB
  • Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19 (7 pages).pdf 995.5 kB
  • Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.pdf 196.2 kB
  • Cannabidiol potentiates pharmacological effects of D9THC via CB1 receptor-dependent mechanism.pdf 407.3 kB
  • Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism.pdf 442.6 kB
  • Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.pdf 412.4 kB
  • Cannabidiol protects against hepatic ischemia - reperfusion injury by attenuating inflammatory signaling and response, oxidative - nitrative stress, and cell death.pdf 2.9 MB
  • Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis.pdf 399.1 kB
  • Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain- an intravital microscopy study.pdf 804.5 kB
  • Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients.pdf 402.9 kB
  • Cannabidiol reverses the reduction in social interaction produced by low dose D9THC in rats.pdf 415.1 kB
  • Cannabidiol – Recent Advances.pdf 115.1 kB
  • Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.pdf 7.0 MB
  • Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats.pdf 797.5 kB
  • Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis.pdf 504.3 kB
  • Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.pdf 158.6 kB
  • Cannabidiol- from an inactive cannabinoid to a drug with wide spectrum of action.pdf 5.3 MB
  • Cannabidiol- A Promising Drug for Neurodegenerative Disorders.pdf 209.3 kB
  • Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis.pdf 271.5 kB
  • Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa.pdf 815.4 kB
  • Cannabidivarin is anticonvulsant in mouse and rat.pdf 1.4 MB
  • CANNABIELSOIC ACIDS ISOLATION AND SYNTHESIS BY A NOVEL OXIDATIVE CYCLIZATION.pdf 848.0 kB
  • Cannabimimetic Activity of Cannabidiol Monomethyl Ether and Two Stereoisomeric Hexahydrocannabinols in rats and pigeons.pdf 617.4 kB
  • Cannabinoid 2 receptor-and beta Arrestin 2-depressant upregulation of serotonin.pdf 575.0 kB
  • Cannabinoid Action Depends on Phosphorylation of Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa at the Protein Kinase A Site in Striatal Projection Neurons.pdf 463.6 kB
  • Cannabinoid activation of peroxisome proliferator-activated receptors- Potential for modulation of inflammatory disease.pdf 181.0 kB
  • Cannabinoid activation of PPARa; a novel neuroprotective mechanism.pdf 208.8 kB
  • Cannabinoid Addiction - Behavioral Models and Neural Correlates.pdf 173.3 kB
  • Cannabinoid Agonist Signal Transduction in Rat Brain - Comparison of Cannabinoid Agonists in Receptor Binding, G-Protein Activation, and Adenylyl Cyclase Inhibition.pdf 164.6 kB
  • Cannabinoid agonists attenuate capsaicin-induced responses in human skin.pdf 126.9 kB
  • Cannabinoid agonists increase the interaction between Arrestin 2 and ERK1-2 and upregulate B-Arrestin 2 and 5-HT2A receptors.pdf 1.5 MB
  • Cannabinoid analgesia.pdf 243.8 kB
  • Cannabinoid Biology - The search for new therapeutic targets.pdf 671.8 kB
  • Cannabinoid CB1 receptor antagonists for atherosclerosis and cardiometabolic Disorders - New Hopes, Old Concerns.pdf 635.8 kB
  • Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice- The role of serotonin and different forebrain neuronal subpopulations.pdf 644.2 kB
  • Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia-reperfusion model.pdf 202.3 kB
  • Cannabinoid CB2 receptor- a new target for controlling neural cell survival.pdf 672.2 kB
  • Cannabinoid CB2 receptors in human brain inflammation.pdf 157.1 kB
  • Cannabinoid CB2 receptors- Immunohistochemical localization in rat brain.pdf 1.5 MB
  • Cannabinoid Conference 2011 - IACM 6th Conference on Cannabinoids in Medicine and 5th European Workshop on Cannabinoid Research.pdf 11.9 MB
  • Cannabinoid control of neuroinflammation related to multiple sclerosis.pdf 247.5 kB
  • Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.pdf 1.1 MB
  • Cannabinoid ester constituents from high-potency Cannabis sativa.pdf 120.3 kB
  • Cannabinoid facilitation of behavioral and biochemical hedonic taste responses.pdf 379.0 kB
  • Cannabinoid facilitation of fear extinction memory recall in humans.pdf 366.1 kB
  • Cannabinoid Function in Learning, Memory and Plasticity.pdf 257.0 kB
  • Cannabinoid hyperemesis acute renal failure - a common sequela of cannabinoid hyperemesis syndrome.pdf 179.2 kB
  • Cannabinoid hyperemesis syndrome with extreme hydrophilia.pdf 379.5 kB
  • Cannabinoid Hyperemesis Syndrome.pdf 932.4 kB
  • Cannabinoid inhibition of adenylate cyclase - relative activity of constituents and metabolites of marihuana.pdf 741.2 kB
  • Cannabinoid Inhibition of Adenylate Cyclase Pharmacology of the Response in Neuroblastoma Cell Membranes.pdf 1.4 MB
  • Cannabinoid Inhibition of Adenylate Cyclase Pharmacology of the Response inNeuroblastoma Cell Membranes.pdf 1.4 MB
  • Cannabinoid modulation of executive functions.pdf 199.1 kB
  • Cannabinoid Modulation of Neuroinflammatory Disorders.pdf 506.3 kB
  • Cannabinoid modulation of neuronal function after oxygen-glucose deprivation in area CA1 of the rat hippocampus.pdf 567.7 kB
  • Cannabinoid modulation of noradrenergic circuits- Implications for psychiatric disorders.pdf 643.0 kB
  • Cannabinoid modulation of prefrontal–limbic activation during fear extinction learning and recall in humans.pdf 1.1 MB
  • Cannabinoid modulation of the dopaminergic circuitry- Implications for limbic and striatal output.pdf 1.6 MB
  • Cannabinoid pharmacology - the first 66 years.pdf 186.4 kB
  • Cannabinoid pharmacology- implications for additional cannabinoid receptor subtypes.pdf 119.9 kB
  • Cannabinoid physiology and pharmacology- 30 years of progress.pdf 520.1 kB
  • Cannabinoid rearrangements - Synthesis of Δ5-tetrahydrocannabinol.pdf 410.5 kB
  • Cannabinoid receptor 2 - Potential role in immunomodulation.pdf 1.8 MB
  • Cannabinoid receptor activation reduces TNFa-Induced surface localization of AMPAR-type glutamate receptors and excitotoxicity.pdf 783.4 kB
  • Cannabinoid receptor antagonists - pharmacological opportunities, clinical experience, and translational prognosis.pdf 539.1 kB
  • Cannabinoid Receptor CB1 Antagonists - State of the Art and Challenges.pdf 387.4 kB
  • Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory system.pdf 1.9 MB
  • Cannabinoid Receptor CB2 Modulates Axon Guidance.pdf 1.7 MB
  • CANNABINOID RECEPTOR GENES.pdf 2.3 MB
  • Cannabinoid receptor ligands - clinical and neuropharmacological considerations, relevant to future drug discovery and development.pdf 222.3 kB
  • Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies.pdf 422.7 kB
  • Cannabinoid receptor ligands review.pdf 511.2 kB
  • Cannabinoid receptor signaling in progenitor- stem cell proliferation and differentiation.pdf 3.8 MB
  • Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.pdf 695.2 kB
  • Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch.pdf 2.7 MB
  • Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck.pdf 1.3 MB
  • Cannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma.pdf 808.3 kB
  • Cannabinoid Receptors - Where They are and What They do.pdf 139.0 kB
  • Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — a short review.pdf 398.3 kB
  • Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures- a short review.pdf 318.9 kB
  • Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation.pdf 344.7 kB
  • Cannabinoid Receptors and Their Endogenous Agonist, Anandamide.pdf 1.2 MB
  • CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS.pdf 127.2 kB
  • Cannabinoid receptors and their ligands.pdf 372.4 kB
  • Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis.pdf 251.9 kB
  • Cannabinoid receptors in acute and chronic complications of atherosclerosis.pdf 171.5 kB
  • Cannabinoid receptors- nomenclature and pharmacological principles.pdf 819.0 kB
  • Cannabinoid signalling regulates inflammation and energy balance- The importance of the gut-brain axis.pdf 494.9 kB
  • Cannabinoid signalling.pdf 268.7 kB
  • Cannabinoid Structure-Activity Relationships - Correlation of Receptor Binding and in Vivo Activities.pdf 2.0 MB
  • Cannabinoid system in the skin – a possible target for future therapies in dermatology.pdf 398.3 kB
  • Cannabinoid Tolerance and Dependence.pdf 233.5 kB
  • Cannabinoid-2 receptor mediates protection against hepatic ischemia-reperfusion injury.pdf 1.2 MB
  • Cannabinoid-Based Medicines for Neurological disorders - clinical evidence.pdf 116.0 kB
  • Cannabinoid-Based Medicines for Neurological.pdf 116.0 kB
  • Cannabinoid-induced alterations in brain disposition of drugs of abuse.pdf 642.3 kB
  • Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.pdf 363.3 kB
  • Cannabinoid-induced effects on the nociceptive system - a neurophysiological study in patients with secondary progressive multiple sclerosis.pdf 217.4 kB
  • Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex. Franklin 2012.pdf 1.3 MB
  • Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.pdf 1.3 MB
  • Cannabinoid-Induced Hyperemesis - A conundrum - From Clinical Recognition to Basic Science Mechanisms.pdf 118.4 kB
  • Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.pdf 783.8 kB
  • Cannabinoid.pdf 1.2 MB
  • Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets.pdf 908.5 kB
  • Cannabinoids activate an inwardly rectifying Potassium conductance and inhibit Q-Type Calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.pdf 2.2 MB
  • Cannabinoids Alter Spontaneous Firing, Bursting, and Cell Synchrony of Hippocampal Principal Cells.pdf 1.8 MB
  • Cannabinoids Ameliorate Impairments Induced by Chronic Stress to Synaptic Plasticity and Short-Term Memory.pdf 2.6 MB
  • Cannabinoids and appetite - Food craving and food pleasure.pdf 140.0 kB
  • Cannabinoids and Appetite Stimulation.pdf 1.1 MB
  • Cannabinoids and brain injury – therapeutic implications.pdf 76.4 kB
  • Cannabinoids and Brain Injury- Therapeutic Implications.pdf 80.4 kB
  • Cannabinoids and cardiometabolic risk.pdf 76.7 kB
  • Cannabinoids and ceramide Two lipids acting hand-by-hand.pdf 174.5 kB
  • CANNABINOIDS AND EMOTIONALITY - A NEUROANATOMICAL PERSPECTIVE.pdf 355.5 kB
  • Cannabinoids and experimental models of multiple sclerosis.pdf 283.5 kB
  • Cannabinoids and glaucoma.pdf 190.9 kB
  • Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.pdf 277.4 kB
  • Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase.pdf 325.4 kB
  • Cannabinoids and multiple sclerosis.pdf 138.7 kB
  • Cannabinoids and neuroinflammation.pdf 233.2 kB
  • Cannabinoids and neuronal damage- Differential effects of THC, AEA and 2-AG on ....pdf 2.0 MB
  • Cannabinoids and neuroprotection in CNS inflammatory disease.pdf 103.2 kB
  • CANNABINOIDS AND PSYCHOSIS- PHARMACOLOGICAL STUDIES WITH IV D9THC in humans.pdf 134.0 kB
  • Cannabinoids and the gut- New developments and emerging concepts.pdf 539.1 kB
  • Cannabinoids and the immune system- An overview.pdf 244.6 kB
  • Cannabinoids and the immune system- Potential for the treatment of inflammatory disease.pdf 312.6 kB
  • Cannabinoids and their actions.pdf 52.5 kB
  • Cannabinoids and their medicinal potential.pdf 432.2 kB
  • Cannabinoids and Viral Infections.pdf 129.9 kB
  • Cannabinoids as therapeutic agents in cardiovascular disease- a tale of passions and illusions.pdf 178.9 kB
  • Cannabinoids as Therapeutics.pdf 2.1 MB
  • Cannabinoids down-regulate PI3K-Akt and Erk signalling pathways and activate proapoptotic function of Bad protein.pdf 925.9 kB
  • Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.pdf 217.8 kB
  • Cannabinoids for control of chemotherapy induced nausea and vomiting - quantitative systematic review.pdf 189.1 kB
  • Cannabinoids for Medicinal Applications in the United States.pdf 161.0 kB
  • Cannabinoids for the pharmaceutical industry.pdf 238.2 kB
  • Cannabinoids for the treatment of dementia (Review).pdf 225.8 kB
  • Cannabinoids for Therapeutic Use - Designing Systems to Increase Efficacy and Reliability.pdf 164.4 kB
  • Cannabinoids in bipolar affective disorder - a review and discussion of their therapeutic potential.pdf 257.7 kB
  • Cannabinoids in Clinical Practice.pdf 147.4 kB
  • Cannabinoids in disguise- D9THC-like effects of tetramethylcyclopropyl ketone indoles.pdf 579.4 kB
  • Cannabinoids in health and disease.pdf 265.9 kB
  • Cannabinoids in medicine- A review of their therapeutic potential.pdf 416.4 kB
  • Cannabinoids in Models of Chronic Inflammatory Conditions.pdf 244.4 kB
  • Cannabinoids in multiple sclerosis - do they have a therapeutic role.pdf 116.6 kB
  • Cannabinoids in neurodegeneration and neuroprotection.pdf 218.8 kB
  • Cannabinoids in oral fluid following passive exposure to marijuana smoke.pdf 203.6 kB
  • Cannabinoids in the treatment of glaucoma.pdf 362.5 kB
  • Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons- Implications for Huntington's disease.pdf 1.3 MB
  • Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons- Implications for Huntington’s disease.pdf 1.3 MB
  • Cannabinoids inhibit human keratinocyte proliferation through a non-CB1 - CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.pdf 286.0 kB
  • Cannabinoids Inhibit N- and P,Q-Type Calcium Channels in Cultured Rat Hippocampal Neurons.pdf 337.3 kB
  • Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.pdf 843.0 kB
  • Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.pdf 470.8 kB
  • Cannabinoids mediate inflammation-induced intestinal permeability.pdf 1.2 MB
  • Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.pdf 1.2 MB
  • Cannabinoids of diverse structure inhibit two DOI-induced 5-HT2A receptor-mediated behaviors in mice.pdf 354.2 kB
  • Cannabinoids on the Brain.pdf 1.5 MB
  • Cannabinoids Promote Oligodendrocyte Progenitor Survival- Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase-Akt Signaling.pdf 1.1 MB
  • Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro - Relevance to Parkinson’s disease.pdf 266.4 kB
  • Cannabinoids, endogenous ligands and synthetic analogs.pdf 828.0 kB
  • CANNABINOIDS, HIPPOCAMPAL FUNCTION AND MEMORY.pdf 863.8 kB
  • Cannabinoids. 3 Synthetic Approaches to 9-Ketocannabinoids..pdf 1.1 MB
  • Cannabinoids.pdf 6.8 MB
  • Cannabinol Derivatives - Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase.pdf 231.1 kB
  • Cannabis (hemp) positive skin tests and respiratory symptoms.pdf 150.1 kB
  • Cannabis (Marijuana) — Effects on Human behavior and performance.pdf 212.3 kB
  • Cannabis - a controversial 21st century drug of antiquity.pdf 4.7 MB
  • Cannabis - A MEDICAL DICTIONARY, BIBLIOGRAPHY, AND ANNOTATED RESEARCH GUIDE TO INTERNET REFERENCES.pdf 1.0 MB
  • Cannabis - A Short Review Cannabis - Its Use, Functions, and Prevalence.pdf 514.8 kB
  • Cannabis - a trigger for acute myocardial infarction - a case report.pdf 78.4 kB
  • Cannabis - a trigger for acute myocardial infarction. A case report.pdf 78.4 kB
  • Cannabis - Effects of consumption on health.pdf 500.3 kB
  • Cannabis - Effects on Hunger and Thirst.pdf 1.8 MB
  • Cannabis - Forgetting and the Botany of Desire.pdf 361.1 kB
  • Cannabis - from cultivar to chemovar.pdf 308.6 kB
  • Cannabis - Our position for a Canadian public policy - Cannabis report on the Senate special committee on illegal drugs.pdf 3.2 MB
  • Cannabis - pharmacology and toxicology in animals and humans.pdf 2.5 MB
  • CANNABIS - The Genus Cannabis.pdf 2.4 MB
  • Cannabis abuse and serious suicide attempts.pdf 157.0 kB
  • Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.pdf 134.0 kB
  • Cannabis abuse in adolescence and the risk of psychosis- A brief review of the preclinical evidence.pdf 341.8 kB
  • Cannabis Activists Handbook.pdf 4.0 MB
  • Cannabis acute and chronic effects – the dutch experience.pdf 45.8 kB
  • Cannabis affects people differently – intersubject variation in the psychotogenic effects of D9THC - a functional magnetic resonance imaging study with healthy volunteers.pdf 845.0 kB
  • Cannabis Alleviates Symptoms Of Crohn’s Disease.pdf 245.2 kB
  • Cannabis and Amyotrophic Lateral Sclerosis - Hypothetical and Practical Applications, and a Call for Clinical Trials.pdf 158.8 kB
  • Cannabis and anxiety- a critical review of the evidence.pdf 112.2 kB
  • Cannabis and Breastfeeding.pdf 87.5 kB
  • Cannabis and cancer chemotherapy - A comparison of oral delta-9-thc and prochlorperazine.pdf 951.6 kB
  • Cannabis and cannabinoid receptors.pdf 263.7 kB
  • Cannabis and Cannabinoids - Pharmacology and Rationale for Clinical Use.pdf 692.4 kB
  • Cannabis and Cannabis Extracts- Greater Than the Sum of Their Parts.pdf 179.5 kB
  • CANNABIS AND COGNITIVE FUNCTIONING.pdf 24.2 MB
  • Cannabis and D9-tetrahydrocannabinol (THC) for weight loss.pdf 131.7 kB
  • Cannabis and D9THC for weight loss.pdf 153.9 kB
  • CANNABIS AND DAMAGE TO HEALTH - Toxicological aspects, neuropsychological, medical, social and address lines for the prevention.pdf 21.1 MB
  • Cannabis and depression- An integrative data analysis of four Australasian cohorts.pdf 446.3 kB
  • Cannabis and driving - A new perspective.pdf 196.6 kB
  • Cannabis and driving skills.pdf 399.6 kB
  • Cannabis and driving- Results from a general population survey.pdf 202.9 kB
  • Cannabis and driving- the use of LC–MS to detect D9THC in oral fluid samples.pdf 113.3 kB
  • Cannabis and endogenous cannabinoid systems.pdf 222.5 kB
  • Cannabis and Harm Reduction - a nursing perspective.pdf 95.3 kB
  • Cannabis and Insomnia.pdf 1.0 MB
  • Cannabis and Its Derivatives - Review of Medical Use.pdf 95.5 kB
  • Cannabis and Motor Function- fMRI Changes Following 28 Days of Discontinuation.pdf 497.0 kB
  • Cannabis and myocardial infarction without angiographic stenosis in young patient- guilty or not guilty- A case report.pdf 321.4 kB
  • Cannabis and Natural Cannabis Medicines.pdf 2.6 MB
  • Cannabis and sleep - A complex and unfinished story.pdf 272.8 kB
  • Cannabis and the Brain - A user's guide.pdf 147.3 kB
  • Cannabis and the brain.pdf 223.4 kB
  • Cannabis and the developing brain- Insights from behavior.pdf 315.6 kB
  • Cannabis Arteritis Revisited - Ten New Case Reports.pdf 770.3 kB
  • Cannabis as a precipitant of cardiovascular emergencies.pdf 66.5 kB
  • Cannabis as a Substitute for Alcohol - A Harm-Reduction Approach.pdf 81.2 kB
  • Cannabis as a substitute for alcohol and other drugs - A dispensary-based survey of substitution effect in Canadian medical cannabis patients.pdf 147.4 kB
  • Cannabis as a substitute for alcohol and other drugs.pdf 177.3 kB
  • Cannabis as medicine - time for the phoenix to rise.pdf 143.5 kB
  • Cannabis Based Medicines- GW Pharmaceuticals High CBD, High THC, Medicinal Cannabis – GW Pharmaceuticals, THC - CBD ratio.pdf 162.9 kB
  • Cannabis Britannica - A History of the Present.pdf 111.7 kB
  • Cannabis careers revisited- Applying Howard S. Becker’s theory to present-day cannabis use.pdf 270.1 kB
  • Cannabis consumption initiation among adolescents- A longitudinal study.pdf 240.9 kB
  • Cannabis cue-elicited craving and the reward neurocircuitry.pdf 666.8 kB
  • Cannabis cue-induced brain activation correlateswith drug craving in limbic and visual salience regions- Preliminary results.pdf 1.6 MB
  • Cannabis Dependence Its Nature - Consequences and Treatment.pdf 1.3 MB
  • Cannabis dependence, cognitive control and attentional bias for cannabis words.pdf 439.2 kB
  • Cannabis derivatives therapy for a seronegative stiff-person syndrome - a case report.pdf 473.4 kB
  • Cannabis Effects on Driving Skills.pdf 128.1 kB
  • Cannabis exposure associated with weight reduction and B-cell protection in an obese rat model.pdf 885.9 kB
  • Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philedelphia chromosome mutation.pdf 961.4 kB
  • Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008.pdf 378.9 kB
  • Cannabis for dyskinesia in Parkinson disease - a randomized double-blind crossover study.pdf 323.2 kB
  • Cannabis hope for inflammatory bowel disease.pdf 14.3 kB
  • Cannabis improves symptoms of ADHD.pdf 158.9 kB
  • Cannabis in acute migraine treatment project - Response to NIH Critique - Ethan Russo, M.D..pdf 345.5 kB
  • Cannabis in France during XIXth century- A medical history.pdf 1.3 MB
  • Cannabis in India - ancient lore and modern medicine.pdf 137.6 kB
  • Cannabis in Movement Disorders.pdf 80.0 kB
  • Cannabis in the Treatment of Alcoholism.pdf 265.3 kB
  • CANNABIS INDICA - AN HISTORICAL AND PHARMACOLOGICAL STUDY OF THE DRUG.pdf 512.3 kB
  • Cannabis indica - Part 5 - The synthesis of cannabinol.pdf 378.1 kB
  • Cannabis indica, a study.pdf 242.6 kB
  • Cannabis induced acute coronary syndrome in a young female.pdf 811.3 kB
  • Cannabis is more than simply D9THC.pdf 97.5 kB
  • Cannabis law reform in Western Australia - an opportunity to test theories of marginal deterrence and legitimacy.pdf 102.0 kB
  • Cannabis Oil- chemical evaluation of an upcoming cannabis-based medicine.pdf 778.8 kB
  • Cannabis pests.pdf 153.0 kB
  • Cannabis policies and user practices- Market separation, price, potency, and accessibility in Amsterdam and San Francisco.pdf 186.9 kB
  • Cannabis Policy, Implementation and Outcomes.pdf 861.6 kB
  • Cannabis potency and contamination - a review of the literature.pdf 111.7 kB
  • Cannabis prices and dynamics of cannabis use.pdf 300.5 kB
  • Cannabis Responsive Head Injury Induced Mutiple Disabilities- A Case Report.pdf 354.2 kB
  • Cannabis sativa - an optimization study for ROI.pdf 2.9 MB
  • Cannabis sativa L. - Effect of drying time and temperature on cannabinoid profile of stored leaf tissue.docx 28.9 kB
  • Cannabis sativa L. - Effect of drying time and temperature on cannabinoid profile of stored leaf tissue.pdf 306.2 kB
  • Cannabis sativa products- current situation and prospects in medicine.pdf 1.2 MB
  • Cannabis sativa- An ancient wild edible plant of India.pdf 182.4 kB
  • Cannabis Smoke Condensate I- The Effect of Different preparation methods on THC levels.pdf 208.8 kB
  • Cannabis smoke condensate III- The cannabinoid content of vaporised Cannabis sativa.pdf 698.8 kB
  • Cannabis smoking and acute coronary syndrome - Two illustrative cases.pdf 661.2 kB
  • Cannabis substitution - An adjunctive therapeutic tool in the treatment of alcoholism.pdf 43.6 kB
  • Cannabis supply into and within Australia.pdf 214.3 kB
  • Cannabis tea revisited - A systematic evaluation of the cannabinoid composition of cannabis tea.pdf 376.6 kB
  • Cannabis Treatments in obstetrics and gynecology - a historical overview.pdf 181.2 kB
  • Cannabis use amongst patients with inflammatory bowel disease.pdf 161.3 kB
  • Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls.pdf 249.9 kB
  • Cannabis use and bipolar disorder - Search for association through a review of literature.pdf 193.9 kB
  • Cannabis use and cannabis use disorders and their relationship to mental disorders- A 10-year prospective-longitudinal community study in adolescents.pdf 474.5 kB
  • Cannabis use and cardiovascular complications - are we aware enough.pdf 335.6 kB
  • Cannabis use and delinquent behaviors in a non-clinical sample of adolescents.pdf 137.0 kB
  • Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence- A TRAILS study.pdf 270.7 kB
  • Cannabis use and expression of mania in the general population.pdf 149.3 kB
  • Cannabis use and mental health-related quality of life among individuals with anxiety disorders.pdf 373.4 kB
  • CANNABIS USE AND MISUSE.pdf 854.8 kB
  • Cannabis use and related harms in the transition to young adulthood- A longitudinal study of Australian secondary school students.pdf 246.9 kB
  • Cannabis use and risk of psychotic or affective mental health outcomes- a systematic review.pdf 249.0 kB
  • Cannabis use and suicidal ideation.pdf 550.1 kB
  • Cannabis use before age 15 and subsequent executive functioning.pdf 323.5 kB
  • CANNABIS USE DISORDER TREATMENT AND ASSOCIATED HEALTH CARE COSTS IN NEW SOUTH WALES, 2007.pdf 1.4 MB
  • Cannabis use disorders are comparatively prevalent among nonwhite racial-ethnic groups and adolescents- A national study.pdf 372.4 kB
  • Cannabis use during a voluntary quit attempt- An analysis from ecological momentary assessment.pdf 593.6 kB
  • Cannabis use in a Swiss male prison- Qualitative study exploring detainees’ and staffs’ perspectives.pdf 592.0 kB
  • Cannabis use in adolescents.pdf 192.1 kB
  • Cannabis use in patients with fibromyalgia - effect on symptoms relief and health-related quality of life.pdf 107.1 kB
  • Cannabis use in sickle cell disease - a questionnaire study.pdf 74.7 kB
  • Cannabis use in Spanish patients with multiple sclerosis- Fulfilment of patients' expectations.pdf 159.4 kB
  • CANNABIS USE IN THE UNITED STATES - IMPLICATIONS FOR POLICY.pdf 465.4 kB
  • Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers.pdf 231.1 kB
  • Cannabis Use is Quantitatively Adssociated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users.pdf 545.3 kB
  • Cannabis Use Motives and Personality Risk Factors.pdf 312.8 kB
  • Cannabis use, cognition and brain structure in first-episode psychosis.pdf 283.8 kB
  • Cannabis use, cognitive performance and mood in a sample of workers.pdf 140.5 kB
  • Cannabis users have higher premorbid IQ than other patients with first onset psychosis.pdf 286.1 kB
  • Cannabis versus THC - response to Russo and McPartland.pdf 95.4 kB
  • Cannabis with high cannabidiol content is associated with fewer psychotic experiences.pdf 374.4 kB
  • Cannabis with high D9THC contents affects perception and visual selective attention acutely. An event-related potential study.pdf 555.9 kB
  • Cannabis with high Δ9-THC contents affects perception and visual selective attention acutely - An event-related potential study.pdf 553.6 kB
  • Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients.pdf 351.1 kB
  • Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.pdf 209.1 kB
  • Cannabis Yields and Dosage - A guide to the production and use of medical marijuana.pdf 1.5 MB
  • Cannabis, 1977.pdf 7.1 MB
  • Cannabis, a complex plant - different compounds and different effects on individuals.pdf 1.5 MB
  • Cannabis, cannabinoids and reproduction.pdf 213.8 kB
  • Cannabis, possible cardiac deaths and the coroner in Ireland.pdf 135.0 kB
  • Cannabis, road traffic, and work right - Medicine - Politics (non-english).pdf 2.1 MB
  • Cannabis-Associated Arterial Disease.pdf 231.4 kB
  • Cannabis-based medicines in multiple sclerosis – A review of clinical studies.pdf 418.6 kB
  • CANNABIS-INDUCED BRAIN ISCHEMIA.pdf 63.8 kB
  • Cannabis-induced cerebral and myocardial infarction in a young woman.pdf 189.6 kB
  • Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man.pdf 249.9 kB
  • Cannabis-induced cytotoxicity in leukemic cell lines- the role of the cannabinoid receptors and the MAPK pathway.pdf 415.8 kB
  • Cannabis-related impairment and social anxiety- The roles of gender and cannabis use motives.pdf 251.8 kB
  • Cannabis.pdf 103.7 kB
  • Cannabis.rar 11.0 GB
  • Cannabis.zip 11.2 GB
  • Cannabis; adverse effects from an oromucosal spray.pdf 424.9 kB
  • Cannabis; extracting the medicine.pdf 14.8 MB
  • Cannabisol, a novel D9-THC dimer possessing a unique methylene bridge, isolated from Cannabis sativa.pdf 616.4 kB
  • Cannabiss use and risk of psychotic or affective mental health outcomes - a systematic review.pdf 233.1 kB
  • CANNABUNOID LEVEL IN THE LEAVES AS A TOOL FOR THE EARLY discrimination of Cannabis chemovariants.pdf 460.8 kB
  • Capitalism Plus Dope Equals Genocide [1970] - By Michael Cetewayo Tabor (Political Prisoner, NY 21).pdf 209.1 kB
  • Capitalism Plus Dope Equals Genocide [1970] - By Michael Cetewayo Tabor (Political Prisoner, NY 21).pdf.docx 150.8 kB
  • Carbon and nitrogen stable isotopes as indicative of geographical origin of marijuana samples seized in the city of Sao Paulo (Brazil).pdf 492.1 kB
  • Carboxylation of resorcinols with methylmagnesium carbonate. Synthesis of cannabinoid acids.pdf 130.8 kB
  • Cardiac asystole following cannabis (marijuana) usage – Additional mechanism for sudden death.pdf 776.2 kB
  • Cardiovascular Consequences of marijuana use.pdf 663.4 kB
  • Cardiovascular System Effects of Marijuana.pdf 649.9 kB
  • Care and Feeding of the Endocannabinoid System - A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System.pdf 479.2 kB
  • CB1 cannabinoid receptor-G protein association- a possible mechanism for differential signaling.pdf 765.1 kB
  • CB1 cannabinoid receptors are involved in neuroprotection via NF-kB inhibition.pdf 126.4 kB
  • CB1 receptor activation inhibits neuronal and astrocytic intermediary metabolism in the rat hippocampus.pdf 874.1 kB
  • CB1 receptor antagonists - new discoveries leading to new perspectives.pdf 242.1 kB
  • CB2 - a cannabinoid receptor with an identity crisis.pdf 209.8 kB
  • CB2 - Therapeutic target-in-waiting.pdf 213.1 kB
  • CB2 Cannabinoid Receptor Targets Mitogenic Gi Protein – Cyclin D1 Axis in Osteoblasts.pdf 424.0 kB
  • CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons.pdf 849.2 kB
  • CBD and (-)D9THC are Neuroprotective Antioxidants.pdf 932.7 kB
  • CBD as potential anticancer drug.pdf 1.2 MB
  • CB₂ cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons.pdf 1.5 MB
  • Cellular and Molecular Mechanisms Underlying Learning and Memory Impairments Produced by Cannabinoids.pdf 747.3 kB
  • Cellular mechanisms of D9-tetrahydrocannabinol behavioural sensitization.pdf 228.3 kB
  • Cellular Mechanisms Underlying the Anxiolytic Effect of Low Doses of Peripheral D9THC in Rats.pdf 270.9 kB
  • Central and peripheral mechanisms contribute to the antiemetic actions of D9THC against 5-hydroxytryptophan-induced emesis.pdf 265.9 kB
  • CERAMIDE SENSITIZES ASTROCYTES TO OXIDATIVE STRESS- Protective Role of Cannabinoids.pdf 761.3 kB
  • Ceramide Signaling.pdf 3.7 MB
  • Ceramide- a new second messenger of cannabinoid action.pdf 106.6 kB
  • Cerebellar activity and disturbed time sense after THC.pdf 201.9 kB
  • Cerebrovascular perfusion in marijuana users during a month of monitered abstinence.pdf 410.1 kB
  • Challenges of marijuana research.pdf 51.8 kB
  • CHANGES IN HUMAN EVENT RELATED POTENTIALS WITH PROLONGED DELTA-9-TETRAHYDROCANNABINOL (THC) USE.pdf 1.2 MB
  • Changes of HDL-Lipid Composition as Related to D9THC Action.pdf 190.7 kB
  • Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application.pdf 741.2 kB
  • Characteristics of hemp (Cannabis sativa L.) seed oil.pdf 259.9 kB
  • Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.).pdf 219.2 kB
  • Characterization of anandamide-induced tolerance- comparison to D9-THC-induced interactions with dynorphinergic systems.pdf 847.9 kB
  • Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors.pdf 1.2 MB
  • Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.pdf 471.2 kB
  • Characterization of Medicinal Properties of Cannabis sativa L. Roots.pdf 859.0 kB
  • Characterization of Stolbur (16SrXII) Group Phytoplasmas Associated with Cannabis sativa Witches'-broom Disease in Iran.pdf 777.2 kB
  • Characterization of the Solutol HS15-water phase diagram and the impact of the D9-tetrahydrocannabinol solubilization.pdf 456.3 kB
  • Chemical characterisation of oxidative degradation products of D9-THC.pdf 281.1 kB
  • Chemical characterisation of oxidative degradation products of D9THC.pdf 305.7 kB
  • Chemical characterization of lignin and lipid fractions in industrial hemp bast fibers used for manufacturing high-quality paper pulps.pdf 81.8 kB
  • Chemical characterization of pitch deposits produced in the manufacturing of high-quality paper pulps from hemp fibers.pdf 356.4 kB
  • Chemical constituents of marijuana - The complex mixture of natural cannabinoids.pdf 147.5 kB
  • Chemical constituents of marijuana- The complex mixture of natural cannabinoids.pdf 175.6 kB
  • Chemical Ecology of Cannabis.pdf 117.2 kB
  • Chemical stability and bioadhesive properties of an ester prodrug of D9THC in poly(ethylene oxide) matrices- Effect of formulation additives.pdf 707.8 kB
  • Chemistry, Metabolism, and Toxicology of Cannabis- clinical implications.pdf 195.3 kB
  • Chemoenzymatic synthesis of 2-arachidonoylglycerol, an endogenous ligand for cannabinoid receptors.pdf 200.0 kB
  • Chromatographic and Spectroscopic Data of Cannabinoids from Cannabis sativa L..pdf 704.3 kB
  • Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function.pdf 880.2 kB
  • Chronic administration during early adulthood does not alter the hormonally dependent disruptive effects of DTHC on complex behavior in female rats.pdf 371.0 kB
  • Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients.pdf 1.6 MB
  • Chronic cannabinoid agonist (WIN55,212-2) exposure alters hippocampal dentate gyrus spine density in adult rats.pdf 947.7 kB
  • Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats.pdf 110.0 kB
  • Chronic Cannabis Use in the Compassionate Investigational New Drug Program - An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis.pdf 386.2 kB
  • Chronic D9THC treatment in rhesus monkeys – differential tolerance and cross-tolerance among cannabinoids.pdf 922.4 kB
  • Chronic D9THC treatment produces antinociceptive tolerance in mice without altering Protein Kinase A activity in mouse brain and spinal cord.pdf 241.1 kB
  • Chronic effects of cannabis on sensory gating.pdf 450.4 kB
  • Chronic effects of cannabis use on the human reward system- An fMRI study.pdf 2.4 MB
  • Chronic exposure to D9THC downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas.pdf 522.1 kB
  • Chronic toxicology of Cannabis.pdf 173.7 kB
  • Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit hyperactivity disorder and substance use disorders.pdf 271.1 kB
  • Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cells.pdf 892.7 kB
  • Clinical correlates of cannabis use among adolescent psychiatric inpatients.pdf 292.4 kB
  • Clinical pharmacodynamics of Cannabinoids.pdf 230.2 kB
  • Clinical Relevance of Cannabis Tolerance and Dependence.pdf 1.1 MB
  • Clinical service desires of medical cannabis patients.pdf 249.6 kB
  • Cloning and over-expression of a cDNA encoding a polyketide synthase from Cannabis sativa.pdf 457.4 kB
  • Cluster Attacks Responsive to Recreational Cannabis and Dronabinol.pdf 43.9 kB
  • CNS effects of CB2 cannabinoid receptors- beyond neuro-immuno-cannabinoid activity.pdf 472.3 kB
  • Cognition and Long-Term Use of Ganja (Cannabis).pdf 75.8 kB
  • Cognition and motor control as a function of D9THC concentration in serum and oral fluid- Limits of impairment.pdf 327.3 kB
  • Cognitive and clinical outcomes associated with cannabis use in patients with bipolar disorder.pdf 165.6 kB
  • Cognitive and subjective dose-response effects of acute oral D9-tetrahydrocannabinol (THC) in infrequent cannabis users.pdf 238.8 kB
  • Cognitive and subjective dose-response effects of acute oral THC in infrequent Cannabis users.pdf 241.7 kB
  • Cognitive functioning of long-term heavy cannabis users seeking treatment.pdf 143.1 kB
  • Cognitive mechanisms underlying risky decision-making in chronic cannabis users.pdf 778.3 kB
  • Cold - resistance of hemp (Cannabis Sativa L.).pdf 27.5 kB
  • Colonic perforation- A lethal consequence of cannabis body packing.pdf 471.1 kB
  • Colorado Family Physicians’ Attitudes Toward Medical Marijuana.pdf 633.2 kB
  • Combined effects of acute, very-low-dose ethanol and D9THC in healthy human volunteers.pdf 230.7 kB
  • Combined effects of THC and caffeine on working memory in rats.pdf 951.1 kB
  • Combined effects of Δ-9-THC and CBD in man.pdf 97.2 kB
  • Comorbid Alcohol and Cannabis Use Disorders Among High-Risk Youth at Intake Into Residential Care.pdf 295.8 kB
  • Comparing Hemp Seed Yields of an on-farm scientific field experiment to an on-farm agronomic evaluation under organic growing conditions in Lower Australia.pdf 99.6 kB
  • Comparison and analysis of different Cannabis samples by headspace solid-phase microextraction combined with gas chromatography-mass spectrometry.pdf 1.2 MB
  • Comparison between GC–MS and the EMIT (VIVATWIN) immunoassays for the determination of delta 9-THC-COOH.pdf 84.0 kB
  • Comparison in the In Vitro Inhibitory Effects of Major Phytocannabinoids and Polycyclic Aromatic Hydrocarbons Contained in Marijuana Smoke on Cytochrome P450 2C9 Activity (28 pages).pdf 1.0 MB
  • Comparison in the In Vitro Inhibitory Effects of Major Phytocannabinoids and Polycyclic Aromatic Hydrocarbons Contained in Marijuana Smoke on Cytochrome P450 2C9 Activity (7 pages).pdf 670.9 kB
  • Comparison of bast fibre yield and mechanical fibre properties of hemp (Cannabis sati6a L.) cultivars.pdf 173.7 kB
  • Comparison of bast fibre yield and mechanical fibre properties of hemp (Cannabis sativa L.) cultivars.pdf 147.6 kB
  • Comparison of Cannabis sativa by Random Amplification of Polymorphic DNA (RAPD) and HPLC of cannabinoids - a preliminary study.pdf 5.1 MB
  • Comparison of clinical trial recruitment populations -Treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants.pdf 97.3 kB
  • Comparison of Hemp Varieties Using Random Amplified Polymorphic DNA Markers.pdf 144.6 kB
  • Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.pdf 380.4 kB
  • Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers.pdf 471.1 kB
  • Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care- One year outcomes.pdf 758.2 kB
  • Concerning kif, a Cannabis sativa L. preparation smoked in the Rif mountains of northern Morocco.pdf 386.1 kB
  • Concomitant consumption of marijuana, alcohol and tobacco oral squamous cell carcinoma development and progression- Recent advances and challenges.pdf 321.1 kB
  • Conditioned taste avoidance induced by D9THC in the Fischer (F344) and Lewis (LEW) rat strains.pdf 503.3 kB
  • Conditioning of Heavy Metal-Polluted River Sediment by Cannabis sativa L..pdf 483.0 kB
  • Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users.pdf 383.5 kB
  • CONJUGATE DEVIATION OF THE EYES AFTER Cannabis indica INTOXICATION.pdf 456.3 kB
  • Consequences of Cannabis Use - A Survey of Scientific Studies Published up to and including the Autumn of 2003.pdf 405.7 kB
  • Constituents of Cannabis sativa L. I - Propyl homologs of cannabinoids from an Indian variant.pdf 170.3 kB
  • Constituents of Cannabis sativa L. VI - Propyl Homologs in Samples of Known Geographical Origin.pdf 265.6 kB
  • Constituents of Cannabis sativa L. VII - Use of Silyl derivatives in routine analysis.pdf 472.5 kB
  • Constituents of Cannabis sativa L. XI - CBD and CBC in samples of known geographical origin.pdf 356.8 kB
  • Constituents of Cannabis sativa L. XIII - Stability of Dosage Form Prepared by Impregnating Synthetic (-) - Ag-trans- Tetrahydrocannabinol on Placebo Cannabis Plant Material.pdf 356.6 kB
  • Constituents of cannabis sativa L. XVI. - A possible decomposition pathway of D9THC to CBD.pdf 112.4 kB
  • CONSTITUENTS OF CANNABIS SATIVA L., XIV- Intrinsic Problems in Classifying Cannabis based on a single cannabinoid analysis.pdf 89.7 kB
  • Constituents of Cannabis sattva L. II - Absence of CBD in an African variant.pdf 592.7 kB
  • CONSTITUESTS of Cannabis sativa XVII. A review of the natural constituents.pdf 4.2 MB
  • Controlled Clinical Trial of Cannabidiol in Huntington's Disease.pdf 860.2 kB
  • Convenient labour - The prevalence and nature of youth involvement in the Cannabis cultivation industry.pdf 146.8 kB
  • Conversation with Raphael Mechoulam.pdf 130.5 kB
  • Cooking, Kitchen, Edibles, Baking/Adventures with Cannabis Edibles.pdf 8.1 MB
  • Cooking, Kitchen, Edibles, Baking/BAKED - New & Improved! Over 50 Delicious & Easy Weed Cookbook Recipes & Medical Marijuana Cooking Tips.pdf 7.9 MB
  • Cooking, Kitchen, Edibles, Baking/Baked - Over 50 tasty marijuana treats.pdf 12.2 MB
  • Cooking, Kitchen, Edibles, Baking/Calm Effects - Cannabis Infused Sauces.pdf 9.2 MB
  • Cooking, Kitchen, Edibles, Baking/Calm Effects - The Beginning - Sweets and Treats. Second Edition.pdf 12.5 MB
  • Cooking, Kitchen, Edibles, Baking/Calm Effects - Unique Cannabis Appetizers.pdf 9.9 MB
  • Cooking, Kitchen, Edibles, Baking/Cannabis Cookbook - Tasty Marijuana Infused Dessert Recipes.pdf 10.5 MB
  • Cooking, Kitchen, Edibles, Baking/Marijuana Cookbook - Cannabis cooking for comfort.pdf 389.9 kB
  • Cooking, Kitchen, Edibles, Baking/Marijuana cooking - good medicine made easy.pdf 6.2 MB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Brownies.docx 172.1 kB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Butter/Baking a fool of myself..docx 257.3 kB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Butter/Budder instructions.docx 539.1 kB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Butter/Budder.docx 178.0 kB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Butter/Health benefits of hemp butter.docx 104.5 kB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Butter/THC Butter.docx 106.8 kB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Cookies.docx 66.9 kB
  • Cooking, Kitchen, Edibles, Baking/THC in food/Dry Ice Trichome THC Extraction.docx 20.5 kB
  • Cooking, Kitchen, Edibles, Baking/The Cannabis Cookbook.pdf 9.7 MB
  • Cooking, Kitchen, Edibles, Baking/The Cannabis Gourmet Cookbook.pdf 26.9 MB
  • Cooking, Kitchen, Edibles, Baking/The ganja kitchen revolution - the bible of cannabis cuisine.pdf 793.8 kB
  • Cooking, Kitchen, Edibles, Baking/The Hemp Cookbook - From Seed to Shining Seed.pdf 1.5 MB
  • Cooking, Kitchen, Edibles, Baking/The High Art of Baking with Hemp.pdf 11.2 MB
  • Cooking, Kitchen, Edibles, Baking/The Official High Times Cannabis Cookbook More Than 50 Irresistible Recipes That Will Get You High.pdf 2.5 MB
  • Cooking, Kitchen, Edibles, Baking/The Stoner's Cookbook - Cooking with Cannabis - Gourmet 5-minute munchies.pdf 8.8 MB
  • Cooking, Kitchen, Edibles, Baking/The Weed Cookbook - How to Cook with Medical Marijuana 45 Recipes & Cooking Tips.pdf 6.1 MB
  • Cooking, Kitchen, Edibles, Baking/The Weed Cookbook 2 - Medical Marijuana Recipes, Cannabis Cooking Tips & Killer Brownies [HOLIDAY EDITION].pdf 8.5 MB
  • Cooking, Kitchen, Edibles, Baking/UNCLE AMERICA'S MARIJUANA COOKBOOK.pdf 357.8 kB
  • Cooking, Kitchen, Edibles, Baking/What Makes Cannabis Recipes Work - the ingredients and the tactics.pdf 5.2 MB
  • Copper localization in Cannabis sativa L. grown in a copper-rich solution.pdf 221.0 kB
  • Coronary No-Flow and Ventricular Tachycardia Associated With Habitual Marijuana Use.pdf 858.6 kB
  • CORRELATES OF CANNABIS USE DISORDERS AMONG BIPOLAR OUTPATIENTS ENROLLED IN THE BIPOLAR EXPERT CENTERS FRENCH NETWORK.pdf 12.2 kB
  • Correlates of driving under the influence of cannabis.pdf 118.2 kB
  • Correlates of later-onset cannabis use in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC).pdf 235.1 kB
  • Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status.pdf 553.1 kB
  • Crack Heads and Roots Daughters - The Therapeutic Use of Cannabis in Jamaica.pdf 79.1 kB
  • Creating the Cannabis user- A post-structuralist analysis of the re-classification of cannabis in the United Kingdom (2004–2005).pdf 407.1 kB
  • Criminal justice outcomes for cannabis use offences in New Zealand, 1991–2008.pdf 650.2 kB
  • Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.pdf 442.7 kB
  • Cue Reactivity in Cannabis-Dependent Adolescents.pdf 137.1 kB
  • Cultivation & Growing/Cannabis Cultivation - a Complete Grower's Guide.pdf 46.9 MB
  • Cultivation & Growing/Cannabis sativa L. growing on heavy metal contaminated soil - growth, cadmium uptake and photosynthesis.pdf 233.1 kB
  • Cultivation & Growing/Closet Cultivator - Indoor Marijuana Cultivation Made Easy.pdf 3.7 MB
  • Cultivation & Growing/Comparative analysis of hemp fibre grown in year 2010th.pdf 164.5 kB
  • Cultivation & Growing/Differentiating Powdery Mildew from False Powdery Mildew.pdf 802.0 kB
  • Cultivation & Growing/Ed Rosentha'ls Marijuana Growing Tips (1986).pdf 6.2 MB
  • Cultivation & Growing/Ed Rosenthal's Marijuana Growers Handbook (2010).pdf 84.3 MB
  • Cultivation & Growing/Ed Rosenthal's Marijuana Growing Tips.pdf 6.2 MB
  • Cultivation & Growing/Grow Marijuana Weed Indoor or Outdoor - Easy Growing Medical Cannabis.pdf 10.9 MB
  • Cultivation & Growing/Growing Marijuana Indoors - A Foolproof Guide.pdf 724.3 kB
  • Cultivation & Growing/Hemp diseases and pests - management and biological control - an advanced treatise.pdf 9.3 MB
  • Cultivation & Growing/Host-Parasite Relationships in Cannabis.pdf 4.5 MB
  • Cultivation & Growing/How to Grow Cannabis at Home - A Guide to Indoor Medical Marijuana Growing.pdf 27.7 MB
  • Cultivation & Growing/How to grow medical marijuana.pdf 4.9 MB
  • Cultivation & Growing/Impact of nitrogen fertilizer rates on industrial hemp growth and development.pdf 5.7 MB
  • Cultivation & Growing/Jahniella bohemica - A Rediscovered Species that Infests Hemp Stalks.pdf 3.6 MB
  • Cultivation & Growing/Marijuana 101 – Professor Lee’s introduction to growing Grade A bud.pdf 13.8 MB
  • Cultivation & Growing/Marijuana Buds for Less Grow 8 oz. of Bud for Less Than $100.pdf 8.6 MB
  • Cultivation & Growing/Marijuana Grow Basics - The Easy Guide for Cannabis Aficionados.pdf 98.9 MB
  • Cultivation & Growing/MARIJUANA GROWERS HANDBOOK - Indoor - Greenhouse Edition.pdf 463.3 kB
  • Cultivation & Growing/Marijuana Horticulture - The Indoor-Outdoor Medical Growers Bible (Part5).pdf 104.4 MB
  • Cultivation & Growing/Marijuana Mass Production Made Easy - British Columbia Hydroponic Growers Guide.pdf 61.3 MB
  • Cultivation & Growing/New Hemp Diseases and Pests in New Zealand.pdf 5.2 MB
  • Cultivation & Growing/Organic Marijuana - Soma Style - The Pleasures of Cultivating Connoisseur Cannabis.pdf 10.8 MB
  • Cultivation & Growing/Review of Flowering Control in Industrial Hemp.pdf 426.3 kB
  • Cultivation & Growing/Temperature and Moisture Content for Storage Maintenance of Germination Capacity of Seeds of Industrial Hemp, Marijuana, and Ditchweed Forms of Cannabis sativa.pdf 174.9 kB
  • Cultivation & Growing/The arbuscular mycorrhizal fungus Glomus mosseae induces growth and metal accumulation changes in Cannabis sativa L..pdf 166.4 kB
  • Cultivation & Growing/The Beginner’s Guide to GROWING MARIJUANA - EVERYTHING YOU NEED to Start Growing Weed at Home.pdf 918.4 kB
  • Cultivation & Growing/The Big Book of Buds Volume 4 - marijuana varieties from the world's greatest seed breeders.pdf 41.1 MB
  • Cultivation & Growing/The Cannabis Breeder's Bible - The Definitive Guide to Marijuana Genetics, Cannabis Botany and Creating Strains for the Seed Market.pdf 12.2 MB
  • Cultivation & Growing/The Cannabis Grow Bible - The Definitive Guide to Growing Marijuana for Recreational and Medical Use.pdf 9.3 MB
  • Cultivation & Growing/The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield.pdf 122.3 kB
  • Cultivation & Growing/The Hemp Russet Mite.pdf 3.8 MB
  • Cultivation & Growing/THE MARIJUANA GROWER'S GUIDE.pdf 858.0 kB
  • Cultivation & Growing/The results of an experimental indoor hydroponic Cannabis growing study, using the ‘Screen of Green’ (ScrOG) method- Yield, THC and DNA analysis.pdf 1.4 MB
  • Cultivation & Growing/UV-B RADIATION EFFECTS ON PHOTOSYNTHESIS, growth and cannabinoid production of two Cannabis sativa chemotypes.pdf 536.0 kB
  • Cultivation & Growing/White Leaf Spot.pdf 3.2 MB
  • Cultivation & Growing/Why small-scale cannabis growers stay small- Five mechanisms that prevent small-scale growers from going large scale.pdf 313.9 kB
  • CULTIVATION, EXTRACTION, and analysis of Cannabis sativa L..pdf 783.0 kB
  • Current and former marijuana use - preliminary findings of a longitudinal study of effects on IQ in young adults.pdf 197.6 kB
  • Current status and future scenarios of hemp breeding.pdf 445.6 kB
  • D8THC induces cytotoxicity in macrophage J774-1cells- Involvement of cannabinoid receptor 2 and p38 MAPK.pdf 1.6 MB
  • D9-Tetrahydrocannabinol (D9-THC) attenuates mouse sperm motility and male fecundity.pdf 1.1 MB
  • D9-tetrahydrocannabinol-induced MAPK-ERK and Elk-1 activation in vivo depends on dopaminergic transmission.pdf 498.0 kB
  • D9-THC AND 11-OH-A 9-THC - BEHAVIORAL EFFECTS AND RELATIONSHIP TO PLASMA AND BRAIN LEVELS.pdf 505.2 kB
  • D9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling.pdf 2.7 MB
  • D9THC - Effect on Acquisition and Retention of a One-Trial Passive Avoidance Response.pdf 317.4 kB
  • D9THC accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures.pdf 593.7 kB
  • D9THC and cannabidiol alter cytokine production by human immune cells.pdf 79.3 kB
  • D9THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner.pdf 531.7 kB
  • D9THC ATTENUATES MDMA-INDUCED HYPERTHERMIA IN RHESUS MONKEYS.pdf 2.0 MB
  • D9THC causes alterations in impulse regulation-related brain function- new insights from a pharmaco-imaging study.pdf 60.0 kB
  • D9THC differentially suppresses cisplatin-induces emesis and indices of motor function via cannabonoid CB1 receptors receptors in the least shrew.pdf 318.9 kB
  • D9THC FAILS TO STIMULATE CONSUMPTION OF A HIGHLY PALATABLE FOOD IN THE RAT.pdf 332.8 kB
  • D9THC IMPAIRS REVERSAL LEARNING BUT NOT EXTRA-DIMENSIONAL SHIFTS IN RHESUS MACAQUES.pdf 284.4 kB
  • D9THC increases nerve growth factor production by prostate PC-3 cells - Involvement of CB1 cannabinoid receptor and Raf-1.pdf 249.1 kB
  • D9THC induces non-specific psychotropic effects reflected in resting-state brain function- a pharmaco-imaging study.pdf 46.1 kB
  • D9THC is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.pdf 433.7 kB
  • D9THC prevents cerebral infarction via hypothalamic-independent hypothermia.pdf 316.7 kB
  • D9THC protects hippocampal neurons from excitotoxicity.pdf 719.4 kB
  • D9THC regulates the p53 post-translational modifiers Murine double minute 2 and the Small Ubiquitin MOdifier protein in the rat brain.pdf 1.9 MB
  • D9THC selectively increases aspartyl cathepsin D proteolytic activity and impairs lysozyme processing by macrophages.pdf 160.6 kB
  • D9THC stimulates food intake in Lewis rats Effects on chow, high-fat and sweet high-fat diets.pdf 159.6 kB
  • D9THC working memory system capacity- a pharmacological MRI study.pdf 65.3 kB
  • D9THC-induced induced conditioned place preference and intracerebroventricular self-administration in rats.pdf 196.9 kB
  • D9THC.pdf 124.8 kB
  • D9THCV testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.pdf 193.7 kB
  • Daily marijuana use and suicidality- The unique impact of social anxiety.pdf 269.3 kB
  • DEA - Drug Fact Sheet - Marijuana.pdf 167.4 kB
  • Decarboxylation of D9-tetrahydrocannabinol - Kinetics and molecular modeling.pdf 864.2 kB
  • Decimal code for growth stages of hemp (Cannabis sativa L.).pdf 166.1 kB
  • Decrease in prostaglandin level is a prerequisite for the expression of cannabinoid withdrawal- A quasi abstinence approach.pdf 121.4 kB
  • Decreased depression in marijuana users.pdf 136.3 kB
  • DELTA-9-TETRAHYDROCANNABINOL (THC) IN THE TREATMENT OF END-STAGE OPEN-ANGLE GLAUCOMA.pdf 41.6 kB
  • DELTA-9-TETRAHYDROCANNABINOL (THC) IN THE TREATMENT OF ENDSTAGE OPEN-ANGLE GLAUCOMA.pdf 42.4 kB
  • Delta-9-Tetrahydrocannabinol (THC), the Major Psychoactive Component of Marijuana, Exacerbates Brain Infection by Acanthamoeba.pdf 374.4 kB
  • Delta-9-tetrahydrocannabinol effects in schizophrenia - implications for cognition, psychosis, and addiction.pdf 458.1 kB
  • Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.pdf 122.6 kB
  • Delta-9-tetrahydrocannabinol Shows Antispastic and Analgesic Effects in a Single Case Double-blind Trial.pdf 357.9 kB
  • Delta-9-tetrahydrocannabinol- An Inhibitor of STAT1 oc Protein Tyrosine Phosphorylation.pdf 910.8 kB
  • DELTA-9-TETRAHYDROCANNABINOL-(THC)-MEDIATED INHIBITION OF MACROPHAGE MACROMOLECULAR METABOLISM IS ANTAGONIZED BY HUMAN SERUM PROTEINS AND BY CELL SURFACE PROTEINS.pdf 564.2 kB
  • Delta-9-THC and Nonverbal Communication in Monkeys.pdf 731.3 kB
  • Delta9-tetrahydrocannabinol (THC) impairs working memory system capacity - a pharmacological MRI study.pdf 64.7 kB
  • Delta9-THC causes alterations in impulse regulation-related brain function – new insights from a pharmaco-imaging study.pdf 59.4 kB
  • Delta9-THC induces non-specific psychotropic effects reflected in resting-state brain function - a pharmaco-imaging study.pdf 45.5 kB
  • Derivatives of Dexanabinol. I. Water-Soluble Salts of Glycinate esters.pdf 1.5 MB
  • Derivatives of Dexanabinol. II. Salts of Amino Acid Esters Containing tertiary and quaternary heterocyclic Nitrogen with increased water-solubility.pdf 1.1 MB
  • Design of Competitive Processing Plants for Hemp Fibre Production.pdf 2.1 MB
  • Despite strong behavioral disruption, D9THC does not affect cell proliferation in the adult mouse dentate gyrus.pdf 297.5 kB
  • Detection and disposition of JWH-018 and JWH-073 in mice after exposure to Majic Gold smoke.pdf 478.8 kB
  • Detection of pesticides in seized illegal cannabis plants.pdf 427.5 kB
  • Detection of synthetic cannabinoids in herbal incense products.pdf 481.3 kB
  • Determination of cannabinoids in biological samples using a new solid phase micro-extraction membrane and liquid chromatography–mass spectrometry.pdf 245.8 kB
  • Determination of cannabinoids in cannabis products using liquid chromatography–ion trap mass spectrometry.pdf 404.4 kB
  • Determination of Cannabisin A in Fruits of Cannabis sativa from Three Cultivation Locations (non-english).pdf 251.3 kB
  • Determination of Pesticide Residues in Cannabis Smoke.pdf 1.1 MB
  • Development and Pharmacokinetic Characterization of Pulmonal and Intravenous Delta-9-Tetrahydrocannabinol (THC) in Humans.pdf 142.5 kB
  • Development and validation of an HPLC method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material.pdf 1.2 MB
  • Development of a short cannabis problems questionnaire for adolescents in the community.pdf 139.2 kB
  • Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.pdf 1.5 MB
  • Development of microsatellite markers in Cannabis sativa for DNA typing and genetic relatedness analyses.pdf 314.8 kB
  • Development of tolerance to Δ9-THC in the frog.pdf 248.5 kB
  • Developmental changes in cellular and humoral responses of the burying beetle Nicrophorus vespilloides (Coleoptera, Silphidae).pdf 846.8 kB
  • Developmental Validation of a Cannabis sativa STR Multiplex System for Forensic Analysis.pdf 267.0 kB
  • Dexanabinol (HU-211) - A Nonpsychotropic Cannabinoid With Neuroprotective Properties.pdf 86.0 kB
  • Diagnostic criteria for cannabis withdrawal syndrome.pdf 305.8 kB
  • Die Rolle des Q63R Polymorphismus im Cannabinoid Rezeptor 2 (CNR2) Gen bei chronisch entzünd lichen Darmerkrankungen (German).pdf 1.5 MB
  • Differences in associations between cannabis and stimulant disorders in first admission psychosis.pdf 284.2 kB
  • Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man.pdf 222.0 kB
  • Differential Cannabinoid Receptor Expression during Reactive Gliosis – a Possible Implication for a Nonpsychotropic Neuroprotection.pdf 100.8 kB
  • Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.pdf 337.8 kB
  • DIFFERENTIAL EFFECTS OF CHRONIC ADOLESCENT VS. ADULT THC EXPOSURE IN COMT KNOCKOUT MICE ON PHENOTYPES RELEVANT TO PSYCHOSIS.pdf 88.3 kB
  • Differential effects of D9THC on learning in adolescent and adult rats.pdf 196.6 kB
  • Differential effects of medical marijuana based on strain and route of administration - a three-year observational study.pdf 166.1 kB
  • Differential Effects of Presynaptic versus Postsynaptic Adenosine A2A Receptor Blockade on D9THC Self-Administration in Squirrel Monkeys.pdf 955.4 kB
  • DIFFERENTIAL EFFECTS OF THC AND CBD IN CANNABIS SMOKERS.pdf 124.1 kB
  • Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.pdf 379.3 kB
  • Differential Impairments of Selective Attention Due to frequency and duration of Cannabis use.pdf 823.2 kB
  • Differential Modulation by Delta9-Tetrahydrocannabinol (Δ9-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4+ T cells.pdf 800.8 kB
  • DIFFERENTIAL SUPPRESSION OF T-CELL SUBPOPULATIONS BY THC (DELTA-9-TETRAHYDROCANNABINOL).pdf 349.5 kB
  • Differentiating New Marijuana Use From Residual drug excretion in occasional marijuana users.pdf 1.6 MB
  • Differentiation of drug and non-drug Cannabis using a single nucleotide polymorphism (SNP) assay.pdf 222.6 kB
  • Diminished gray matter in the hippocampus of cannabis users- Possible protective effects of cannabidiol.pdf 263.5 kB
  • Direct and Pituitary-Mediated Effects of D9THC and Cannabinol on the Testis.pdf 489.2 kB
  • Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on D9-THC and D9-THC-acid.pdf 3.9 MB
  • Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on D9THC and D9THCA.pdf 3.9 MB
  • Discovery and Isolation of Anandamide and Other Endocannabinoids.pdf 141.0 kB
  • Discovery of the Endocannabinoid System - A Breakthrough in Neuroscience.pdf 80.5 kB
  • Discrimination of ‘fiber-type’ and ‘drug-type’ Cannabis sativa L. by fluorescent duplex PCR.pdf 191.8 kB
  • Discriminative stimulus properties of D9THC in C57Bl-6J mice.pdf 264.5 kB
  • Dispelling the myth of “smart drugs”- Cannabis and alcohol use problems predict nonmedical use of prescription stimulants for studying.pdf 328.3 kB
  • Disposition of smoked cannabis with high D9THC content – A kinetic model.pdf 500.1 kB
  • Disposition of smoked cannabis with high D9THC content- A kinetic model.pdf 532.2 kB
  • Dissociation of Autonomic and Cognitive Effects of THC in Man.pdf 469.8 kB
  • Dissociation of the Pharmacological Effects of THC by mTOR Blockade.pdf 609.7 kB
  • Distinct effects of D9THC and CBD on Neural Activation during emotional processing.pdf 360.1 kB
  • Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-Tetrahydrocannabinol in vivo.pdf 3.6 MB
  • Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to D9THC. Mechanism underlying greater toxicity.pdf 1.6 MB
  • DISTINGUISHING BLUNTS USERS FROM joint users - a comparison of marijuana use subcultures.pdf 1.5 MB
  • Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.pdf 781.6 kB
  • DISTRIBUTION OF CB1 CANNABINOID RECEPTORS AND THEIR RELATIONSHIP WITH MU-OPIOID RECEPTORS IN THE RAT PERIAQUEDUCTAL GRAY.pdf 1.4 MB
  • Distribution of free and conjugated cannabinoids in human bile samples.pdf 195.2 kB
  • Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe-PS1ΔE9 double transgenic mice.pdf 670.7 kB
  • Disturbances of visual information processing in early states of psychosis and experimental D9THC altered states of consciousness.pdf 239.9 kB
  • Diuretic effects of cannabinoid agonists in mice.pdf 889.1 kB
  • DNA polymorphisms in the tetrahydrocannabinolic acid (THCA) synthase gene in ‘‘drug-type’’ and ‘‘fiber-type’’ Cannabis sativa L..pdf 541.6 kB
  • Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis - A double-blind, randomized, placebo-controlled study on 160 patients.pdf 496.6 kB
  • DO COGNITIVE IMPAIRMENTS RECOVER FOLLOWING cessation of Cannabis use.pdf 688.7 kB
  • Do early experiences with cannabis vary in cigarette smokers.pdf 250.6 kB
  • Do medical cannabis laws encourage cannabis use.pdf 746.9 kB
  • Do THC Concentrations Indicate Recent Use in Chronic Cannabis Users.pdf 365.4 kB
  • Does cannabis use predispose to chronic airflow.pdf 142.9 kB
  • Does marijuana have a future in pharmacopoeia.pdf 93.2 kB
  • Dopamine Release in Chronic Cannabis Users- A [11C]Raclopride Positron Emission Tomography Study.pdf 409.1 kB
  • Dose related risk of motor vehicle crashes after cannabis use.pdf 133.5 kB
  • Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.pdf 857.9 kB
  • Dose-related neurocognitive effects of marijuana use.pdf 148.5 kB
  • Dose-response effect between cannabis use and psychosis liability in a non-clinical population- Evidence from a snowball sample.pdf 422.4 kB
  • Down-regulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects.pdf 3.7 MB
  • Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas- a new marker of cannabinoid antitumoral activity.pdf 1.2 MB
  • Downregulation of Rat Brain Cannabinoid Binding Sites After Chronic D9THC Treatment.pdf 666.7 kB
  • Dramatic improvement of refractory Isaacs' syndrome after treatment with dronabinol.pdf 83.9 kB
  • Driving under the influence of cannabis- Links with dangerous driving, psychological predictors, and accident involvement.pdf 252.6 kB
  • Dronabinol and Prochlorperazine in combination for treatment of cancer chemotherapy -induced nausea and vomiting.pdf 869.6 kB
  • Dronabinol and Retinal Hemodynamics in Humans.pdf 69.3 kB
  • Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.pdf 627.5 kB
  • Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms.pdf 85.0 kB
  • Dronabinol for the Treatment of Cannabis Dependence – A Randomized, Double-Blind, Placebo-Controlled Trial.pdf 664.9 kB
  • Dronabinol in Severe, Enduring Anorexia Nervosa - A Randomized Controlled Trial.pdf 126.1 kB
  • Drug Testing/3’-Hydroxy- and (&)-3’,11-Dihydroxy-D9THC - Biologically Active Metabolites of D9THC.pdf 603.6 kB
  • Drug Testing/A Positive THC Urinalysis From Hemp (Cannabis) Seed Oil.pdf 154.0 kB
  • Drug Testing/Analysis of drugs of abuse in hair- Evaluation of the immunochemical method VMA-T vs. LC–MSMS or GC–MS.pdf 304.9 kB
  • Drug Testing/Analytical and Practical Aspects of Drug Testing in Hair.pdf 6.1 MB
  • Drug Testing/Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.pdf 236.5 kB
  • Drug Testing/Cannabis Metabolites in Urine after 0ral Administration.pdf 174.6 kB
  • Drug Testing/Determination of 22 synthetic cannabinoids in human hair by liquid chromatography–tandem mass spectrometry.pdf 482.9 kB
  • Drug Testing/Direct detection of D9THC in saliva using a novel homogeneous competitive immunoassay with fluorescence quenching.pdf 466.2 kB
  • Drug Testing/Dried blood spots- Liquid chromatography–mass spectrometry analysis of D9THC and its main metabolites.pdf 516.8 kB
  • Drug Testing/Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania - a pilot study.pdf 162.8 kB
  • Drug Testing/Extended urinary D9THC excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.pdf 579.8 kB
  • Drug Testing/Fast confirmation of 11-nor-9-carboxy-D9THC (THC-COOH) in urine by LC-MS-MS using negative atmospheric-pressure chemical ionisation.pdf 117.5 kB
  • Drug Testing/Fast liquid chromatographytandem mass spectrometry determination of cannabinoids in micro volume blood samples after dabsyl derivatization.pdf 1.6 MB
  • Drug Testing/Hair analysis for D9-THC, D9-THC-COOH, CBN and CBD, by GC-MS-EI. Comparison with GCMS-NCI for D9-THC-COOH.pdf 266.3 kB
  • Drug Testing/Hair analysis for D9THCA acid A- New insights into the mechanism of drug incorporation of cannabinoids into hair.pdf 147.5 kB
  • Drug Testing/Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuna smoke.pdf 180.7 kB
  • Drug Testing/High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC–MS-MS.pdf 755.0 kB
  • Drug Testing/Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.pdf 1.1 MB
  • Drug Testing/Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers’ Blood on Per Se Drugged Driving Laws.pdf 212.3 kB
  • Drug Testing/Inconsistent coroner interpretations of cardiac death in the presence of Cannabis in urine.pdf 108.2 kB
  • Drug Testing/Marijuana Use - Persistence and Urinary Elimination.pdf 559.6 kB
  • Drug Testing/Monitoring of chronic Cannabis abuse- An LC–MS-MS method for hair analysis.pdf 577.4 kB
  • Drug Testing/Morphology of Glandular Hairs of Cannabis sativa from Scanning Electron Microscopy.pdf 1.4 MB
  • Drug Testing/PROLONGED COMA IN A CHILD DUE TO HASHISH INGESTION WITH QUANTITATION OF THC METABOLITES IN URINE.pdf 143.4 kB
  • Drug Testing/Rapid samplepre-treatmentpriortoGC–MS and GC–MS-MS urinary toxicological screening.pdf 421.4 kB
  • Drug Testing/Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use.pdf 198.7 kB
  • Drug Testing/Significantly increased detection rate of drugs of abuse in urine following the introduction of new German driving licence re-granting guidelines.pdf 249.6 kB
  • Drug Testing/Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometry.pdf 513.1 kB
  • Drug Testing/Simultaneous determination of THC-COOH and THC-COOH-glucuronide in urine samples by LC-MS-MS.pdf 160.4 kB
  • Drug Testing/Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.pdf 408.1 kB
  • Drug Testing/SPME–GC analysis of THC in saliva samples collected with ‘‘EPITOPE’’ device.pdf 104.3 kB
  • Drug Testing/Stability of pain-related medications, metabolites, and illicit substances in urine.pdf 155.5 kB
  • Drug Testing/STUDIES OF CANNABINOID METABOLITES - A FREE RADICAL IMMUNOASSAY.pdf 213.3 kB
  • Drug Testing/Tandem mass spectrometry- a helpful tool in hair analysis for the forensic expert.pdf 509.1 kB
  • Drug Testing/Target screening and confirmation of 35 licit and illicit drugs and metabolites in hair by LC–MSMS.pdf 295.5 kB
  • Drug Testing/Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC–MS-MS.pdf 520.8 kB
  • Drug Testing/Testing Human Hair for Cannabis. III. Rapid Screening Procedure for the Simultaneous Identification of D9THC, Cannabinol, and Cannabidiol.pdf 291.3 kB
  • Drug Testing/The standardization of results on hair testing for drugs of abuse- An interlaboratory exercise in Lombardy Region, Italy.pdf 244.4 kB
  • Drug Testing/Urinary excretion profiles of 11-nor-9-carboxy-D9THC and 11-hydroxy-D9-THC. Cannabinoid metabolites to creatinine ratio study IV.pdf 100.1 kB
  • Drug Testing/Urinary excretion profiles of 11-nor-9-carboxy-D9THC- Study III. A D9-THC-COOH to creatinine ratio study.pdf 161.0 kB
  • Drug Testing/Urinary excretion profiles of 11-nor-9-carboxy-D9THC. A D9THC-COOH to creatinine ratio study #2.pdf 123.4 kB
  • Drug Testing/Δ9-THC, 11-OH-Δ9-THC and Δ9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.pdf 84.1 kB
  • Drugs and drug policy in America - A documentary history (book review).pdf 123.8 kB
  • Drugs Derived from Cannabinoids. 2.1a Basic Esters of Nitrogen and Carbocyclic Analogs.pdf 1.0 MB
  • Drugs Related to Tetrahydrocannabinol.pdf 1.6 MB
  • DSM-5 cannabis use disorder - A phenotypic and genomic perspective.pdf 796.8 kB
  • Duration of cannabis use - a novel phenotype.pdf 124.9 kB
  • Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence- THC effects.pdf 600.0 kB
  • Dynorphin B and spinal analgesia- induction of antinociception by the cannabinoids CP55,940, D9-THC and anandamide.pdf 139.6 kB
  • Early medical use of cannabis.pdf 135.0 kB
  • Early Phenylpropanoid Biosynthetic Steps in Cannabis sativa- Link between Genes and Metabolites.pdf 2.9 MB
  • Economic Impact of Industrial Hemp in Kentucky.pdf 2.0 MB
  • Economics and Marijuana - Consumption, Pricing and Legalisation.pdf 2.5 MB
  • EEG Deficits in Chronic Marijuana Abusers during monitered abstinence - preliminary findings.pdf 569.2 kB
  • Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects - a randomized, placebo-controlled study.pdf 524.7 kB
  • Effect of a subchronic treatment with D9THC on D2-D3 dopamine receptors as measured in rats with [18F]Fallypride and [3H]-(+)-PHNO.pdf 48.8 kB
  • Effect of Acute Marijuana on Cardiovascular function and CNS pharmacokinetics of water - effect in occasional and chronic users.pdf 230.4 kB
  • Effect of alcoholic extract of Cannabis sativa leave on neuronal density of CA1, CA2 and CA3 regions of rat hippocampus.pdf 360.0 kB
  • Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats.pdf 1.4 MB
  • Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.pdf 362.1 kB
  • Effect of D-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults.pdf 112.9 kB
  • EFFECT OF D9THC ADMINISTRATION ON HEPATIC FUNCTIONS.pdf 487.1 kB
  • Effect of D9THC on behavioral despair and on pre- and postsynaptic serotonergic transmission.pdf 522.9 kB
  • EFFECT OF D9THC ON MITOCHONDRIAL PROCESSES.pdf 642.2 kB
  • Effect of dronabinol on progression in progressive multiple sclerosis (CUPID) - a randomised, placebo-controlled trial.pdf 418.5 kB
  • Effect of dronabinol therapy on physical activity in anorexia nervosa - a randomised, controlled trial.pdf 229.7 kB
  • Effect of illicit recreational drugs upon sleep- Cocaine, ecstasy and marijuana.pdf 215.4 kB
  • Effect of marihuana on intraocular and blood pressure in glaucoma.pdf 461.9 kB
  • Effect of reclassification of cannabis on hospital admissions a timeline series analysis.pdf 654.7 kB
  • Effect of sublingual application of cannabinoids on intraocular pressure - A pilot study.pdf 42.1 kB
  • Effect of the synthetic cannabinoid nabilone on spermatogenesis in mice.pdf 609.4 kB
  • Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders.pdf 433.4 kB
  • Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.pdf 404.0 kB
  • Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans - a randomized, placebo-controlled study.pdf 872.8 kB
  • Effects of ABA on primary terpenoids and D9-tetrahydrocannabinol in Cannabis sativa L. at flowering stage.pdf 501.3 kB
  • Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats.pdf 345.9 kB
  • Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow.pdf 511.9 kB
  • EFFECTS OF CANNABIDIOL ON BEHAVIORAL SEIZURES CAUSED BY CONVULSANT DRUGS OR CURRENT IN MICE.pdf 408.3 kB
  • Effects of Cannabis sativa on Hematological Indices in Rats and Men.pdf 290.0 kB
  • Effects of Cannabis sativa on maze performance of the Rat.pdf 619.6 kB
  • Effects of cannabis smoking on oral soft tissues.pdf 3.7 MB
  • Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.pdf 428.3 kB
  • EFFECTS OF CHRONIC ADMINISTRATION OF D9THC ON THE CARDIOVASCULAR SYSTEM, AND PRESSOR AND BEHAVIORAL RESPONSES TO BRAIN STIMULATION IN FREELY MOVING RATS.pdf 510.6 kB
  • Effects of D9-tetrahydrocannabinol, (R)-methanandamide, SR 141716, and d-amphetamine before and during daily D9-tetrahydrocannabinol dosing.pdf 206.7 kB
  • Effects of D9THC and a Water Soluble Ester of D9THC on Schedule-controlled Behavior.pdf 288.8 kB
  • Effects of D9THC and Social Context on Marijuana Self-Administration by Humans.pdf 486.8 kB
  • Effects of D9THC on evaluation of emotional images.pdf 778.9 kB
  • Effects of D9THC on Food and Water Intake of Deprivation Experienced Rats.pdf 354.6 kB
  • Effects of D9THC on Human Platelet Phospholipids - MACROPHAGE CELL LINES.pdf 279.0 kB
  • Effects of D9THC on Human Working Memory Function.pdf 764.2 kB
  • Effects of D9THC on sucrose palatability as measured by the taste reactivity test.pdf 105.5 kB
  • EFFECTS OF D9THC ON THE IMMUNE RESPONSE IN MICE.pdf 3.8 MB
  • Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro.pdf 183.2 kB
  • EFFECTS OF DRONABINOL ON ANOREXIA AND DISTURBED BEHAVIOR IN PATIENTS WITH ALZHEIMER'S DISEASE.pdf 147.8 kB
  • Effects of ethanol, D9THC, or their combination on object recognition memory and object preference in adolescent and adult male rats.pdf 320.2 kB
  • Effects of Expectancies on Subjective Responses to Oral D9THC.pdf 199.2 kB
  • Effects of frequent marijuana use on memory-related regional cerebral blood flow.pdf 320.0 kB
  • Effects of Gibberellic Acid on Primary Terpenoids and D9THC in Cannabis sativa at Flowering Stage.pdf 351.4 kB
  • Effects of Gibberellic Acid on Primary Terpenoids and THC in Cannabis sativa at flowering stage.pdf 363.9 kB
  • Effects of ipsapirone and cannabidiol on human experimental anxiety.pdf 667.8 kB
  • Effects of limited enzymatic hydrolysis with trypsin on the functional properties of hemp (Cannabis sativa L.) protein isolate.pdf 321.8 kB
  • Effects of Long-Term Cannabis Use on Selective attention - an event-related potential study.pdf 569.7 kB
  • Effects of long-term exposure to D9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.pdf 417.8 kB
  • Effects of long-term exposure to D9THC on expression of cannabinoid receptor CB1 mRNA in different rat brain regions.pdf 428.2 kB
  • Effects of Marihuana (D9THC) on Behavior Patterns and Social Roles in Colonies of CBA Mice.pdf 1.4 MB
  • EFFECTS OF MARIJUANA ON SODIUM AND POTASSIUM (NA+ & P+) IONS homeostasis among smokers in Benin city (Nigeria).pdf 65.2 kB
  • Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications - A Systematic Review.pdf 486.9 kB
  • Effects of motivational groups for people with psychosis who use cannabis.pdf 288.9 kB
  • Effects of oral cannabis and dronabinol on driving capacity.pdf 648.4 kB
  • Effects of oral THC maintenance on smoked marijuana self-administration.pdf 153.1 kB
  • Effects of Smoked Cannabis and Oral 9-Tetrahydrocannabinol on Nausea and Emesis After Cancer Chemotherapy - A Review of State Clinical Trials.pdf 111.5 kB
  • Effects of Smoked Marijuana in Experimentally Induced Asthma.pdf 296.1 kB
  • Effects of Smoking Marijuana on Brain.pdf 242.5 kB
  • Effects of synthetic D9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man.pdf 163.8 kB
  • EFFECTS OF TETRA HYDRO CANNABINOL TO THE DENDRITC TREE AND SYNAPSES OF THE ACCUMBENS NUCLEUS OF WISTAR RATS.pdf 113.6 kB
  • Effects of THC and CBD in man.pdf 1.3 MB
  • EFFECTS OF THC AND CBD ON PHOSPHOLIPASE AND OTHER ENZYMES REGULATING ARACHIDONATE METABOLISM.pdf 546.9 kB
  • Effects of THC and Lofexidine in a Human Laboratory Model of Marijuana Withdrawal and Relapse.pdf 1.3 MB
  • Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol.pdf 520.0 kB
  • Effects of the antidepressant fluoxetine on the immune parameters and acetylcholinesterase activity of the clam Venerupis philippinarum.pdf 744.1 kB
  • Effects of the cannabinoid CB receptor antagonist, SR141716A, after D9-tetrahydrocannabinol withdrawal.pdf 140.0 kB
  • Effects of Varying Marijuana Potency on Deposition of Tar and Lung During Smoking.pdf 92.5 kB
  • Effects on Cell Viability.pdf 168.8 kB
  • Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats.pdf 973.9 kB
  • Efficacy and safety of dexanabinol in severe traumatic brain injury - results of a phase III randomised, placebo-controlled, clinical trial.pdf 100.6 kB
  • Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus - a preliminary study..pdf 396.6 kB
  • Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting - A Systematic Literature Review.pdf 764.9 kB
  • Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.pdf 336.3 kB
  • Electroencephalographic correlates of marihuana-induced euphoria.pdf 1.2 MB
  • Electrophysiological evidence of early attentional bias to drug-related pictures in chronic cannabis users.pdf 622.7 kB
  • Elicitation studies in cell suspension cultures of Cannabis sativa L..pdf 1.2 MB
  • Emerging properties of cannabinoid medicines in management of multiple sclerosis.pdf 90.1 kB
  • Emerging strategies for exploiting cannabinoid receptor agonists as medicines.pdf 201.9 kB
  • Enantiomeric cannabidiol derivatives - synthesis and binding to cannabinoid receptors.pdf 209.3 kB
  • Enantiomeric cannabinoids - stereospecificity of psychotropic activity.pdf 338.3 kB
  • ENANTIOSELECTIVE SYNTHESIS AND PHARMACOLOGY OF 11-HYDROXY-(1'S,2'R)-DIMETHYLHEPTYL-AS-THC.pdf 211.8 kB
  • Enantioselective synthesis of 11-hydro-(1’S,2’R)- dimethylheptyl-D8THC, a very potent CB1 agonist.pdf 122.5 kB
  • Enantioselective Total Synthesis of (-)‑Δ8‑THC and (-)‑Δ9‑THC via Catalytic Asymmetric Hydrogenation and SNAr Cyclization.pdf 381.1 kB
  • Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor - Antagonism by Anandamide.pdf 128.7 kB
  • Endocannabinoid Systemand Synaptic Plasticity - Implications for Emotional Responses.pdf 1.2 MB
  • Endocannabinoids & The Endocannabinoid system/A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.pdf 597.9 kB
  • Endocannabinoids & The Endocannabinoid system/Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation.pdf 803.4 kB
  • Endocannabinoids & The Endocannabinoid system/Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis.pdf 4.2 MB
  • Endocannabinoids & The Endocannabinoid system/An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.pdf 177.8 kB
  • Endocannabinoids & The Endocannabinoid system/An entourage effect - inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.pdf 310.2 kB
  • Endocannabinoids & The Endocannabinoid system/An introduction to the endocannabinoid system- from the early to the latest concepts.pdf 399.5 kB
  • Endocannabinoids & The Endocannabinoid system/Anandamide - an update.pdf 490.8 kB
  • Endocannabinoids & The Endocannabinoid system/At the heart of the matter- the endocannabinoid system in cardiovascular function and dysfunction.pdf 1.5 MB
  • Endocannabinoids & The Endocannabinoid system/Cannabinoid receptors and endocannabinoids - evidence for new players.pdf 213.0 kB
  • Endocannabinoids & The Endocannabinoid system/Cannabinoids and the Endocannabinoid System.pdf 178.3 kB
  • Endocannabinoids & The Endocannabinoid system/Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation.pdf 258.0 kB
  • Endocannabinoids & The Endocannabinoid system/Cannabis and endocannabinoid modulators - Therapeutic promises and challenges.pdf 276.1 kB
  • Endocannabinoids & The Endocannabinoid system/CONTRIBUTIONS OF ENDOCANNABINOID SIGNALING TO PSYCHIATRIC DISORDERS IN HUMANS- GENETIC AND BIOCHEMICAL EVIDENCE.pdf 843.8 kB
  • Endocannabinoids & The Endocannabinoid system/Critical role of the endogenous cannabinoid system in mouse pup suckling and growth.pdf 181.8 kB
  • Endocannabinoids & The Endocannabinoid system/Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.pdf 318.1 kB
  • Endocannabinoids & The Endocannabinoid system/Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.pdf 136.8 kB
  • Endocannabinoids & The Endocannabinoid system/Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.pdf 1.2 MB
  • Endocannabinoids & The Endocannabinoid system/Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice.pdf 278.4 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid biosynthesis and inactivation, from simple to complex.pdf 866.3 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.pdf 777.9 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid overactivity and intestinal inflammation.pdf 171.0 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid signaling as a synaptic circuit breaker in neurological disease.pdf 638.7 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid signaling in neurotoxicity and neuroprotection.pdf 316.3 kB
  • Endocannabinoids & The Endocannabinoid system/ENDOCANNABINOID SIGNALING IN THE AMYGDALA ANATOMY, SYNAPTIC SIGNALING, BEHAVIOR, AND ADAPTATIONS TO STRESS.pdf 981.8 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid signaling in the brain - biosynthetic mechanisms in the limelight.pdf 751.2 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid signaling in the brain.pdf 308.6 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid signaling system and brain reward - emphasis on dopamine.pdf 275.9 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid system and mood disorders- Priming a target for new therapies.pdf 704.9 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid system dysfunction in mood and related disorders.pdf 401.8 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoid system in cardiovascular disorders- new pharmacolotherapeutic opportunities.pdf 547.6 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids - The Brain and Body's Marijuana and Beyond.pdf 6.4 MB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and cannabinoid receptor genetics.pdf 1.9 MB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and fatty acid amides in cancer inflammation and related disorders.pdf 244.6 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and liver disease - review.pdf 122.7 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and pregnancy.pdf 595.9 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and the cardiovascular response to stress.pdf 859.6 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and the Control of Energy Balence. Matias and Di Marzo 2007.pdf 1.1 MB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and the Control of Energy Homeostasis.pdf 720.0 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and the gastrointestinal tract.pdf 2.8 MB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and Traumatic Brain Injury.pdf 131.2 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids and vascular function.pdf 107.7 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids as autoregulatory signaling molecules - coupling to nitric oxide and a possible association with the relaxation response.pdf 130.3 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids in the regulation of appetite and body weight.pdf 217.2 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediateed exitotoxic damage.pdf 395.9 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids, Blood Pressure and the Human Heart.pdf 174.6 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids, FOXO and the metabolic syndrome- Redox, function and tipping point – The view from two systems.pdf 939.8 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids- endogenous cannabinoid receptor ligands with neuromodulatory action.pdf 211.1 kB
  • Endocannabinoids & The Endocannabinoid system/Endocannabinoids.pdf 593.4 kB
  • Endocannabinoids & The Endocannabinoid system/Endogenous cannabinoid system as a modulator of food intake.pdf 684.5 kB
  • Endocannabinoids & The Endocannabinoid system/Endogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation.pdf 28.4 kB
  • Endocannabinoids & The Endocannabinoid system/Endogenous cannabinoids - a new target in the treatment of obesity.pdf 39.9 kB
  • Endocannabinoids & The Endocannabinoid system/Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.pdf 954.8 kB
  • Endocannabinoids & The Endocannabinoid system/Energy balance regulation by endocannabinoids at central and peripheral levels.pdf 460.2 kB
  • Endocannabinoids & The Endocannabinoid system/Exercise, the endocannabinoid system and metabolic health.pdf 261.2 kB
  • Endocannabinoids & The Endocannabinoid system/From endocannabinoid profiling to ‘endocannabinoid therapeutics'.pdf 357.6 kB
  • Endocannabinoids & The Endocannabinoid system/Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.pdf 307.8 kB
  • Endocannabinoids & The Endocannabinoid system/Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis. A non-genomic anti-inflammatory switch.pdf 552.9 kB
  • Endocannabinoids & The Endocannabinoid system/Gut feelings about the endocannabinoid system.pdf 276.3 kB
  • Endocannabinoids & The Endocannabinoid system/Immune control by endocannabinoids - New mechanisms of neuroprotection.pdf 180.2 kB
  • Endocannabinoids & The Endocannabinoid system/Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.pdf 818.6 kB
  • Endocannabinoids & The Endocannabinoid system/Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.pdf 209.1 kB
  • Endocannabinoids & The Endocannabinoid system/Involvement of the endocannabinoid system in executive function- a pharmacological fMRI study with D9THC.pdf 78.6 kB
  • Endocannabinoids & The Endocannabinoid system/Involvement of the endocannabinoid system in working memory- a pharmacological MRI study with D9THC.pdf 44.8 kB
  • Endocannabinoids & The Endocannabinoid system/Kavalactones and the endocannabinoid system- The plant-derived yangonin is a novel CB1 receptor ligand.pdf 500.8 kB
  • Endocannabinoids & The Endocannabinoid system/Lipids, lipid rafts and caveola- Their importance for GPCR signaling and their centrality to the endocannabinoid system.pdf 355.3 kB
  • Endocannabinoids & The Endocannabinoid system/Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.pdf 1.2 MB
  • Endocannabinoids & The Endocannabinoid system/Minireview- Receptor-dependent and receptor-independent endocannabinoid signaling- A therapeutic target for regulation of cancer growth.pdf 161.2 kB
  • Endocannabinoids & The Endocannabinoid system/Modulating the endocannabinoid system in human health and disease – successes and failures.pdf 313.4 kB
  • Endocannabinoids & The Endocannabinoid system/Modulation of the Endocannabinoid System in Cardiovascular Disease - therapeutic potential and limitations.pdf 1.2 MB
  • Endocannabinoids & The Endocannabinoid system/Modulation of the endocannabinoid system- Neuroprotection or neurotoxicity.pdf 357.5 kB
  • Endocannabinoids & The Endocannabinoid system/More surprises lying ahead. The endocannabinoids keep us guessing.pdf 447.6 kB
  • Endocannabinoids & The Endocannabinoid system/Multiple Functions of endocannabinoid signaling in the brain.pdf 1.7 MB
  • Endocannabinoids & The Endocannabinoid system/Neuromodulatory role of the endocannabinoid signaling system in alcoholism - an overview.pdf 528.0 kB
  • Endocannabinoids & The Endocannabinoid system/NEURONAL POPULATIONS MEDIATING THE EFFECTS OF ENDOCANNABINOIDS ON STRESS AND EMOTIONALITY.pdf 1.6 MB
  • Endocannabinoids & The Endocannabinoid system/New insights on endocannabinoid transmission in psychomotor disorders.pdf 281.1 kB
  • Endocannabinoids & The Endocannabinoid system/Noladin ether, a putative novel endocannabinoids – inactivation mechanisms and a sensitive method for its quantification in rat tissues.pdf 130.7 kB
  • Endocannabinoids & The Endocannabinoid system/Non-psychotropic analgesic drugs from the endocannabinoid system “Magic bullet” or “multiple-target” strategies.pdf 455.6 kB
  • Endocannabinoids & The Endocannabinoid system/Not Too Excited- Thank Your Endocannabinoids.pdf 56.9 kB
  • Endocannabinoids & The Endocannabinoid system/Pharmacological Exploitation of the Endocannabinoid System- New Perspectives for the treatment of depression and anxiety disorders.pdf 3.8 MB
  • Endocannabinoids & The Endocannabinoid system/Pharmacotherapeutic targeting of the endocannabinoid signaling system- Drugs for obesity and the metabolic syndrome.pdf 961.3 kB
  • Endocannabinoids & The Endocannabinoid system/Phylogenomic and chemotaxonomic analysis of the endocannabinoid system.pdf 242.0 kB
  • Endocannabinoids & The Endocannabinoid system/Phytocannabinoids and Endocannabinoids.pdf 610.5 kB
  • Endocannabinoids & The Endocannabinoid system/Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat.pdf 448.2 kB
  • Endocannabinoids & The Endocannabinoid system/Potential roles of (endo)cannabinoids in the treatment of glaucoma - from intraocular pressure control to neuroprotection.pdf 419.0 kB
  • Endocannabinoids & The Endocannabinoid system/Psychopharmacology of the endocannabinoids- far beyond anandamide.pdf 2.0 MB
  • Endocannabinoids & The Endocannabinoid system/Recent advances in the understanding of the role of the endocannabinoid system in liver diseases.pdf 672.9 kB
  • Endocannabinoids & The Endocannabinoid system/Receptor-independent actions of cannabinoids on cell membranes - Focus on endocannabinoids.pdf 702.9 kB
  • Endocannabinoids & The Endocannabinoid system/Regulation of male fertility by the endocannabinoid system.pdf 388.7 kB
  • Endocannabinoids & The Endocannabinoid system/Role of cannabis and endocannabinoids in the genesis of schizophrenia.pdf 536.0 kB
  • Endocannabinoids & The Endocannabinoid system/Role of endocannabinoids and endovanilloids in Ca2+ signalling.pdf 712.1 kB
  • Endocannabinoids & The Endocannabinoid system/Role of the endocannabinoid system in depression and suicide.pdf 343.4 kB
  • Endocannabinoids & The Endocannabinoid system/Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas.pdf 878.1 kB
  • Endocannabinoids & The Endocannabinoid system/The brain endocannabinoid system in the regulation of energy balence.pdf 617.7 kB
  • Endocannabinoids & The Endocannabinoid system/The emerging role of the endocannabinoid system in cardiovascular disease.pdf 603.8 kB
  • Endocannabinoids & The Endocannabinoid system/The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase-A Mediates Retrograde Suppression of Synaptic Transmission.pdf 547.3 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid nervous system - unique opportunities for therapeutic intervention.pdf 184.8 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid pathway in Huntington’s disease - A comparison with other neurodegenerative diseases.pdf 1.0 MB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid signaling system - Pharmacological and therapeutic aspects.pdf 240.3 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid signaling system- Pharmocological and therapeutic aspects.pdf 286.1 kB
  • Endocannabinoids & The Endocannabinoid system/The Endocannabinoid System - An Osteopathic Perspective.pdf 486.4 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system - current pharmacological research and therapeutic possibilities.pdf 216.8 kB
  • Endocannabinoids & The Endocannabinoid system/THE ENDOCANNABINOID SYSTEM - PHYSIOLOGY AND PHARMACOLOGY.pdf 1.5 MB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system and cardiometabolic risk.pdf 498.1 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system and emotional processing- A pharmacological fMRI study with D9THC.pdf 3.1 MB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system and emotional processing- pathophysiology and therapeutic potential.pdf 396.6 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system and gut–brain signalling.pdf 400.8 kB
  • Endocannabinoids & The Endocannabinoid system/THE ENDOCANNABINOID SYSTEM AND ITS THERAPEUTIC EXPLOITATION.pdf 540.5 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system and migraine.pdf 762.9 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system and nondrug rewarding behaviours.pdf 611.1 kB
  • Endocannabinoids & The Endocannabinoid system/The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications.pdf 2.4 MB
  • Endocannabinoids & The Endocannabinoid system/The Endocannabinoid System and the Brain.pdf 270.4 kB
  • Endocannabinoids & The Endocannabinoid system/The Endocannabinoid System as a Target for Obesity Treatment. Aronne et al 2008.pdf 188.2 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system as a target for the treatment of neurodegenerative disease.pdf 262.7 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system as a target for the treatment of neuronal damage.pdf 648.9 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system as a target for therapeutic drugs.pdf 130.0 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system as a target for treatment of Cannabis Dependence.pdf 372.6 kB
  • Endocannabinoids & The Endocannabinoid system/The Endocannabinoid System as an Emerging Target of pharmacology.pdf 2.4 MB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system in anxiety, fear memory and habituation.pdf 892.8 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system in critical neurodevelopmental periods- sex differences and neuropsychiatric implications.pdf 620.6 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.pdf 689.9 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.pdf 331.6 kB
  • Endocannabinoids & The Endocannabinoid system/The Endocannabinoid System in the Regulation of Cardiometabolic Risk Factors.pdf 287.7 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system, eating behavior and energy homeostasis- The end or a New Beginning. Bermudez-Silva et al.pdf 240.1 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system- emotion, learning and addiction.pdf 591.4 kB
  • Endocannabinoids & The Endocannabinoid system/The endocannabinoid system- Role in glucose and energy metabolism.pdf 180.1 kB
  • Endocannabinoids & The Endocannabinoid system/The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.pdf 545.7 kB
  • Endocannabinoids & The Endocannabinoid system/The genetic basis of the endocannabinoid system and drug addiction in humans.pdf 3.4 MB
  • Endocannabinoids & The Endocannabinoid system/The inhibitory action of exo- and endocannabinoids on [3H]GABA release are mediated by both CB1 and CB2 receptors in the mouse hippocampus.pdf 340.6 kB
  • Endocannabinoids & The Endocannabinoid system/The multiple functions of the endocannabinoid system- a focus on the regulation of food intake.pdf 904.0 kB
  • Endocannabinoids & The Endocannabinoid system/The rat pineal gland comprises an endocannabinoid system.pdf 802.6 kB
  • Endocannabinoids & The Endocannabinoid system/The role of endocannabinoids in gonadal function and fertility along the evolutionary axis.pdf 585.0 kB
  • Endocannabinoids & The Endocannabinoid system/The role of the endocannabinoid system in lipogenesis and fatty acid metabolism.pdf 325.9 kB
  • Endocannabinoids & The Endocannabinoid system/The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants.pdf 296.3 kB
  • Endocannabinoids & The Endocannabinoid system/Therapeutic opportunities through modulation of the endocannabinoid system.pdf 105.8 kB
  • Endocannabinoids & The Endocannabinoid system/Therapeutic Potential of Endocannabinoid‐Hydrolysing Enzyme Inhibitors.pdf 139.1 kB
  • Endocannabinoids & The Endocannabinoid system/Time-dependent alterations of the endocannabinoid system and synaptic markers following adolescent D9THC administration in female rats.pdf 49.3 kB
  • Endocannabinoids & The Endocannabinoid system/Time-dependent vascular actions of D9-tetrahydrocannabinol Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma.pdf 246.4 kB
  • Endocannabinoids & The Endocannabinoid system/Understanding Metabolic Homeostasis and Imbalance- What Is the Role of the Endocannabinoid System.pdf 548.7 kB
  • Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.pdf 283.6 kB
  • Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation.pdf 676.9 kB
  • ENDOCANNABINOIDS INHIBIT RELEASE OF NERVE GROWTH FACTOR BY INFLAMMATION-ACTIVATED MAST CELLS.pdf 564.1 kB
  • Endocannabinoids.pdf 593.6 kB
  • Endocrine Effects of Marijuana.pdf 187.7 kB
  • Endogenous and Synthetic Cannabinoids - Recent Advances.pdf 1.5 MB
  • Endogenous cannabinoid system as a modulator of food intake.pdf 671.6 kB
  • Endogenous cannabinoids and appetite.pdf 177.3 kB
  • Endogenous cannabinoids revisited - A biochemistry perspective.pdf 2.3 MB
  • Endophytic fungi harbored in Cannabis sativa L. – diversity and potential as biocontrol agents against host plant-specific phytopathogens.pdf 535.3 kB
  • ENERAL PHARMACOLOGICAL ACTIONS OF SOME SYNTHETIC THC derivatives.pdf 2.4 MB
  • Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.pdf 517.8 kB
  • Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal D9THC.pdf 398.7 kB
  • Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules.pdf 323.6 kB
  • Environmental Costs of Hemp Prohibition in the United States.pdf 53.9 kB
  • Environmental Risks and Opportunities in Cannabis Cultivation.pdf 1.3 MB
  • Epilepsy & Seizures/Alcohol and Marijuana- Effects on Epilepsy and Use by Patients with Epilepsy.pdf 60.3 kB
  • Epilepsy & Seizures/ANTI CONVULSANT ACTIVITY OF 4 OXYGENATED CANNABIDIOL DERIVATIVES.pdf 1.7 MB
  • Epilepsy & Seizures/Anti-epileptic Action of Marijuana-Active Substances.pdf 18.6 kB
  • Epilepsy & Seizures/Anticonvulsant Activity of D8- and D9THC in Rats.pdf 573.6 kB
  • Epilepsy & Seizures/Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus.pdf 440.1 kB
  • Epilepsy & Seizures/Antiepileptic potential of cannabidiol analogs.pdf 4.9 MB
  • Epilepsy & Seizures/Cannabidiol - Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.pdf 303.5 kB
  • Epilepsy & Seizures/Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.pdf 445.4 kB
  • Epilepsy & Seizures/Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.pdf 404.2 kB
  • Epilepsy & Seizures/Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.pdf 478.6 kB
  • Epilepsy & Seizures/Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy.pdf 583.2 kB
  • Epilepsy & Seizures/Cannabinoids for epilepsy (Review).pdf 210.7 kB
  • Epilepsy & Seizures/Cannabinoids- Defending the Epileptic Brain.pdf 56.1 kB
  • Epilepsy & Seizures/Chronic administration of CBD to healthy volunteers and epileptic patients.pdf 1.6 MB
  • Epilepsy & Seizures/Convulsions Associated with the Use of a Synthetic Cannabinoid Product.pdf 80.9 kB
  • Epilepsy & Seizures/D9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats.pdf 676.2 kB
  • Epilepsy & Seizures/Delta-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats.pdf 674.0 kB
  • Epilepsy & Seizures/Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.pdf 1.5 MB
  • Epilepsy & Seizures/Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus.pdf 876.5 kB
  • Epilepsy & Seizures/Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans.pdf 265.0 kB
  • Epilepsy & Seizures/Effect of Cannabidiol and of Other Cannabis Sativa compounds on hippocampal seizure discharges.pdf 406.0 kB
  • Epilepsy & Seizures/EFFECTS OF CANNABIDIOL ON BEHAVIORAL SEIZURES CAUSED BY CONVULSANT DRUGS OR CURRENT IN MICE.pdf 412.7 kB
  • Epilepsy & Seizures/Endocannabinoid system protects against cryptogenic seizures.pdf 221.2 kB
  • Epilepsy & Seizures/Endocannabinoids block status epilepticus in cultured hippocampal neurons.pdf 1.1 MB
  • Epilepsy & Seizures/Endogenous Сannabinoid System in the Brain- Role in Regulation of Seizure Activity [russian].pdf 222.0 kB
  • Epilepsy & Seizures/Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of delta9-tetrahydrocannabinol- incomplete paper.pdf 992.5 kB
  • Epilepsy & Seizures/Factors associated with medication adherence in patients with epilepsy and recommendations for improvement.pdf 290.1 kB
  • Epilepsy & Seizures/Forebrain-Specific Inactivation of Gq-G11 Family G Proteins Results in Age-Dependent Epilepsy and Impaired Endocannabinoid Formation.pdf 444.6 kB
  • Epilepsy & Seizures/Marijuana use and the risk of new onset seizures.pdf 555.3 kB
  • Epilepsy & Seizures/Marijuana, endocannabinoids, and epilepsy - Potential and challenges for improved therapeutic intervention.pdf 219.9 kB
  • Epilepsy & Seizures/Medical marijuana for epilepsy - Winds of change.pdf 117.4 kB
  • Epilepsy & Seizures/On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures.pdf 233.5 kB
  • Epilepsy & Seizures/Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy.pdf 43.7 kB
  • Epilepsy & Seizures/regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.pdf 923.2 kB
  • Epilepsy & Seizures/Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.pdf 181.0 kB
  • Epilepsy & Seizures/Seizure exacerbation in two patients with focal epilepsy following marijuana cessation.pdf 877.0 kB
  • Epilepsy & Seizures/Selective Antiepileptic Effects of N-Palmitoylethanolamide, a Putative Endocannabinoid.pdf 80.0 kB
  • Epilepsy & Seizures/The case for assessing cannabidiol in epilepsy.pdf 113.5 kB
  • Epilepsy & Seizures/The effects of ... AM-251... and ACEA on penicillin-induced epileptiform activity in rats.pdf 356.6 kB
  • Epilepsy & Seizures/The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus.pdf 1.3 MB
  • Epilepsy & Seizures/The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy.pdf 392.1 kB
  • Epilepsy & Seizures/The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice.pdf 826.6 kB
  • Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase - Dual Targets ... to Protect against Seizure Pathology.pdf 648.5 kB
  • Essential oil of Cannabis sativa L.pdf 589.6 kB
  • ESSENTIAL OILS AND THEIR CONSTITUENTS XX1X THE ESSENTIAL OIL OF MARIHUANA - Composition of genuine Indian Cannabis sativa L..pdf 217.2 kB
  • Essential oils of different cultivars of Cannabis sativa L. and their antimicrobial activity.pdf 71.8 kB
  • Established and Potential Therapeutic applications of cannabinoids in oncology.pdf 1.1 MB
  • Establishing expertise - Canadian community-based medical cannabis dispensaries as embodied health movement organisations.pdf 294.4 kB
  • Estimated Cost of Production for Legalized Cannabis.pdf 349.0 kB
  • Estimating the economic value of British Columbia’s domestic cannabis market- Implications for provincial cannabis policy.pdf 472.2 kB
  • Ethanol increases plasma D9THC levels and subjective effects after marihuana smoking in human volunteers.pdf 130.2 kB
  • Ethephon application stimulats cannabinoids and plastidic terpenoids production in Cannabis sativa at flowering stage.pdf 599.3 kB
  • Ethylene- Sources, Symptoms, and Prevention for Greenhouse Crops [Cannabis not mentioned].pdf 240.8 kB
  • Evaluating the public interest - regulation of industrial hemp under the controlled substances act.pdf 251.8 kB
  • Evaluation of 11-hydroxy-Δ8-THC-dimethylheptyl effects on cytokine profile and locomotor tests in an experimental model of multiple sclerosis.pdf 64.5 kB
  • Evaluation of a Vaporizing Device (Volcano) for the pulmonary administration of THC.pdf 176.2 kB
  • Evaluation of herbal cannabis characteristics by medical users - a randomized trial.pdf 448.0 kB
  • Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.pdf 389.7 kB
  • Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease - Importance of antioxidant and cannabinoid receptor-independent properties.pdf 340.8 kB
  • Evidence for novel cannabinoid receptors.pdf 240.4 kB
  • Evidence Ignored - The United States Army's Panama Canal Zone Studies on Marijuana, 1916-1933.pdf 360.1 kB
  • Evidence that (-)-7-hydroxy-4’-dimethylheptyl-cannabidiol activates a non-CB1, non-CB2, non-TRPV1 target in the mouse vas deferens.pdf 227.6 kB
  • Evidence that the plant cannabinoid cannabigerol is a highly potent a2-adrenoreceptor agonist and moderately potent 5HT1A receptor agonist.pdf 461.0 kB
  • Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants.pdf 220.3 kB
  • Examination of the immunosuppressive effect of D9THC in streptozotocin-induced autoimmune diabetes.pdf 1.1 MB
  • Excretion of D9THC in sweat.pdf 258.8 kB
  • Exercise increases plasma THC concentrations in regular cannabis users.pdf 1.2 MB
  • Exhaled breath for drugs of abuse testing - Evaluation in criminal justice settings.pdf 241.4 kB
  • Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes - a systematic review.pdf 407.3 kB
  • Experimental and Computational Studies into an ATPH-Promoted exo-Selective IMDA Reaction - A Short Total Synthesis of D9THC.pdf 403.5 kB
  • Explaining associations between cannabis use disorders in adolescence and later major depression- A test of the psychosocial failure model.pdf 132.8 kB
  • Exploratory study of the psychopathological profiles of adolescent cannabis users.pdf 169.7 kB
  • Exploring the association between cannabis use and depression.pdf 112.1 kB
  • Exploring the substituent effects on a novel series of C10-dimethyl-aryl D8THC analogs.pdf 555.1 kB
  • Exposure to a high-fat diet decreases sensitivity to D9THC induced motor effects in female rats.pdf 461.9 kB
  • Exposure to Bath Salts and Synthetic Tetrahydrocannabinol from 2009 to 2012 in the United States.pdf 709.1 kB
  • Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma- growth inhibition by receptor activation.pdf 1.3 MB
  • Extractum Cannabis indicae (non-english).pdf 103.1 kB
  • Factors associated with variability and stability of cannabis use in young adulthood.pdf 820.3 kB
  • Factors determining yield and quality of illicit indoor cannabis (Cannabis spp.) production.pdf 276.8 kB
  • Failure of Cannabinoid Compounds to Stimulate Estrogen Receptors.pdf 1.0 MB
  • Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats - an examination of behavioural consequences.pdf 817.0 kB
  • Fatal coronary artery thrombosis associated with Cannabis smoking.pdf 338.9 kB
  • Fatty acid composition and oxidation stability of hemp (Cannabis sativa L.)- seed oil extracted by supercritical carbon dioxide.pdf 239.7 kB
  • FBI - more than half of all violent crimes nationwide, and four in five property crimes, went unsolved in 2012.pdf 36.8 kB
  • FDA - MARINOL® (Dronabinol) Capsules - FDA.pdf 225.4 kB
  • Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey- role of fatty acid amide hydrolase.pdf 450.3 kB
  • Female-Associated DNA Polymorphisms of Hemp (Cannabis sativa L.).pdf 615.6 kB
  • Female-Associated DNA Polymorphisms of Hemp.pdf 615.6 kB
  • Fibre hemp and marihuana - assessing the differences between distinct varieties.pdf 716.8 kB
  • Fidelity to Motivational Interviewing and subsequent cannabis cessation among adolescents.pdf 186.6 kB
  • Field Testing of Collection Cards for Cannabis sativa Samples With a Single Hexanucleotide DNA Marker.pdf 164.5 kB
  • First systematic evaluation of the potency of Cannabis sativa plants grown in Albania.pdf 248.7 kB
  • Flavonoid Glycosides and Cannabinoids from the pollen of Cannabis sativa L..pdf 68.4 kB
  • Flowering dynamics in monoecious and dioecious hemp genotypes.pdf 153.1 kB
  • FOLIAR PIGMENTS AND THEYR DYNAMICS DURING DIFFERENT vegetation phenophases in five cultivars of Cannabis sativa L..pdf 994.4 kB
  • From cannabis to cannabinergics- new therapeutic opportinities.pdf 387.2 kB
  • Frontal lobe dysfunction in long-term cannabis users.pdf 98.0 kB
  • Functional and structural properties and in vitro digestibility of acylated hemp (Cannabis sativa L.) protein isolates.pdf 871.5 kB
  • Functional neuroanatomy of the endocannabinoid system.pdf 227.6 kB
  • Future of Cannabis and Cannabinoids in therapeutics.pdf 84.9 kB
  • G-protein Receptor Kinase 5 Regulates the Cannabinoid Receptor 2-induced Up-regulation of Serotonin 2A Receptors.pdf 1.2 MB
  • Gas Chromatographic Determination of Tetrahydrocannabinol in Cannabis.pdf 15.8 kB
  • GC-MS Analysis of the Total D9THC Content of both drug and fiber type Cannabis seeds.pdf 287.6 kB
  • GC-MS Analysis of the Total D9THC Content of Both Drug- and Fiber-Type Cannabis Seeds.pdf 287.5 kB
  • Gender differences in cannabis use disorders- Results from the National Epidemiologic Survey of Alcohol and Related Conditions.pdf 395.2 kB
  • Gender moderates the impact of stereotype threat on cognitive function in cannabis users.pdf 292.8 kB
  • Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.pdf 779.5 kB
  • General and oral health implications of cannabis use.pdf 47.3 kB
  • Generalizability of clinical trials for cannabis dependence to community samples.pdf 191.6 kB
  • Genetic dissection of the psychotomimetic effects of cannabinoid exposure.pdf 414.5 kB
  • Genetic individualization of Cannabis sativa by a short tandem repeat multiplex system.pdf 277.7 kB
  • Genetic Variation in Hemp and Marijuana (Canbabis sativa L.) According to Amplified Fragment Length Polymorphisms.pdf 90.0 kB
  • Genetics and marker-assisted selection of the chemotype in Cannabis sativa L..pdf 283.3 kB
  • Granny Storm Crow's List for January 2012.pdf 5.6 MB
  • Granny Storm Crow's List for January 2013.pdf 330.0 kB
  • Granny Storm Crow's List for July 2013.pdf 377.3 kB
  • Great Schism - Social Norms and Marijuana Prohibition.pdf 1.1 MB
  • GREENHOUSE PROPAGATION OF CANNABIS SATIVA L. BY vegetative cuttings.pdf 270.5 kB
  • Grey matter alterations associated with cannabis use- Results of a VBM study in heavy cannabis users and healthy controls.pdf 429.9 kB
  • Growing medicine - Small‐scale cannabis cultivation for medical purposes in six different countries.pdf 240.3 kB
  • Half-Baked Science - A Primer on Medicinal Cannabis.pdf 82.6 kB
  • Handbook of cannabis therapeutics - from bench to bedside.pdf 3.8 MB
  • Harm reduction associated with inhalation and oral administration of cannabis and THC.pdf 206.3 kB
  • Has the intake of THC by cannabis users changed over the last decade - Evidence of increased exposure by analysis of blood THC concentrations in impaired drivers.pdf 347.8 kB
  • Hash & Hashish/ACUTE EFFECTS OF CANNABIS ON COGNITIVE, perceptual, and motor performance in chronic hashish users.pdf 498.8 kB
  • Hash & Hashish/Behavioral Effects of Hashish in Mice - I. Social Interactions and Nest-building Behavior of Males.pdf 771.5 kB
  • Hash & Hashish/Behavioral Effects of Hashish in Mice - III. Social Interactions Between Two Residents and an Intruder Male.pdf 789.3 kB
  • Hash & Hashish/Cannabinoids in hair strategy to prove marijuana-hashish consumption.pdf 109.1 kB
  • Hash & Hashish/Cannabis - Marijuana & Hashish (1977).pdf 1.1 MB
  • Hash & Hashish/Cannabis Alchemy - The Art of Modern Hashmaking.pdf 18.8 MB
  • Hash & Hashish/Cannabis Haschisch & Marihuana (non-english).pdf 9.3 MB
  • Hash & Hashish/Cannabis in Amsterdam - A Geography of Hashish and Marihuana.pdf 202.9 kB
  • Hash & Hashish/Cannabis VII - Identification of cannabinol methyl ether from hashish.pdf 197.6 kB
  • Hash & Hashish/Cannabis, the mind and society - the hash realities.pdf 560.2 kB
  • Hash & Hashish/Cannabivarin and Tetrahydrocannabivarin, two new constituents of hashish.pdf 271.6 kB
  • Hash & Hashish/Changes induced by hashish constituents on human erythrocyte phospholipids.pdf 256.6 kB
  • Hash & Hashish/Classification of hashish by pyrolysis –gas chromatography.pdf 415.1 kB
  • Hash & Hashish/Discriminative Response Control Produced with Hashish, Tetrahydrocannabinols (D8THC and D9THC), and Other Drugs.pdf 953.2 kB
  • Hash & Hashish/Effect of hashish smoke sublimate on hypothalamic noradrenaline studied by the fluorescence method.pdf 1.6 MB
  • Hash & Hashish/EFFECTS OF ACUTE AND CHRONIC INHALATION OF HASHISH, Marijuana, and D9THC ELECTRICAL ACTIVITY IN MAN - EVIDENCE FOR TISSUE TOLERANCE.pdf 663.3 kB
  • Hash & Hashish/Effects of Hashish on Isolation Induced Aggression in Wild Mice.pdf 537.5 kB
  • Hash & Hashish/EFFECTS OF PRE- AND PERINATAL EXPOSURE TO HASHISH EXTRACTS ON THE ONTOGENY OF BRAIN DOPAMINERGIC NEURONS.pdf 835.6 kB
  • Hash & Hashish/Folk Methodology of Charas (Hashish) Production and Its Marketing at Afridi Tirah, Federally Administered Tribal Areas (FATA), Pakistan.pdf 2.1 MB
  • Hash & Hashish/HASHASHISH COMPONENTS - PHOTOCHEMICAL PRODUCTION of CANNABICYCLOL FROM CANNARICHROMENE.pdf 91.3 kB
  • Hash & Hashish/Hashish (1)- Ceric ammonium nitrate oxidation of Δ6a, 1 0 a-THC's.pdf 141.2 kB
  • Hash & Hashish/Hashish - A Simple One-Step Synthesis of ( - )-D1THC from p-Mentha-2,8-dien-l-01 and Olivctol.pdf 657.5 kB
  • Hash & Hashish/Hashish - I - The Structure of Cannabidiol.pdf 421.0 kB
  • Hash & Hashish/Hashish - Synthesis of ( + )-2', 11-dihydroxy-A 9-tetrahydrocannabinol (THC), a metabolite of D9THC.pdf 188.7 kB
  • Hash & Hashish/HASHISH - SYNTHESIS OF (-)- D9THC AND ITS BIOLOGICALLY POTENT METABOLITE 3'-RYDROEY-D9-THC..pdf 199.1 kB
  • Hash & Hashish/Hashish - Synthesis of d1-δ1,6-cis-tetrahydrocannabinol (THC).pdf 192.6 kB
  • Hash & Hashish/HASHISH - SYNTHESIS OF dl-D1-6-CIS-TETRAHYDROCANNABINOL (THC).pdf 192.4 kB
  • Hash & Hashish/HASHISH - The Joy of making and curing.pdf 3.3 MB
  • Hash & Hashish/HASHISH [2].pdf 208.4 kB
  • Hash & Hashish/HASHISH COMPONRNTS. PHOTOCHRMICAL PRODUCTION OP CANNABICYCLOL FROM CANNARICHROMene.pdf 91.5 kB
  • Hash & Hashish/HASHISH EXTRACT IMPAIRS LEARNING OF SUBMISSIVE BEHAVIOR IN MICE.pdf 59.3 kB
  • Hash & Hashish/Hashish extract impairs retention of defeat-induced submissive behavior in mice.pdf 464.8 kB
  • Hash & Hashish/Hashish IV - Some acid catalyzed transformations in cannabinoids.pdf 128.0 kB
  • Hash & Hashish/Hashish research — an overview.pdf 84.6 kB
  • Hash & Hashish/Hashish smoke interfers with Sidman avoidance in mice.pdf 239.2 kB
  • Hash & Hashish/Hashish Smoking and T-Lymphoeytes.pdf 306.7 kB
  • Hash & Hashish/Hashish VI - Conversion of ... and (-) D1Tetrahydrocannabinols.pdf 189.4 kB
  • Hash & Hashish/HASHISH XIII - ON THE NATURE OF THE BEAM TEST.pdf 602.1 kB
  • Hash & Hashish/Hashish! by Robert Clarke.pdf 61.2 MB
  • Hash & Hashish/HASHISH-IV - THE ISOLATION AND STRUCTURE OF CANNABINOLICCANNABIDIOLIC AND CANNABIGEROLIC ACIDS.pdf 556.1 kB
  • Hash & Hashish/HASHISH-VII - THE ISOMERIZATION OF CANNABIDIOL.pdf 528.9 kB
  • Hash & Hashish/Hashish.pdf 821.2 kB
  • Hash & Hashish/HEADSPACE VOLATILES OF MARIHUANA AND HASHISH - GAS CHROMATOGRAPHIC ANALYSIS OF SAMPLES OF DIFFERENT GEOGRAPHIC ORIGIN.pdf 478.0 kB
  • Hash & Hashish/IDENTIFICATION OF CANNABIVARINS IN HASHISH BY A NEW METHOD of combined gas chromatography mass spectrometry.pdf 485.2 kB
  • Hash & Hashish/Increased resistance-to-extinction of an avoidance response in rats following the administration of hashish resin.pdf 315.0 kB
  • Hash & Hashish/Isolation and structure of D1THC and other neutral cannabinoids from hashish.pdf 1.1 MB
  • Hash & Hashish/Isolation, structure, and partial synthesis of an active constituent of hashish.pdf 249.8 kB
  • Hash & Hashish/Levels of erythrocyte 2,3 DPG and ATP in heavy hashish smokers.pdf 243.6 kB
  • Hash & Hashish/PANEL ON MARIHUANA (HASHISH) AND OTHER PSYCHOMIMETICS.pdf 84.5 kB
  • Hash & Hashish/PROLONGED COMA IN A CHILD DUE TO HASHISH INGESTION WITH QUANTITATION OF THC METABOLITES IN URINE.pdf 143.4 kB
  • Hash & Hashish/Psychopharmacological Activity of the Active constituents of hashish and some related cannabinoids.pdf 618.6 kB
  • Hash & Hashish/Recent Advances in the Chemistry of Hashish.pdf 1.8 MB
  • Hash & Hashish/Simultaneous separation and identification of hashish constituents by coupled LC-MS (HPLC-MS).pdf 414.8 kB
  • Hash & Hashish/Some chromatographic aspects of hashish analysis. II.pdf 256.2 kB
  • Hash & Hashish/STUDIES ON HASHISH - I. ISOLATION & IDENTIFICATION OF CANNABINOLS AND EFFECT OF CERTAIN FACTORS.pdf 679.4 kB
  • Hash & Hashish/Studies on Non-Cannabinoids of Hashish - Isolation and Identification of Some Hydrocarbons.pdf 125.7 kB
  • Hash & Hashish/STUDIES ON NON-CANNABINOIDS OF HASHISH II - An approach to correlate the geographical origin of Cannabis with hydrocarbon content by chromatographic analysis.pdf 222.5 kB
  • Hash & Hashish/Tetrahydrocannabinolcarboxylic Acid, a Component of Hashish.pdf 112.3 kB
  • Hash & Hashish/THE ABSOLUTE CONFIGURATION OF D1 TETRAHYDROCANNABINOL, THE MAJOR ACTIVE CONSTITUENT OF HASHISH.pdf 115.6 kB
  • Hash & Hashish/THE ABSOLUTE CONFIGURATION OF D1THC, the major active constituent of hashish.pdf 115.6 kB
  • Hash & Hashish/The effect of hashish compounds on phospholipid phase transition.pdf 295.2 kB
  • Hash & Hashish/The Hasheesh Eater - Being Passages from the Life of a Pythagorean.pdf 1.3 MB
  • Hash & Hashish/The Herb - Hashish versus Medieval Muslim Society.pdf 144.5 kB
  • Hash & Hashish/The interaction of hashish compounds with planar lipid bilayer membranes (BLM).pdf 390.2 kB
  • Hash & Hashish/The Isolation and Structure of D1THC and Other Neutral Cannabinoids from Hashish.pdf 1.1 MB
  • Hash & Hashish/The Significance of Lymphocyte Lipid changes after smoking hashish.pdf 336.2 kB
  • HE RELATIONSHIP BETWEEN CHEMICAL COMPOSITION AND geographical origin of Cannabis.pdf 360.2 kB
  • Headspace Solid Phase Microextraction Gas Chromatography Mass Spectrometric Analysis of the Volatile Constituents of Cannabis sativa L. from Kashmir.pdf 89.3 kB
  • Health aspects of Cannabis (1986).pdf 5.0 MB
  • Health Aspects of Cannabis.pdf 4.9 MB
  • Health care use by frequent marijuana smokers who do not smoke tobacco.pdf 1.0 MB
  • HEALTH CONSEQUENCES OF ACUTE AND CHRONIC MARIJUANA USE.pdf 2.9 MB
  • Health outcomes associated with long-term regular cannabis and tobacco smoking.pdf 235.7 kB
  • Heavy marijuana users show increased serum apolipoprotein C-III levels- evidence from proteomic analyses.pdf 435.3 kB
  • Heavy metal tolerance and accumulation of Cd, Cr and Ni by Cannabis sativa L..pdf 193.4 kB
  • Heishman_1997_Pharmacology-Biochemistry-and-Behavior.pdf 314.7 kB
  • Hemp (Cannabis sativa L.) as an Environmentally friendly energyplant.pdf 154.2 kB
  • Hemp (Cannabis sativa L.) Cultivation in the Tai'an District of Shandong Province, Peoples Republic of China.pdf 778.9 kB
  • Hemp (Cannabis) Cultivation and Use in the Republic of Korea.pdf 9.6 MB
  • Hemp - A New Crop with New Uses for North America.pdf 14.8 MB
  • Hemp - American History Revisited - The Plant With a Divided History.pdf 977.6 kB
  • Hemp as an agricultural commodity.pdf 508.9 kB
  • Hemp Diseases and Pests - Management and Biological Control.pdf 33.5 MB
  • Hemp Fibres for Nonwoven Insulation Materials.pdf 171.8 kB
  • Hemp for Headache - An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment.pdf 206.1 kB
  • Hemp Lime Bio-composite as a Building Material in Irish Construction.pdf 2.7 MB
  • Hemp Paper.pdf 119.9 kB
  • Hemp seed cake in organic broiler diets.pdf 374.5 kB
  • Hemp vs. Marijuana - The Federal Battle to Control the Meaning of Cannabis.pdf 1.0 MB
  • Hempseed Oil - Influence of the Genotype on the Composition in a Two-Year Study.pdf 694.8 kB
  • Heterogeneity in the composition of marijuana seized in California.pdf 215.2 kB
  • HETEROZYGOUS NEUREGULIN 1 MICE DISPLAY GREATER BASELINE AND D9THC-INDUCED c-Fos EXPRESSION.pdf 2.8 MB
  • High in America The True Story Behind NORML and the Politics of Marijuana.pdf 3.7 MB
  • High Performance Liquid Chromatographic Profiling of Cannabis Products.pdf 382.7 kB
  • High Performance Liquid Chromatography (HPLC) - Methods for analyzing cannabis.pdf 177.3 kB
  • High Times, Low Sats - Diffuse Pulmonary Infiltrates Associated with Chronic Synthetic Cannabinoid Use.pdf 411.8 kB
  • High-Pressure Access to the Δ9-cis- and Δ9-trans-Tetrahydrocannabinols Family.pdf 1.4 MB
  • Hippocampal Cannabinoid-1 Receptor Upregulation Upon Endothelin-B Receptor Deficiency - A Neuroprotective Substitution Effect.pdf 322.3 kB
  • Hippocampal Neurotoxicity of D9-Tetrahydrocannabinol.pdf 356.6 kB
  • Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin.pdf 242.5 kB
  • History of Cannabis and Its Preparations in Saga, Science, and Sobriquet.pdf 1.7 MB
  • History of cannabis as a medicine - a review.pdf 1.1 MB
  • History of cannabis use is not associated with alterations in striatal dopamine D2-D3 receptor availability.pdf 341.1 kB
  • History of Therapeutic Cannabis.pdf 321.5 kB
  • HIV & AIDS/A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men.pdf 582.4 kB
  • HIV & AIDS/Cannabis therapeutics in HIV - AIDS.pdf 1.9 MB
  • HIV & AIDS/Cannabis Use in HIV for Pain and Other Medical Symptoms.pdf 113.3 kB
  • HIV & AIDS/Dronabinol and marijuana in HIV+ marijuana smokers - acute effects on caloric intake and mood.pdf 140.6 kB
  • HIV & AIDS/Dronabinol and marijuana in HIV-positive marijuana smokers - Caloric intake, mood, and sleep.pdf 243.9 kB
  • HIV & AIDS/Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers - a controlled laboratory study.pdf 243.1 kB
  • HIV & AIDS/Marijuana Effectiveness as an HIV Self-Care Strategy.pdf 150.5 kB
  • HIV & AIDS/Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea.pdf 73.8 kB
  • HIV & AIDS/Medical Marijuana in HIV-Positive Patients - What Do We Know.pdf 138.1 kB
  • HIV & AIDS/Medicinal and Recreational Marijuana Use by Patients Infected with HIV.pdf 236.0 kB
  • HIV & AIDS/Patterns of Marijuana Use Among Patients With HIV – AIDS Followed in a Public Health Care Setting.pdf 396.7 kB
  • HIV & AIDS/Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy - A Systematic Review and Meta-Analysis of Randomised Controlled Trials.pdf 220.6 kB
  • HIV & AIDS/Smoked Medicinal Cannabis for Neuropathic Pain in HIV - A randomized, crossover clinical trial.pdf 131.2 kB
  • HIV & AIDS/The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.pdf 805.9 kB
  • HIV & AIDS/The Safety and Pharmacokinetics of Single-Agent and Combination Therapy with Megestrol Acetate and Dronabinol for the Treatment of HIV Wasting Syndrome.pdf 1.9 MB
  • How important are sex differences in cannabinoid action.pdf 199.5 kB
  • How lipophilic cannabinergic ligands reach their receptor sites.pdf 504.6 kB
  • How to be a pot star like me - what every marijuana enthusiast should know - High Times Books (2000).pdf 3.8 MB
  • HPLC of Cannabis quantitative analysis of acidic and neutral cannabinoids.pdf 527.0 kB
  • HU-308 - A specific agonist for CB2, a peripheral cannabinoid receptor.pdf 155.3 kB
  • HU-331 - a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity.pdf 171.0 kB
  • Hubble Bubble Equals Trouble – The Hazards of Water Pipe Smoking.pdf 1.1 MB
  • Human Cannabinoid Pharmacokinetics.pdf 336.8 kB
  • Human pharmacology of 1S and 1R enantiomers of delta-3-tetrahydrocannabinol.pdf 237.9 kB
  • Human Studies of Cannabinoids and Medicinal Cannabis.pdf 366.4 kB
  • Hyper-priming in cannabis users- A naturalistic study of the effects of cannabis on semantic memory function.pdf 318.7 kB
  • Hyperemesis Gravidarum and Clinical Cannabis - To eat or not to eat.pdf 107.0 kB
  • Hyperphagia in Pre-Fed Rats Following Oral D9THC.pdf 109.1 kB
  • Hypnotic and Antiepileptic Effects of CBD.pdf 1.4 MB
  • Hypothesis - cannabinoid therapy for the treatment of gliomas.pdf 359.5 kB
  • IACM 2nd Conference on Cannabinoids in Medicine.pdf 134.9 kB
  • IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS.pdf 918.9 kB
  • Identification of candidate genes affecting THC biosynthesis in Cannabis sativa.pdf 477.3 kB
  • Identification of candidate genes affecting Δ9-tetrahydrocannabinol biosynthesis in Cannabis sativa.pdf 486.4 kB
  • Identification of DNA markers linked to the male sex in dioecious hemp.pdf 214.4 kB
  • Identification of Marijuana (Cannabis sativa L.).pdf 284.5 kB
  • Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides.pdf 1.5 MB
  • IL-1 p and TNFcv Modulate D9THC- Induced Catalepsy in Mice.pdf 713.2 kB
  • Illegally green - Environmental costs of hemp prohibition.pdf 986.6 kB
  • Illicit and abused drugs in sewage sludge - Method optimization and occurrence.pdf 1.4 MB
  • Imaging dopamine transmission parameters in cannabis dependence.pdf 338.5 kB
  • Immune function alterations in mice tolerant to D9THC functional and biochemical parameters.pdf 227.8 kB
  • Immune responses and ultrastructural changes of hemocytes in freshwater crab Sinopotamon henanense exposed to elevated cadmium.pdf 1.5 MB
  • IMMUNOCHEMICAL LOCALIZATION OF THC IN CRYOFIXED GLANDULAR TRICHOMES OF CANNABIS.pdf 253.0 kB
  • Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients - A Pilot Prospective Study.pdf 211.3 kB
  • Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by D9THC in human CD4+ T cells.pdf 1.4 MB
  • Impairment of Recent Memory by Marihuana and THC in Rhesus Monkeys.pdf 322.8 kB
  • Improved accessibility to the desoxy analogues of D9-tetrahydrocannabinol and cannabidiol.pdf 586.5 kB
  • Improved accessibility to the desoxy analogues of D9THC and cannabidiol.pdf 586.5 kB
  • Improvement in Refractory Obsessive Compulsive Disorder With Dronabinol.pdf 85.8 kB
  • Improving the quality of the cannabis debate - defining the different domains.pdf 207.3 kB
  • Impulsivity differences in recreational cannabis users and binge drinkers in a university population.pdf 494.3 kB
  • In Memoriam - Ralph Steeley - Obscured by smoke - MMJ and the need for representation enforcement review.pdf 8.8 MB
  • In Planta Imaging of THC acid in Cannabis sativa L. with Hyperspectral coherent anti-Stokes Raman Scattering Microscopy.pdf 3.1 MB
  • In Vitro - In Vivo Correlation Studies for Transdermal D8-THC Development.pdf 157.4 kB
  • In Vitro Antioxidant Properties of Hemp Seed (Cannabis sativa L.) Protein Hydrolysate Fractions.pdf 324.4 kB
  • In vitro effects of Δ9tetrahydrocannabinol (THC) on bull sperm.pdf 154.3 kB
  • In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation.pdf 382.7 kB
  • In vivo 1H magnetic resonance spectroscopy in young-adult daily marijuana users.pdf 539.6 kB
  • In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice - Inhalation versus intraperitoneal injection.pdf 1.2 MB
  • In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to D9-tetrahydrocannabinol.pdf 301.6 kB
  • Increase of mesenchymal stem cell migration by CBD via activation of p42-44 MAPK.pdf 628.2 kB
  • Increased cannabinoids concentrations found in specimens from fatal aviation accidents between 1997 and 2006.pdf 168.5 kB
  • Increasing the selectivity of the discriminative stimulus effects of D9THC- complete substitution with methanandamide.pdf 291.7 kB
  • Increasing the selectivity of the discriminative stimulus effects of THC - complete substitution with methanandamide.pdf 274.8 kB
  • Indications of a dose–response relationship between cannabis use.pdf 354.5 kB
  • Indigenous Uses and Ethnobotany of Cannabis sativa L. (Hemp) in Uttaranchal (India).pdf 139.4 kB
  • Individual and Country-Level Effects of Cannabis-Related Perceptions on Cannabis Use. A Multilevel Study Among Adolescents in 32 European Countries.pdf 283.1 kB
  • Industrial Heinp (Cannabis savita L) - The Geography of a Controversial Plant.pdf 768.7 kB
  • INDUSTRIAL HEMP – A PROMISING SOURCE FOR BIOMASS PRODUCTION.pdf 606.8 kB
  • Influence of mevinolin on chloroplast terpenoids in Cannabis sativa.pdf 375.8 kB
  • Influence of plasticizers on the stability and release of a prodrug of D9THC incorporated in poly (ethylene oxide) matrices.pdf 1.3 MB
  • Influence of Tetrahydrocannabinols ( D8THC and D9THC) on Body Weight, Food, and Water Intake in Rats.pdf 372.7 kB
  • Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.pdf 476.0 kB
  • Influence of the serotonin transporter gene polymorphism, cannabis and childhood sexual abuse on phenotype of bipolar disorder- A preliminary study.pdf 197.3 kB
  • Information for CPS, Probation, etc. on Marijuana Addiction and Marijuana & Driving.pdf 49.1 kB
  • Inhalation exposure to smoke from synthetic “marijuana” produces potent cannabimimetic effects in mice.pdf 653.9 kB
  • Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor V synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.pdf 651.2 kB
  • Inhibition of FAAH and activation of PPAR- New approaches to the treatment of cognitive dysfunction and drug addiction.pdf 647.3 kB
  • Inhibition of p38-Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis.pdf 703.4 kB
  • Inhibition of Protein Kinase A and Cyclic AMP Response Element (CRE)-Specific Transcription Factor Binding by D9THC.pdf 1.2 MB
  • Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice.pdf 218.0 kB
  • Inhibitory effect of Cannabichromene on Inflammation-induced Hypermotility in Mice. Izza et al 2012.pdf 1.5 MB
  • Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.pdf 1.5 MB
  • Inter simple sequence repeats separate efficiently hemp from marijuana (Cannabis sativa L.).pdf 496.8 kB
  • Interaction between cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) – influence of administration interval and dose ratio between the cannabinoids.pdf 65.0 kB
  • Interaction between non-psychotropic cannabinoids in marihuana- effect of CBG on the anti-nausea or anti-emetic effects of CBD in rats and shrews.pdf 246.2 kB
  • Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1).pdf 201.9 kB
  • Interactions between specific parameters of cannabis use and verbal memory.pdf 405.6 kB
  • Interactions between THC and cannabidiol in mouse models of cannabinoid activity.pdf 217.2 kB
  • Interactions between the cannabinoid and dopaminergic systems- Evidence from animal studies.pdf 1.1 MB
  • Interactions between the CB1 receptor agonist D9THC and the CB1 receptor antagonist SR-141716 in rats- Open-field revisited.pdf 360.3 kB
  • Interfertility and chromosomal uniformity in Cannabis.pdf 298.0 kB
  • Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model.pdf 1.7 MB
  • International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands - Beyond CB1 and CB2.pdf 736.8 kB
  • International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands- beyond CB₁ and CB₂.pdf 713.9 kB
  • Interrelationships of glandular trichomes and cannabinoid content. I - Developing pistillatebracts of Cannabis sativa L (Cannabaceae).pdf 356.9 kB
  • Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass Metabolism.pdf 189.2 kB
  • Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (Dronabinol).pdf 329.6 kB
  • Intraocular Pressure, Ocular Toxicity and Neurotoxicity after administration of cannabinol or cannabigerol.pdf 560.3 kB
  • Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories - the generation R study.pdf 177.1 kB
  • Introduction- Cannabis- From Pariah to Prescription.pdf 445.0 kB
  • Investigation of drugs of abuse and relevant metabolites in Dutch sewage water by liquid chromatography coupled to high resolution mass spectrometry.pdf 677.9 kB
  • Investigation of Marinol (THC) Effects upon fMRI Activation During Active and Passive Driving Using Independent Component Analysis and SPM.pdf 213.2 kB
  • Investigations into the Hypothesis of Transgenic Cannabis.pdf 118.5 kB
  • Involvement of Central and Peripheral Cannabinoid Receptors in the Regulation of Heart Resistance to Arrhythmogenic Effects of Epinephrine.pdf 313.1 kB
  • Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception.pdf 665.7 kB
  • INVOLVEMENT OF HINDBRAIN AND PERIPHERAL PROSTANOIDS IN GASTRIC MOTOR AND CARDIOVASCULAR RESPONSES TO D9THC IN THE RAT.pdf 171.8 kB
  • Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury.pdf 515.7 kB
  • Involvement of somatodendritic 5-HT1A receptors in D9THC- induced hypothermia in the rat.pdf 165.6 kB
  • INVOLVEMENT OF SUBTHALAMIC NUCLEUS IN THE STIMULATORY EFFECT OF D9THC ON DOPAMINERGIC NEURONS.pdf 567.3 kB
  • Involvement of the endocannabinoid system in executive function - a pharmacological fMRI study with delta9-tetrahydrocannabinol (THC).pdf 64.8 kB
  • Involvement of the endocannabinoids system in working memory - a pharmacological MRI study with delta9-THC.pdf 44.2 kB
  • Involvement of the α4β2 nicotinic receptor subtype in nicotine-induced attenuation of D9THC cerebellar ataxia- Role of cerebellar nitric oxide.pdf 476.1 kB
  • Influence of the Growth Stage of Hemp (Cannabis sativa L.) on Fatty Acid Content, Chemical Composition and Gross Energy.pdf 417.1 kB
  • Is cannabis use psychotogenic.pdf 55.7 kB
  • Is industrial hemp a sustainable construction material.pdf 1.7 MB
  • Is lipid signaling through cannabinoid 2 receptors part of a protective system.pdf 1.3 MB
  • Is the cardiovascular system a therapeutic target for cannabidiol.pdf 962.7 kB
  • Is there an astrocyte–neuron ketone body shuttle.pdf 79.0 kB
  • Is Thromboangiitis Obliterans Presentation influenced by Cannabis addiction.pdf 367.3 kB
  • Isolation and measurement of the endogeneous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.pdf 418.9 kB
  • Isolation of cannabinoids from the plant cannabis sativa L. and its potential anticancer activity.pdf 359.3 kB
  • Isolation of D9-THCA-A from hemp and analytical aspects concerning the determination of D9-THC in cannabis products.pdf 323.6 kB
  • Isolation of D9THCA-A from hemp and analytical aspects concerning the determination of D9THC in Cannabis products.pdf 336.2 kB
  • Isolation of endophytic fungi from Cannabis sativa and study their antifungal potential.pdf 140.8 kB
  • Isolation of microsatellite markers in Cannabis sativa L. (marijuana).pdf 87.1 kB
  • Isotope effect studies on the dehydrogenation of D1THC in the'rat.pdf 346.6 kB
  • It's Just a Plant, a Children's Story of Marijuana 2006.pdf 1.5 MB
  • Joint Ventures - Inside America's Almost Legal Marijuana Industry.pdf 1.1 MB
  • KEEP OFF THE GRASS - A scientific enquiry into the biological effects of Marijuana.pdf 8.3 MB
  • Keep Off the Grass - The Economics of Prohibition and U.S. Drug Policy.pdf 161.8 kB
  • Ketocannabinoids with therapeutic indications - Patent US 7183313 B2.pdf 2.6 MB
  • Ketone body synthesis in the brain - possible neuroprotective effects.pdf 242.0 kB
  • Kinetics of Enzyme Inhibition and Antihypertensive Effects of hempseed (Cannabis sativa L.) protein hydrolysates.pdf 380.4 kB
  • Koola_2013_Psychiatry-Research.pdf 358.7 kB
  • Kronic hysteria- Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm.pdf 670.7 kB
  • L-( +)-ISOLEUCINE BETAINE IN CANNABIS SEEDS.pdf 252.6 kB
  • Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.pdf 159.9 kB
  • Lack of Hippocampal Volume Change in Long-term Heavy Cannabis Users.pdf 621.8 kB
  • Latest advances in cannabinoid receptor agonists.pdf 1.1 MB
  • Latest advances in cannabinoid receptor antagonists and inverse agonists.pdf 1.4 MB
  • LC–MS method for the estimation of D8THC and 11-nor-D8THC-9-COOH in plasma.pdf 263.7 kB
  • LEARN BEFORE YOU BURN - THC IMPAIRS ENCODING BUT NOT RETRIEVAL OF VERBAL INFORMATION.pdf 96.5 kB
  • Legalization, Decriminalization & Medicinal Use of Cannabis - A Scientific and Public Health Perspective.pdf 844.6 kB
  • Legalizing Marijuana - Point Counterpoint.pdf 1.9 MB
  • Legionnaires Disease in Cannabis Smokers.pdf 567.5 kB
  • Letter - Cannabinoid medicines and the need for the scientific method.pdf 129.7 kB
  • Letter to the Editor regarding a report about the potential for commonly used baby cleansers to interfere with cannabinoid (THC) immunoassays.pdf 157.7 kB
  • Life cycle assessment of raw materials for non-wood pulp mills - Hemp and flax.pdf 993.7 kB
  • Life cycle environmental analysis of hemp production for non-wood pulp.pdf 96.1 kB
  • Life Sentences - The Collateral Sanctions Associated with Marijuana Offenses.pdf 289.2 kB
  • Ligands that target cannabinoid receptors in the brain- from THC to anandamide and beyond.pdf 173.1 kB
  • Linkage Analysis Followed by Association Show NRG1 Associated with Cannabis Dependence in African Americans.pdf 655.0 kB
  • Local politics and retail cannabis markets- The case of the Dutch coffeeshops.pdf 255.4 kB
  • Long lasting consequences of cannabis exposure in adolescence.pdf 171.8 kB
  • Long term marijuana users seeking medical cannabis in California (2001-2007) - demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants..pdf 150.1 kB
  • Long-term behavioral and biochemical effects of an ultra-low dose of D9-tetrahydrocannabinol (THC) - neuroprotection and ERK signaling.pdf 478.5 kB
  • Long-term cannabis use - characteristics of users in an Australian rural area.pdf 164.0 kB
  • Long-term cognitive deficits induced by a single, extremely low dose of THC- Behavioral, pharmacological and biochemical studies in mice.pdf 333.2 kB
  • Long-term consequences of a single treatment of mice with an ultra-low dose of D9THC.pdf 828.8 kB
  • Long-term effects of exposure to cannabis.pdf 96.1 kB
  • Long-term effects of frequent cannabis use on working memory and attention- n fMRI study.pdf 211.0 kB
  • Long-term effects of marijuana use on the brain.pdf 765.1 kB
  • Long-Term Efficacy and Safety of Dronabinol for Acquired Immunodeficiency Syndrome-Associated Anorexia.pdf 662.0 kB
  • Long-term heavy marijuana users make costly decisions on a gambling task.pdf 78.9 kB
  • Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence.pdf 350.6 kB
  • Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.pdf 1.3 MB
  • Lot A2 test, THC modelling of the bentonite buffer.pdf 1.1 MB
  • Low efficacy of non-opioid drugs in opioid withdrawal symptoms.pdf 60.0 kB
  • LY320135, a Novel Cannabinoid CB1 Receptor Antagonist, Unmasks Coupling of the CB1 Receptor to Stimulation of cAMP Accumulation.pdf 145.9 kB
  • Maintenance of Cannabis germplasm in the Vavilov Research Institute Gene Bank.pdf 538.8 kB
  • Making residential cannabis growing operations actionable - A critical policy analysis.pdf 133.4 kB
  • Male–female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function.pdf 231.1 kB
  • Manipulating brain connectivity with δ9-tetrahydrocannabinol- A pharmacological resting state FMRI study.pdf 781.8 kB
  • Manure Application and Cannabis Cultivation Influence on Speciation of Lead and Cadmium by Selective Sequential Extraction.pdf 293.9 kB
  • Marihuana Chemistry.pdf 1.5 MB
  • Marihuana extraction and purification for oral administration of known amounts of D9THC.pdf 206.5 kB
  • MARIHUANA INTOXICATION A Clinical Study of Cannabis Sativa Intoxication.pdf 2.6 MB
  • MARIHUANA RESEARCH findings - 1976.pdf 1.8 MB
  • Marijuan aand medicine - assessing the science base.pdf 123.8 kB
  • Marijuana (2003).pdf 295.1 kB
  • Marijuana (Cannabis) as Medicine.pdf 92.5 kB
  • Marijuana - A comprehensive series for clinicians volume.pdf 6.4 MB
  • MARIJUANA - EFFECTS ON HUMAN BEHAVIOR.pdf 5.7 MB
  • MARIJUANA - Guide to Buying, Growing, Harvesting, and Making Medical Marijuana Oil and Delicious Candies to Treat Pain and Ailments.pdf 8.4 MB
  • Marijuana - Prenatal and Postnatal Exposure in the human.pdf 53.2 kB
  • Marijuana - respiratory tract effects.pdf 2.1 MB
  • Marijuana -Drugs - the Straight Facts.pdf 9.9 MB
  • Marijuana and cannabinoid regulation of brain reward circuits - minireview.pdf 218.0 kB
  • Marijuana and cannabinoid research - methods and protocols.pdf 4.2 MB
  • Marijuana and glaucoma.pdf 127.7 kB
  • Marijuana and health hazards - methodological issues in current research (1975).pdf 3.8 MB
  • Marijuana and multiple sclerosis.pdf 92.8 kB
  • Marijuana and the Cannabinoids.pdf 2.7 MB
  • Marijuana and youth - clinical observations on motivation and learning.pdf 1.9 MB
  • Marijuana as a trigger of cardiovascular events - speculation or scientific certainty.pdf 73.6 kB
  • Marijuana as medicine - assessing the science base.pdf 123.8 kB
  • Marijuana as Medicine - The Science Beyond the Controversy.pdf 3.5 MB
  • Marijuana as scapegoat, cannabis as medicine - a cognitive-rhetorical analysis of a Canadian drug-policy problem.pdf 663.6 kB
  • Marijuana Botany An Advanced Study - The Propagation and Breeding of Distinctive Cannabis.pdf 241.3 kB
  • Marijuana Botany.pdf 553.0 kB
  • Marijuana Chemistry Genetics, Processing, and Potency.pdf 2.9 MB
  • Marijuana Decision Will Have Little Impact.pdf 70.0 kB
  • Marijuana for intractable hiccups.pdf 44.7 kB
  • Marijuana for parkinsonian tremor.pdf 446.5 kB
  • Marijuana in Medicine.pdf 1.2 MB
  • Marijuana in the management of amyotrophic lateral sclerosis.pdf 595.1 kB
  • Marijuana Myths, Marijuana Facts - A review of the scientific evidence.pdf 16.1 MB
  • Marijuana Odor Perception- Studies Modeled from Probable Cause Cases.pdf 158.2 kB
  • Marijuana Poisoning.pdf 114.3 kB
  • Marijuana Prohibition in the United States - History and analysis of a failed policy.pdf 3.6 MB
  • Marijuana smoking - Cardiovascular effects in man and possible mechanisms.pdf 626.5 kB
  • Marijuana smoking and fungal sensitization.pdf 255.1 kB
  • Marijuana Smoking vs Cannabinoids for Glaucoma Therapy.pdf 189.4 kB
  • Marijuana use - sequelae and implications for health promotion.pdf 176.9 kB
  • Marijuana use and long-term mortality among survivors of acute myocardial infarction.pdf 147.0 kB
  • Marijuana Use and the Development of Status Asthmaticus - A case report.pdf 64.3 kB
  • Marijuana Use and Well-Being in University Students.pdf 282.4 kB
  • Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivity.pdf 925.3 kB
  • Marijuana Use May Protect Against Diabetes.pdf 60.8 kB
  • Marijuana withdrawal among adults seeking treatment for Cannabis dependence.pdf 146.1 kB
  • Marijuana withdrawal and aggression among a representative sample of U.S. marijuana users.pdf 366.5 kB
  • Marijuana withdrawal in humans - effects of oral THC or divalproex.pdf 309.9 kB
  • Marijuana, Alcohol and Actual Driving Performance .pdf 153.1 kB
  • Marijuana, Tetrahydrocannabinol, and Pulmonary Antibacterial Defenses.pdf 1.4 MB
  • Marinol Versus Natural Cannabis - Pros, Cons and Options for Patients.pdf 216.6 kB
  • Maternal Cannabis Use Alters Ventral Striatal Dopamine D2 Gene Regulation in the Offspring Dopamine D2 Gene Regulation in the Offspring.pdf 927.5 kB
  • Maternal Exposure to D9THC Alters Indolamine Levels and Turnover in Adult Male and Female Rat Brain Regions.pdf 234.1 kB
  • May 1971, Oval Office Conversation Transcripts- Nixon Talking About Marijuana.doc 117.8 kB
  • May 1971, Oval Office Conversation Transcripts- Nixon Talking About Marijuana.docx 73.1 kB
  • May 1971, Oval Office Conversation Transcripts- Nixon Talking About Marijuana.pdf 248.9 kB
  • MDMA - Interactions with other psychoactive drugs.pdf 395.4 kB
  • Measured environmental contributions to cannabis abuse-dependence in an offspring of twins design.pdf 226.8 kB
  • Measurement of the Three Phases of Muricidal Behavior Induced by D9THC in Isolated, Fasting Rats.pdf 508.4 kB
  • Mechanical properties of lime–hemp concrete containing shives and fibres.pdf 215.8 kB
  • Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233.pdf 2.8 MB
  • Mechanisms underlying the lifetime co-occurrence of tobacco and cannabis use in adolescent and young adult twins.pdf 216.6 kB
  • Medial temporal structures and memory functions in adolescents with heavy cannabis use.pdf 721.8 kB
  • MEDICAL CANNABIS DISPENSING COLLECTIVES AND LOCAL REGULATION.pdf 135.6 kB
  • MEDICAL CANNABIS IN THE UNITED STATES.pdf 281.6 kB
  • Medical Consequences of Marijuana Use - A Review of current literature.pdf 220.8 kB
  • Medical Genomics and Nimbus Informatics reported and published online the complete 400 million base-pair genomic sequence of Cannabis sativa.pdf 4.5 MB
  • Medical Marijuana - A comprehensive review.pdf 671.0 kB
  • Medical Marijuana - Clearing Away the Smoke.pdf 121.7 kB
  • Medical Marijuana - Implications for Home Infusion Providers.pdf 465.9 kB
  • Medical marijuana - Medical necessity versus political agenda.pdf 242.5 kB
  • Medical marijuana - Out of the Shadows.pdf 554.1 kB
  • Medical Marijuana - The Conflict Between Scientific Evidence and Political Ideology. Part 1 of 2.pdf 220.5 kB
  • Medical Marijuana - The Conflict Between Scientific Evidence and Political Ideology. Part 2 of 2.pdf 218.5 kB
  • Medical marijuana - the conflict between scientific evidence and political ideology. Part one of two.pdf 413.5 kB
  • MEDICAL MARIJUANA ACCESS IN THE U.S. - A Patient-Focused Analysis of the Patchwork of State Laws - A White Paper prepared by Americans for Safe Access.pdf 4.5 MB
  • Medical marijuana and the developing role of the pharmacist.pdf 227.2 kB
  • MEDICAL MARIJUANA AND THE MEDIA.pdf 8.5 MB
  • Medical marijuana and the Supreme Court.pdf 287.6 kB
  • Medical Marijuana for the treatment of migrane headaches - an evidence review.pdf 482.2 kB
  • Medical Marijuana use - Experiences of people with multiple sclerosis.pdf 226.3 kB
  • Medical Marijuana, American Federalism, and the Supreme Court.pdf 62.3 kB
  • Medical Marijuana.pdf 80.1 kB
  • Medical Use of Cannabis in the Netherlands.pdf 122.4 kB
  • Medical Utility of Cannabis Sativa.pdf 294.2 kB
  • Medical, social, and law characteristics of intoxicant’s users medically examined in police custody.pdf 285.8 kB
  • Medicalizing cannabis-Science, medicine and policy, 1950-2004 - An overview of a work in progress.pdf 81.7 kB
  • Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis.pdf 256.3 kB
  • Medicinal applications of D9THC and marijuana..pdf 619.8 kB
  • Medicinal cannabis - Is D9THC necessary for all its effects.pdf 293.6 kB
  • Medicinal cannabis - Rational guidelines for dosing.pdf 313.4 kB
  • Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel.pdf 116.7 kB
  • Medicinal Cannabis in Oncology Practice - Still a Bridge Too Far.pdf 77.7 kB
  • Medicinal cannabis in oncology.pdf 180.8 kB
  • Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists.pdf 208.8 kB
  • Medicinal Properties of Cannabis according to medieval manuscripts of Azerbaijan.pdf 69.7 kB
  • Medicinal use of cannabis – history and current use.pdf 386.6 kB
  • Meiotic Chromosomes of Monoecious Kentucky Hemp (Cannabis sativa).pdf 1.3 MB
  • Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.pdf 479.2 kB
  • Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.pdf 215.4 kB
  • METABOLISM AND DISPOSITION OF TETRAHYDROCANNABINOLS in naive subjects and chronic marijuana users.pdf 655.0 kB
  • Metabolism of Δ1(6)-THC, an Active Marihuana Constituent.pdf 221.2 kB
  • Metabolomic Differentiation of Cannabis sativa cultivars using 1H NMR Spectroscopy and Principal Component Analysis.pdf 242.6 kB
  • Microbial metabolism of cannflavin A and B isolated from Cannabis sativa.pdf 246.7 kB
  • Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.pdf 1.8 MB
  • Micromorphology of the epidermic surfaces of female plants of Cannabis sativa L.pdf 340.5 kB
  • Microscopic Study on Hemp Bast Fibre Formation.pdf 6.9 MB
  • Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice - evidence for a ‘‘CB3’’ receptor.pdf 276.3 kB
  • Mississippi-Grown Cannabis satiua L. - Preliminary observation on chemical definition of phenotype and variations in THC content versus age, sex, and plant part.pdf 362.2 kB
  • Mississippi-Grown Cannabis satiua L. III - cannabinoid and cannabinoid acid content.pdf 301.2 kB
  • Mississippi-Grown Cannabis sativa - Preliminary Observation on Chemical Definition of Phenotype and Variations in THC Content versus Age, Sex, and Plant Part.pdf 362.2 kB
  • Mississippi-Grown Marihuana - Cannabis sativa cultivation and observed morphological variations.pdf 3.5 MB
  • Mitigation of post-traumatic stress symptoms by Cannabis resin - A review of the clinical and neurobiological evidence.pdf 229.9 kB
  • Mitigation of post‐traumatic stress symptoms by Cannabis resin - A review of the clinical and neurobiological evidence.pdf 229.9 kB
  • Mixed consumption of cannabis and “Spice”.pdf 232.1 kB
  • Modeling of ligand binding to G protein coupled receptors- cannabinoid CB1, CB2 and adrenergic β 2 AR.pdf 960.6 kB
  • Modelling post-emergent hemp phenology (Cannabis sativa L.) - Theory and evaluation.pdf 1.0 MB
  • Modification of THC-Actions by Cannabinol and Cannabidiol in the Rat.pdf 588.1 kB
  • Modulation of Adipocyte Biology by D9THC.pdf 211.0 kB
  • Modulation of D9THC-induced increase of cortical and hippocampal.pdf 506.1 kB
  • Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum.pdf 287.3 kB
  • Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.pdf 213.9 kB
  • Molecular and cellular basis of cannabinoid and opioid interactions.pdf 148.2 kB
  • Molecular and cellular mechanisms of excitotoxic neuronal death.pdf 385.5 kB
  • Molecular biology of cannabinoid receptors.pdf 287.3 kB
  • Molecular Cloning and heterologous expression of D1THCA synthase from Cannabis.pdf 850.2 kB
  • Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas - Role for Oxidative Stress.pdf 356.6 kB
  • Molecular mechanisms of cannabinoid addiction.pdf 908.7 kB
  • Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity.pdf 457.3 kB
  • Molecular model of cannabis sensitivity in developing neural circuits.pdf 835.4 kB
  • Molecular probes for the cannabinoid receptors.pdf 341.3 kB
  • Molecular targets for cannabidiol and its synthetic analogues - effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.pdf 162.1 kB
  • MONO- AND SESQUI-TERPENE HYDROCARBONS OF THE ESSENTIAL OIL OF CANNABIS SATIVA.pdf 146.8 kB
  • Monoclonal antibody against tetrahydrocannabinolic acid distinguishes Cannabis sativa samples from different plant species.pdf 148.4 kB
  • Mood Disorders, Marijuana Use May Be Linked.pdf 116.9 kB
  • Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC).pdf 1.3 MB
  • Mortality following treatment for cannabis use disorders- Predictors and causes.pdf 210.0 kB
  • Motion sickness, stress and the endocannabinoid system.pdf 343.7 kB
  • Motivations to quit cannabis use in an adult non-treatment sample- Are they related to relapse.pdf 227.9 kB
  • Motor effects of D9THC in cerebellar Lurcher mutant mice.pdf 268.5 kB
  • Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.pdf 624.2 kB
  • Mouse cerebellar nicotinic–cholinergic receptor modulation of Δ9-THC ataxia- Role of the α4β2 subtype.pdf 472.9 kB
  • Multi-class differentiation of cannabis seedlings in a forensic context.pdf 686.9 kB
  • Multinational overview of cannabis production regimes.pdf 718.0 kB
  • Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.pdf 510.4 kB
  • Multiple Sclerosis & ALS/An Open-Label Pilot Study of Cannabis-Based Extracts for Bladder Dysfunction in Advanced Multiple Sclerosis.pdf 51.6 kB
  • Multiple Sclerosis & ALS/Cannabinoid influence on cytokine profile in multiple sclerosis.pdf 130.8 kB
  • Multiple Sclerosis & ALS/Cannabinoids and Multiple Sclerosis.pdf 194.6 kB
  • Multiple Sclerosis & ALS/Cannabinoids control spasticity and tremor in a multiple sclerosis model.pdf 378.4 kB
  • Multiple Sclerosis & ALS/Cannabinoids control spasticity and tremor in amultiple sclerosis model.pdf 378.4 kB
  • Multiple Sclerosis & ALS/Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study) – multicenter randomised placebo-controlled trial.pdf 125.5 kB
  • Multiple Sclerosis & ALS/Cannabinoids in multiple sclerosis (CAMS) study - safety and efficacy data for 12 months follow up.pdf 97.1 kB
  • Multiple Sclerosis & ALS/Cannabis use as described by people with multiple sclerosis.pdf 29.1 kB
  • Multiple Sclerosis & ALS/Cannabis use in patients with multiple sclerosis.pdf 236.3 kB
  • Multiple Sclerosis & ALS/Cannabis use in Spanish patients with multiple sclerosis - Fulfilment of patients' expectations.pdf 141.2 kB
  • Multiple Sclerosis & ALS/Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.pdf 333.3 kB
  • Multiple Sclerosis & ALS/Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis.pdf 309.1 kB
  • Multiple Sclerosis & ALS/Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis.pdf 88.4 kB
  • Multiple Sclerosis & ALS/Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.pdf 242.0 kB
  • Multiple Sclerosis & ALS/Nabilone in the treatment of multiple sclerosis.pdf 147.8 kB
  • Multiple Sclerosis & ALS/Patterns of cannabis use among patients with multiple sclerosis.pdf 56.0 kB
  • Multiple Sclerosis & ALS/Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis - A Double-Blind, Placebo Controlled, Crossover Study.pdf 139.6 kB
  • Multiple Sclerosis & ALS/Safety, tolerability, and efficacy of orally administered cannabinoids in MS.pdf 134.2 kB
  • Multiple Sclerosis & ALS/Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.pdf 293.9 kB
  • Multiple Sclerosis & ALS/Survey of cannabis use in patients with amyotrophic lateral sclerosis.pdf 214.7 kB
  • Multiple Sclerosis & ALS/Tetrahydrocannabinol for tremor in multiple sclerosis.pdf 319.6 kB
  • Multiple Sclerosis & ALS/THE (ENDO)CANNABINOID SYSTEM IN MULTIPLE SCLEROSIS AND AMYOTROPHIC LATERAL SCLEROSIS.pdf 270.0 kB
  • Multiple Sclerosis & ALS/The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.pdf 691.2 kB
  • Multiple Sclerosis & ALS/The effect of cannabis on urge incontinence in patients with multiple sclerosis - a multicentre, randomized placebo-controlled trial (CAMS-LUTS).pdf 299.1 kB
  • Multiple Sclerosis & ALS/The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.pdf 689.9 kB
  • Multiple Sclerosis & ALS/The perceived effects of smoked cannabinoids on patients multiple sclerosis.pdf 724.8 kB
  • Multiple Sclerosis & ALS/Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis - a systematic review.pdf 243.1 kB
  • Multiple Sclerosis and Extract of Cannabis - results of the MUSEC trial.pdf 172.6 kB
  • Muscular dystrophy in adult mice chronically treated with D9THC at behavioural doses.pdf 389.2 kB
  • Myocardial infarction and marijuana.pdf 1.0 MB
  • Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2.pdf 2.9 MB
  • Myocardial infarction during marijuana smoking in a young female.pdf 1.0 MB
  • N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis.pdf 495.2 kB
  • Nabilone - an alternative antiemetic for cancer chemotherapy.pdf 532.6 kB
  • Nabilone - an effective antiemetic agent in patients receiving cancer chemotherapy.pdf 461.1 kB
  • Nabilone as effective therapy for intractable nausea and vomiting in AIDS.pdf 256.4 kB
  • Nabilone Could Treat Chorea and Irritability in Huntington’s Disease.pdf 53.7 kB
  • Nabilone for the Treatment of Paraneoplastic Night Sweats - A Report of Four Cases.pdf 226.5 kB
  • Natural abundance of stable carbon and nitrogen isotopes in Cannabis sativa reflects growth conditions.pdf 156.4 kB
  • Natural cannabinoids- Templates for drug discovery.pdf 297.1 kB
  • Nefazodone decreases anxiety during marijuana withdrawal in humans.pdf 236.8 kB
  • Nematicidal activities of Cannabis sativa L. and Zanthoxylum alatum Roxb. against Meloidogyne incognita.pdf 295.9 kB
  • Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder - a preliminary report.pdf 278.9 kB
  • Neural Basis of D9THC and CBD Effects During Response Inhibition.pdf 735.0 kB
  • Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder.pdf 2.0 MB
  • Neural substrates of faulty decision-making in abstinent marijuana smokers.pdf 396.2 kB
  • Neuroanatomical substrates involved in cannabinoid modulation of defensive responses.pdf 304.6 kB
  • Neurobehavioral effects of D9THC and cannabinoid (CB1) receptor gene expression in mice.pdf 1.1 MB
  • Neurobiology of marijuana abuse.pdf 832.1 kB
  • NEUROCHEMICAL BASIS OF CANNABIS ADDICTION.pdf 887.7 kB
  • Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.pdf 448.0 kB
  • Neuroimaging in cannabis use - a systematic review of the literature.pdf 127.6 kB
  • Neurophysiological and cognitive effects of smoked marijuana in frequent users.pdf 804.4 kB
  • Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication.pdf 207.0 kB
  • Neuroprotection by D9THC, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity.pdf 279.1 kB
  • Neuroprotective agents - Cannabinoids.pdf 866.2 kB
  • Neuroprotective Antioxidants from Marijuana.pdf 589.3 kB
  • Neuroprotective effect of CBD on B-amyloid-induced toxicity in PC12 cells.pdf 224.6 kB
  • Neuropsychological assessment of memory in child and adolescentfirst episode psychosis- Cannabis and the «paradox effect».pdf 906.5 kB
  • Neuropsychological performance in long-term Cannabis users.pdf 117.2 kB
  • NEUROPSYCHOPHARMACOLOGIC STUDIES OF MARIJUANA - SOME SYNTHETIC AND NATURAL THC DERIVATIVES IN ANIMALS AND MAN.pdf 1.5 MB
  • NEW PRODUCTION TECHNIQUES.pdf 2.3 MB
  • New species, combinations, host associations and location records of fungi associated with hemp (Cannabis sativa).pdf 258.7 kB
  • Nixon Tapes Show Roots of Marijuana Prohibition- Misinformation, Culture Wars and Prejudice.doc 81.0 kB
  • Nixon Tapes Show Roots of Marijuana Prohibition- Misinformation, Culture Wars and Prejudice.pdf 71.2 kB
  • No evidence for direct modulatory effects of D9THC on human polymorphonuclear leukocytes.pdf 176.8 kB
  • Non-cannabinoid constituents from a high potency Cannabis sativa variety.pdf 242.9 kB
  • Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics – Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels.pdf 424.5 kB
  • Non-Psychoactive Cannabinoids- new therapeutic opportunities from an ancient herb.pdf 838.9 kB
  • Non-psychotropic plant cannabinoids- new therapeutic opportunities from an ancient herb.pdf 820.7 kB
  • Nonpsychotropic Cannabinoid Acts as a Functional N-methyl-D-aspartate Receptor Blocker.pdf 786.4 kB
  • Nonreporting of cannabis use- Predictors and relationship to treatment outcome in methadone maintained patients.pdf 188.7 kB
  • NORML policy booklet.pdf 128.9 kB
  • Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB2 Cannabinoid receptor agonists - synthesis, pharmacological properties and molecular modeling.pdf 343.2 kB
  • Novel cannabinoid receptors.pdf 205.9 kB
  • Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors.pdf 636.3 kB
  • Novel synthesis of (−)-trans-Δ9,11-tetrahydrocannabinol.pdf 172.7 kB
  • Novel time-dependent vascular actions of D9THC mediated by peroxisome proliferator-activated receptor gamma.pdf 375.3 kB
  • Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors.pdf 3.1 MB
  • Novel, potent THC-anandamide (hybrid) analogs.pdf 583.7 kB
  • Nutritional and Medicinal Guide to Hemp Seed.pdf 130.7 kB
  • O- and C-D-glucosyluronic acid derivatives of D1tetrahydrocannabinol - Synthesis and differential behavior to B-glucuronidase.pdf 348.5 kB
  • Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions.pdf 660.0 kB
  • Observational analysis of feeding induced by D9-THC and anandamide.pdf 391.2 kB
  • Observational analysis of feeding induced by D9THC and anandamide.pdf 397.8 kB
  • Observations on the Cannabis Indica, or Indian Hemp.pdf 724.9 kB
  • OBSERVATIONS ON THE MEDICINAL PROPERTIES OF THE CANNABIS SATIVA OF INDIA.pdf 1.5 MB
  • Occurrence of drugs of abuse and benzodiazepines in river waters from the Madrid Region (Central Spain).pdf 557.0 kB
  • OCULAR HYPOTENSION, OCULAR TOXICITY, AND NEUROTOXICITY IN RESPONSE TO MARIHUANA.pdf 421.7 kB
  • Oil content, tocopherol composition and fatty acid patterns of the seeds of 51 Cannabis sativa L. genotypes.pdf 97.6 kB
  • On being stoned - A psychological study of marijuana intoxication (1971).pdf 34.9 MB
  • On the application of cannabis in paediatrics and epileptology.pdf 184.8 kB
  • On the Limits of Supremacy - Medical Marijuana and the States' Overlooked Power to Legalize Federal Crime.pdf 4.4 MB
  • On the Medical Activity of the Hemp Plant, as Grown in North America.pdf 747.7 kB
  • On the Pharmacological Properties of THC.pdf 99.0 kB
  • On the preparations of the Indian Hemp, or Gunjah.pdf 1.5 MB
  • Opposite Effects of D9THC and Cannabidiol on Human Brain Function and Psychopathology.pdf 631.3 kB
  • OPPOSITE NEURAL EFFECTS OF THE MAIN PSYCHOACTIVE INGREDIENTS OF CANNABIS- NEURAL BASIS FOR POTENTIAL THERAPEUTIC EFFECTS OF CANNABIDIOL.pdf 40.3 kB
  • Oral D9THC suppresses cannabis withdrawl symptoms.pdf 215.6 kB
  • Oral fluid - plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.pdf 763.3 kB
  • Oral THC produces minimal behavioral alterations in preadolescent rats.pdf 235.4 kB
  • Orbitofrontal Volumes in Early Adolescence Predict Initiation of Cannabis Use- A 4-Year Longitudinal and Prospective Study.pdf 717.7 kB
  • Organelle DNA haplotypes reflect crop-use characteristics and geographic origins of Cannabis sativa.pdf 656.8 kB
  • Organized Crime in Cannabis Cultivation in New Zealand - An Economic Analysis.pdf 2.7 MB
  • Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of D9THC in adult female rats.pdf 678.5 kB
  • Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.pdf 1.6 MB
  • Oxford Study Shows Caryophyllene (terpene) as a Dietary Cannabinoid.pdf 526.8 kB
  • Oxidative and genetic responses induced by Δ-9-tetrahydrocannabinol (Δ-9-THC) to Dreissena polymorpha.pdf 430.4 kB
  • Oxidative Stress Produced by Marijuana Smoke - an adverse effect enhanced by cannabinoids.pdf 224.1 kB
  • Pain/A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain.pdf 139.4 kB
  • Pain/A double-blind, randomized, placebo-controlled, parallel-group study ... central neuropathic pain in patients with multiple sclerosis.pdf 408.6 kB
  • Pain/A Multicenter Dose-escalation Study of the Analgesic and Adverse Effects of an Oral Cannabis Extract (Cannador) for Postoperative Pain Management.pdf 419.4 kB
  • Pain/A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy.pdf 354.0 kB
  • Pain/A RANDOMISED CONTROLLED STUDY OF SATIVEX, A CANNABIS BASED MEDICINE, IN NEUROPATHIC PAIN CHARACTERIZED BY ALLODYNIA.pdf 46.1 kB
  • Pain/A randomized double-blind placebo controlled trial assessing the effect of the oral cannabinoid nabilone on pain and quality of life in patients with fibromyalgia.pdf 38.6 kB
  • Pain/A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain.pdf 540.5 kB
  • Pain/An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy.pdf 457.6 kB
  • Pain/Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain - A randomized controlled trial.pdf 113.9 kB
  • Pain/Analgesic properties of nabilone - Evidence of synergistic effect between nabilone and endogenous pain inhibitory mechanisms.pdf 39.7 kB
  • Pain/Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain- mechanisms involved.pdf 165.3 kB
  • Pain/Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.pdf 195.1 kB
  • Pain/Are cannabinoids an effective and safe treatment option in the management of pain - A qualitative systematic review.pdf 231.5 kB
  • Pain/Are oral cannabinoids safe and effective in refractory neuropathic pain.pdf 170.9 kB
  • Pain/Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain.pdf 57.4 kB
  • Pain/Cannabinergic pain medicine - a concise clinical primer and survey of randomized-controlled trial results.pdf 302.5 kB
  • Pain/Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases.pdf 1.4 MB
  • Pain/Cannabinoid CB2 receptors - a therapeutic target for the treatment of inflammatory and neuropathic pain.pdf 317.3 kB
  • Pain/Cannabinoid Mechanisms of Pain Suppression.pdf 486.2 kB
  • Pain/Cannabinoid receptors and pain.pdf 371.3 kB
  • Pain/Cannabinoid Transmission and Pain Perception.pdf 128.1 kB
  • Pain/Cannabinoids - a real prospect for pain relief.pdf 72.3 kB
  • Pain/Cannabinoids against pain - Efficacy and strategies to reduce psychoactivity - a clinical perspective.pdf 255.5 kB
  • Pain/Cannabinoids and pain.pdf 235.6 kB
  • Pain/Cannabinoids as Pharmacotherapies for Neuropathic Pain - From the Bench to the Bedside.pdf 200.8 kB
  • Pain/Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.pdf 897.9 kB
  • Pain/Cannabinoids in Chronic Pain and Palliative Care.pdf 84.6 kB
  • Pain/Cannabinoids in pain management - CB1, CB2 and non-classic receptor ligands.pdf 585.4 kB
  • Pain/Cannabinoids in the management of difficult to treat pain.pdf 209.1 kB
  • Pain/Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain.pdf 127.3 kB
  • Pain/Cannabinoids modulate pain by multiple mechanisms of action.pdf 1.4 MB
  • Pain/Cannabinoid–Opioid Interaction in Chronic Pain.pdf 181.5 kB
  • Pain/Cannabis in painful HIV-associated sensory neuropathy - a randomized placebo-controlled trial.pdf 408.0 kB
  • Pain/Cannabis reduces opioid dose in the treatment of chronic non-cancer pain.pdf 43.6 kB
  • Pain/Cannabis sativa and the Anthropology of Pain.pdf 1.8 MB
  • Pain/Cannabis use for chronic non-cancer pain - results of a prospective survey.pdf 68.9 kB
  • Pain/Cannabis, Pain, and Sleep - Lessons from Therapeutic Clinical Trials of Sativex, a Cannabis-Based Medicine.pdf 452.3 kB
  • Pain/CASE SERIES OF MULTIPLE SCLEROSIS PATIENTS WITH NEUROPATHIC PAIN IMPROVED WITH THE ORAL CANNABINOID NABILONE.pdf 38.4 kB
  • Pain/Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.pdf 1.8 MB
  • Pain/Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain - randomised, crossover, double blind study.pdf 136.9 kB
  • Pain/Delta‐9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief.pdf 415.6 kB
  • Pain/Does the cannabinoid dronabinol reduce central pain in multiple sclerosis - Randomised double blind placebo controlled crossover trial.pdf 127.8 kB
  • Pain/Dose-dependent Effects of Smoked Cannabis on Capsaicininduced Pain and Hyperalgesia in Healthy Volunteers.pdf 1.3 MB
  • Pain/Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.pdf 90.3 kB
  • Pain/Effects of nabilone, a synthetic cannabinoid, on postoperative pain - A RANDOMIZED CONTROLLED TRIAL.pdf 317.2 kB
  • Pain/Effects of nabilone, a synthetic cannabinoid, on postoperative pain.pdf 332.3 kB
  • Pain/Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.pdf 246.3 kB
  • Pain/Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion – results of a randomised controlled trial.pdf 174.3 kB
  • Pain/Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain- The involvement of cannabinoid system.pdf 1.6 MB
  • Pain/Examining the roles of cannabinoids in pain and other therapeutic indications - a review.pdf 297.8 kB
  • Pain/Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.pdf 76.3 kB
  • Pain/Guidelines for use of cannabinoid compounds in chronic pain.pdf 253.4 kB
  • Pain/Initial experiences with medicinal extracts of cannabis for chronic pain - Results from 34 ‘N of 1’ studies.pdf 227.0 kB
  • Pain/Lack of Analgesia by Oral Standardized Cannabis Extract on Acute Inflammatory Pain and Hyperalgesia in Volunteers.pdf 528.9 kB
  • Pain/Lack of analgesic efficacy of oral D-9-tetrahydrocannabinol in postoperative pain.pdf 85.1 kB
  • Pain/Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain - A double-blind placebo-controlled cross-over trial.pdf 93.6 kB
  • Pain/Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain.pdf 74.0 kB
  • Pain/Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.pdf 1.3 MB
  • Pain/Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.pdf 631.3 kB
  • Pain/Marihuana and pain.pdf 80.9 kB
  • Pain/Mechanism of Action of Cannabinoids - How It May Lead to Treatment of Cachexia, Emesis, and Pain.pdf 185.8 kB
  • Pain/More evidence cannabis can help in neuropathic pain.pdf 259.4 kB
  • Pain/Nabilone for the treatment of pain in fibromyalgia.pdf 306.2 kB
  • Pain/Neuropathic orofacial pain - cannabinoids as a therapeutic avenue.pdf 637.0 kB
  • Pain/Novel analgesic interventions in cancer-induced bone pain.pdf 3.0 MB
  • Pain/Open-Label, Add-on Study of Tetrahydrocannabinol for Chronic Nonmalignant Pain.pdf 65.5 kB
  • Pain/Oromucosal THC – CBD for Neuropathic Pain Associated with Multiple Sclerosis - An Uncontrolled, Open-Label, 2-Year Extension Trial.pdf 1.8 MB
  • Pain/Pain relief with oral cannabinoids in familial Mediterranean fever.pdf 234.0 kB
  • Pain/Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.pdf 439.9 kB
  • Pain/Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy - A Systematic Review and Meta-Analysis of Randomised Controlled Trials.pdf 220.6 kB
  • Pain/Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.pdf 90.7 kB
  • Pain/Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.pdf 391.4 kB
  • Pain/RESULTS FROM CONTROLLED STUDIES WITH SINGLE-DOSE, ORAL CANNABINOIDS IN HUMAN MODELS OF ACUTE PAIN.pdf 43.6 kB
  • Pain/Role of Cannabinoids in the Management of Neuropathic Pain.pdf 117.9 kB
  • Pain/Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity.pdf 280.6 kB
  • Pain/Sativex - clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.pdf 197.3 kB
  • Pain/Sativex cannabis based medicine maintains improvements in sleep quality in patients with multiple sclerosis and neuropathic pain.pdf 129.6 kB
  • Pain/Sativex successfully treats neuropathic pain characterized by allodynia - A randomised, double-blind, placebo-controlled clinical trial.pdf 171.9 kB
  • Pain/Smoked cannabis for chronic neuropathic pain - a randomized controlled trial.pdf 316.9 kB
  • Pain/Smoked Medicinal Cannabis for Neuropathic Pain in HIV - A randomized, crossover clinical trial.pdf 131.2 kB
  • Pain/Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain.pdf 658.6 kB
  • Pain/Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.pdf 632.1 kB
  • Pain/Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients - Results of a Multicenter Survey.pdf 1.3 MB
  • Pain/The analgesic effect of oral D9THC, morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.pdf 469.6 kB
  • Pain/The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.pdf 469.6 kB
  • Pain/THE EFFECTS OF SMOKED CANNABIS IN PAINFUL PERIPHERAL NEUROPATHY AND CANCER PAIN REFRACTORY TO OPIOIDS.pdf 73.4 kB
  • Pain/The Endocannabinoid System, Cannabinoids, and Pain.pdf 729.7 kB
  • Pain/The plant cannabinoid D9-tetrahydrocannabivarin can decrease signs of inflammation inflammatory pain in mice.pdf 432.6 kB
  • Pain/The role of endocannabinoids in pain modulation.pdf 358.7 kB
  • Pain/The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.pdf 1.1 MB
  • Pain/The use of cannabinoids in chronic pain.pdf 58.5 kB
  • Pain/Therapeutic potential of cannabis in pain medicine.pdf 334.5 kB
  • Palmitoylethanolamide - From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence.pdf 355.4 kB
  • Parental alcohol dependence, socioeconomic disadvantage and alcohol and cannabis dependence among young adults in the community.pdf 228.7 kB
  • Parental separation and early substance involvement- Results from children of alcoholic and cannabis dependent twins.pdf 589.8 kB
  • PATIENTS IN THE CROSSFIRE - Casualties in the War on Medical Marijuana.pdf 3.2 MB
  • Patterns of alcohol, tobacco and cannabis use and related harm in city, regional and remote areas of Australia.pdf 222.4 kB
  • Patterns of diversity in Cannabis.pdf 1.3 MB
  • Peer influence and gender differences in problematic cannabis use among individuals with social anxiety.pdf 180.2 kB
  • Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.pdf 265.0 kB
  • Perinatal delta-9-tetrahydrocannabinol exposure disrupts social and open field behavior in adult male rats.pdf 228.5 kB
  • Perinatal exposure to D9THC leads to changes in opioid-related behavioral patterns in rats.pdf 634.5 kB
  • Periodontal and Oral Manifestations of Marijuana Use.pdf 935.4 kB
  • PERIPHERAL NERVE INJURY INDUCES CANNABINOID RECEPTOR 2 PROTEIN EXPRESSION IN RAT SENSORY NEURONS.pdf 854.0 kB
  • Persecutory ideation and a history of cannabis use.pdf 180.2 kB
  • Persistent cannabis users show neuropsychological decline from childhood to midlife.pdf 1.3 MB
  • Persistent cannabis users show neuropsychological decline from childhood to midlife.pdf 826.6 kB
  • Pharmaceutical compositions comprising cannabichromene type compounds.pdf 1.0 MB
  • Pharmacodynamic Effects of Dronabinol, a Non-Selective Cannabinoid Receptor Agonist, on Colonic Sensory and Motor Functions in Irritable Bowel Syndrome.pdf 35.3 kB
  • Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome.pdf 364.0 kB
  • Pharmacokinetics and Metabolism of the Plant Cannabinoids, THC, CBD and CBN.pdf 398.3 kB
  • Pharmacokinetics and pharmacodynamics of cannabinoids.pdf 466.7 kB
  • Pharmacokinetics of Nabilone, a Psychotropically Active 9-Ketocannabinoid, in the Dog. Utilization of Quantitative Selected Ion Monitoring and Deuterium Labeling.pdf 613.8 kB
  • Pharmacokinetics, metabolism and drug-abuse potential of nabilone.pdf 566.1 kB
  • Pharmacologic Effects of Marijuana.pdf 284.5 kB
  • Pharmacological actions and therapeutic uses of cannabis - review article.pdf 114.8 kB
  • Pharmacological actions and therapeutic uses of cannabis and cannabinoids.pdf 131.1 kB
  • Pharmacological Actions of Cannabinoids.pdf 684.2 kB
  • Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.pdf 166.0 kB
  • Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.pdf 615.7 kB
  • Pharmacological and therapeutic targets for THC and CBD.pdf 104.5 kB
  • Pharmacological evaluation of aerosolized cannabinoids in mice.pdf 155.0 kB
  • Pharmacological evaluation of dimethylheptyl analogs of D9THC - reassessment of the putative three-point cannabinoid-receptor interaction.pdf 1.3 MB
  • Pharmacological evaluation of dimethylheptyl analogs of Δ9-THC- reassessment of the putative three-point cannabinoid-receptor interaction.pdf 1.4 MB
  • Pharmacological Evaluation of Halogenated D8THC analogs.pdf 329.5 kB
  • Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by D9THC.pdf 344.1 kB
  • Pharmacology and effects of cannabis - a brief review.pdf 383.4 kB
  • Pharmacology and potential therapeutic effects of Cannabis.pdf 266.1 kB
  • Pharmacology and potential therapeutic uses of cannabis.pdf 273.4 kB
  • Pharmacology of Cannabinoid CB1 and CB2 Receptors.pdf 6.4 MB
  • PHARMACOLOGY OF cannabinoid receptors.pdf 789.8 kB
  • Pharmacology of Cannabinoids.pdf 198.5 kB
  • PHOTOCHEMICAL REACTIONS OF CANNABIDIOL CYCLIZATION TO D1THC AND OTHER TRANSFORMATIONS.pdf 403.1 kB
  • Photosynthesis and Cannabinoid content of temperate and tropical populations of Cannabis sativa.pdf 324.2 kB
  • Physical parameters of dew retted and water retted hemp (Cannabis sativa L.) fibres.pdf 696.0 kB
  • Physical Properties and Structure of Composite Made by Using Hemp Hurds and Different Binding Materials.pdf 723.7 kB
  • Physicians and Medical Marijuana.pdf 148.3 kB
  • Physicochemical and functional properties of hemp (Cannabis sativa L.) protein isolate.pdf 113.2 kB
  • Physicochemical Properties, Solubility, and Protein Binding of D9THC.pdf 955.6 kB
  • Physiochemical and pharmacological characterization of a D9THC aerosol generated by a metered dose inhaler.pdf 183.3 kB
  • Phytocannabinoids as novel therapeutic agents in CNS disorders.pdf 2.3 MB
  • Phytocannabinoids beyond the Cannabis plant – do they exist.pdf 361.5 kB
  • Phytocannabinoids in Cannabis sativa - Recent Studies on Biosynthetic Enzymes.pdf 530.6 kB
  • Phytocannabinoids- CNS cells and development- A dead issue.pdf 85.8 kB
  • Phytochemical and genetic analyses of ancient cannabis from Central Asia.pdf 910.2 kB
  • Pivotal Advance- Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia-reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis.pdf 680.7 kB
  • PKS Activities and Biosynthesis of Cannabinoids and Flavonoids in Cannabis sativa L. plants.pdf 274.7 kB
  • Plant cannabinoids- a neglected pharmacological treasure trove.pdf 97.7 kB
  • PLANT, SYNTHETIC, AND ENDOGENOUS Cannabinoids in Medicine.pdf 296.6 kB
  • Plasma and brain pharmacokinetic profile of CBD, CBDV, THCV, and CBG in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.pdf 477.1 kB
  • PLASMA MEMBRANE INHIBITION OF MACROMOLECULAR PRECURSOR TRANSPORT BY THC.pdf 659.6 kB
  • Police custody following driving under the influence of cannabis- A prospective study.pdf 340.6 kB
  • Politi_2008_Phytochemistry.pdf 3.9 MB
  • POLLEN-ANALYTIC EVIDENCE FOR THE CULTIVATION OF Cannabis in England.pdf 587.7 kB
  • Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration- Development, characterization and in vitro evaluation of their antitumoral efficacy.pdf 362.2 kB
  • Polyketide synthases in Cannabis sativa L.pdf 2.9 MB
  • Poor sleep quality as a risk factor for lapse following a cannabis quit attempt.pdf 241.7 kB
  • Post-ischemic brain damage - the endocannabinoid system in the mechanisms of neuronal death.pdf 191.2 kB
  • Post-traumatic stress disorder and medical cannabis use - a naturalistic observational study.pdf 60.7 kB
  • Postmortem redistribution of D9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).pdf 282.4 kB
  • Postmortem redistribution of THC in the pig.pdf 126.7 kB
  • Postmortem redistribution of THC, 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).pdf 256.9 kB
  • Postural syncope after marijuana- a transcranial Doppler study of the hemodynamics.pdf 239.9 kB
  • Potency of D9THC and other cannabinoids in Cannabis in England in 2005 - Implications for Psychoactivity and pharmacology.pdf 111.3 kB
  • Potency Trends of D9THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008.pdf 286.5 kB
  • Potent vasodilation effect of amurensin G is mediated through the phosphorylation of endothelial nitric oxide synthase.pdf 1.8 MB
  • POTENTIAL THERAPEUTIC APPLICATIONS OF NATURALLY OCCURRING AND SYNTHETIC CANNABINOIDS.pdf 1.8 MB
  • POTENTIAL THERAPEUTIC usefulness of marijuana.pdf 926.2 kB
  • Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism.pdf 731.5 kB
  • PPAR-v - A nuclear receptor with affinity for cannabinoids.pdf 1.2 MB
  • PPARs at the crossroads of lipid signaling and inflammation.pdf 981.3 kB
  • Pre- and post-conditioning treatment with an ultra-low dose of D9THC protects against pentylenetetrazole (PTZ)-induced cognitive damage.pdf 383.3 kB
  • Pre-illness cannabis use and the early course of nonaffective psychotic disorders- Associations with premorbid functioning, the prodrome, and.pdf 184.1 kB
  • Precipitated cannabinoid withdrawl is reversed by D9THC or clonidine.pdf 153.0 kB
  • Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain.pdf 393.6 kB
  • Predictors and consequences of simultaneous alcohol and cannabis use in adolescents.pdf 156.9 kB
  • Predictors of cannabis use in men with and without psychosis.pdf 159.9 kB
  • Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa, fa) compared to lean Zucker rats.pdf 343.1 kB
  • Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.pdf 1.0 MB
  • Preliminary Observation With Dronabinol in Patients With Intractable Pruritus Secondary to Cholestatic Liver Disease.pdf 34.6 kB
  • Preliminary, Open-Label, Pilot Study of Add-On Oral D9THC in Chronic Post-Traumatic Stress Disorder.pdf 239.5 kB
  • Prenatal cannabis exposure and infant outcomes- Overview of studies.pdf 447.5 kB
  • Prenatal Exposure to Cannabis - A Critical Review of effects on growth, development, and behavior.pdf 1.1 MB
  • Prenatal Marijuana Exposure and Neonatal Outcomes in Jamaica - An Ethnographic Study.pdf 247.4 kB
  • Prenatal Tetrahydrocannabinol (THC) Alters Components of Executive Function Into Adulthood of the Rat.pdf 53.0 kB
  • Prenatal THC alters cognitive function and amphetamine response from weaning to adulthood in the rat.pdf 623.3 kB
  • Prenatal THC and effects on executive function in the rat.pdf 73.2 kB
  • Prenatal Tobacco Exposure, Biomarkers for Tobacco in Meconium, and Neonatal Growth Outcomes.pdf 130.1 kB
  • Preparative Isolation of Cannabinoids from Cannabis sativa by Centrifugal Partition Chromatography.pdf 275.8 kB
  • Prescribing cannabis - freedom, autonomy, and values.pdf 77.9 kB
  • Prescribing cannabis for harm reduction.pdf 268.1 kB
  • Presence of Cryofibrinogen in a Cannabis user with Digital Ischaemia.pdf 444.4 kB
  • Presence of functional cannabinoid receptors in human endocrine pancreas.pdf 487.2 kB
  • Pretreatment with D9THC increases cocaine-stimulated activity in adolescent but not adult male rats.pdf 324.7 kB
  • Prevalence and correlates of cannabis use in developed and developing countries.pdf 176.9 kB
  • Prevalence and correlates of heavy smoking and nicotine dependence in adolescents with bipolar and cannabis use disorders.pdf 252.7 kB
  • Prevalence of alcohol and other psychoactive substances in injured drivers- Comparison between Belgium and the Netherlands.pdf 353.8 kB
  • Prevalence of drug abuse among workers- Strengths and pitfalls of the recent Italian Workplace Drug Testing (WDT) legislation.pdf 260.7 kB
  • Prevalence of Marijuana Use Disorders in the United States1991-1992 and 2001-2002.pdf 105.1 kB
  • Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a sevenweeks period.pdf 642.4 kB
  • Preventing cannabis users from driving under the influence of cannabis.pdf 201.3 kB
  • Prevention of nausea and vomiting following breast surgery.pdf 114.4 kB
  • Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders.pdf 352.7 kB
  • Problems With the Medicalization of Marijuana.pdf 276.1 kB
  • Prolonged Excretion Half-Life of 11-nor-9-Carboxy-D9-THC Following Cessation in a Chronic, Heavy Marijuana User - Implications for Liver Transplant Assessment.pdf 106.8 kB
  • Prolonged oral cannabinoid administration prevents neuroinflammation, lowers B-amyloid levels and improves cognitive performance in Tg APP 2576 mice.pdf 6.8 MB
  • Propagation through alginate encapsulation of axillary buds of Cannabis sativa L. - an important medicinal plant.pdf 237.0 kB
  • Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.pdf 281.8 kB
  • Prospects for cannabinoid therapies in basal ganglia disorders.pdf 1.5 MB
  • Prospects for New Cannabis-Based Prescription Medicines.pdf 201.5 kB
  • PROSTAGLANDINS AND CANNABIS XV. COMPARISON OF ENANTIOMERIC CANNABINOIDS IN STIMULATING PROSTAGLANDIN SYNTHESIS IN FIBROBLASTS.pdf 528.5 kB
  • Protective effect of tetrahydrocoptisine against ethanol-induced gastric ulcer in mice.pdf 1.6 MB
  • Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin–nicotinamide generated oxidative stress induced diabetes.pdf 377.4 kB
  • Psychiatric effects of cannabis use.pdf 656.6 kB
  • Psychiatric effects of cannabis.pdf 370.3 kB
  • Psychological and Cognitive Effects of Cannabis.pdf 306.2 kB
  • Psychological and social sequelae of cannabis and other illicit drug use by young people- a systematic review of longitudinal, general population studies.pdf 122.0 kB
  • Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents.pdf 196.2 kB
  • Psychometric properties of the CAST and SDS scales in young adult cannabis users.pdf 208.6 kB
  • Psychomotor performance in relation to acute oral administration of D9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.pdf 384.2 kB
  • PSYCHOTROPIC AND NONPSYCHOTROPIC CANNABIS DERIVATIVES INHIBIT HUMAN 5-HT3A RECEPTORS THROUGH A RECEPTOR DESENSITIZATION-DEPENDENT MECHANISM.pdf 1.7 MB
  • PTSD contributes to teen and young adult cannabis use disorders.pdf 144.5 kB
  • Puberty as a highly vulnerable developmental period for the consequences of Cannabis exposure.pdf 192.4 kB
  • Pulmonary function in cannabis users - Support for a clinical trial of the vaporizer.pdf 145.8 kB
  • Pupillary reaction during THC impairment.pdf 122.2 kB
  • Qualitative and Quantitative Aspects of the Inheritance of Chemical Phenotype in Cannabis.pdf 914.4 kB
  • Quality Medicinal Cannabis (non-english).pdf 506.1 kB
  • Quality of chemically modifed hemp fibers.pdf 253.9 kB
  • Quantification of selected synthetic cannabinoids and D9THC in oral fluid by liquid chromatography–tandem mass spectrometry.pdf 1.2 MB
  • Quantification of the influence of friends and antisocial behaviour in adolescent consumption of cannabis using the ZINB model and data mining.pdf 377.2 kB
  • Quantifying cannabis use with the Timeline Followback approach- A psychometric evaluation.pdf 255.3 kB
  • Quantitation of D9THC in Cannabis Using 3-Methyl Benzthiazolinone 2-Hydrazone.pdf 388.4 kB
  • Quantitative analysis of astrogliosis in drug-dependent humans.pdf 3.2 MB
  • Quantitative analysis of D9THC in preserved oral fluid by liquid chromatography–tandem mass spectrometry.pdf 517.1 kB
  • Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting.pdf 149.8 kB
  • Randomised, Double-Blind, Placebo-Controlled Trial to Assess the Potential of Cannabinoid Receptor Stimulation in the Treatment of Dystonia.pdf 152.2 kB
  • Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.pdf 306.0 kB
  • Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.pdf 480.2 kB
  • Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.pdf 391.4 kB
  • RAPD markers encoding retrotransposable elements are linked to the male sex in Cannabis sativa L..pdf 599.5 kB
  • Rapid isolation procedure for D9THCA (THCA) from Cannabis sativa using two flash chromatography systems.pdf 623.4 kB
  • Reactions of cannabinoid tosylhydrazones - Stereochemical aspects.pdf 362.9 kB
  • Reassessing the marijuana gateway effect.pdf 261.8 kB
  • Recent Advances in the Metabolism of Cannabinoids.pdf 660.1 kB
  • Recent Clinical Experience With Dronabinol.pdf 497.7 kB
  • Recent developments in cannabinoid ligands.pdf 277.9 kB
  • Recent Developments In Cannabis Chemistry by Alexander Shulgin.pdf 256.1 kB
  • RECENT TRENDS IN CANNABIS USE IN CANADA.pdf 609.1 kB
  • Receptor mechanism and antiemetic activity of structurally‐diverse cannabinoids against radiation‐induced emesis in the least shrew.pdf 1.1 MB
  • Receptor-Independent Effects of Endocannabinoids on Ion Channels.pdf 250.6 kB
  • Recommended methods for the identification and analysis of cannabis and cannabis products - UN Office on Drugs and Crime.pdf 3.0 MB
  • Recovery of spiked D9THC in oral fluid from polypropylene containers.pdf 395.0 kB
  • Recurrent transient ischemic attacks in a Cannabis smoker.pdf 179.3 kB
  • Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo D9THC exposure-impaired hippocampalcsynaptic plasticity.pdf 780.9 kB
  • Regional Brain Abnormalities Associated With Long-term Heavy Cannabis Use.pdf 150.2 kB
  • Regional cerebral blood flow in long-term heavy cannabis use.pdf 433.5 kB
  • Regional differences in naloxone modulation of D9THC induced Fos expression in rat brain.pdf 782.4 kB
  • Regioselective synthesis of (+-)-11-Nor-9-carboxy-D9THC.pdf 370.5 kB
  • Regioselective synthesis of isotopically labeled D9THCA A (THCA-A-D3) by reaction of D9THC-D3 with magnesium methyl carbonate.pdf 318.1 kB
  • Regulating compassion - An overview of Canada's federal medical cannabis policy and practice.pdf 321.3 kB
  • Regulating Medical Marijuana Dispensaries - An Overview with Preliminary evidence of Their Impact on crime.pdf 1.3 MB
  • Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3.pdf 537.7 kB
  • Regulation of PI3K – Akt - GSK-3 pathway by cannabinoids in the brain.pdf 832.9 kB
  • Reinforcing properties of oral D9THC, smoked marijuana, and nabilone - Influence of previous marijuana use.pdf 719.9 kB
  • Reintoxication - the release of fat-stored D9-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure.pdf 322.9 kB
  • RELATIONSHIP OF AGING AND CYTOKINES TO THE IMMUNOMODULATION BY DELTA-9-TETRAHYDROCANNABINOL ON MURINE LYMPHOID CELLS.pdf 935.1 kB
  • Relative contributions of acculturation and psychopathological factors to cannabis use among adolescents from migrant parents.pdf 201.4 kB
  • Repeated dosing of Δ-9-THC to rats- Effects on antinociceptive potency and plasma concentration of morphine.pdf 67.8 kB
  • Repeated treatment with cannabidiol but not D9THC has a neuroprotective effect without the development of tolerance.pdf 478.6 kB
  • Report of the Ohio State Medical Committee on Cannabis indica.pdf 109.8 kB
  • Reposition of a Dislocated Shoulder Under Use of Cannabis.pdf 47.9 kB
  • Reprint of- Survey of medicinal cannabis use among childbearing women- Patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'.pdf 41.8 kB
  • Residual effects of focal brain ischaemia upon cannabinoid CB1 receptor density and functionality in female rats.pdf 639.6 kB
  • Resolution of chiral cannabinoids on amylose tris(3,5-dimethylphenylcarbamate) chiral stationary phase - effects of structural features and mobile phase additives.pdf 950.6 kB
  • Response inhibition and elevated parietal-cerebellar correlations in chronic adolescent cannabis users.pdf 729.5 kB
  • RESPONSE OF RHESUS MONKEY LYMPHOCYTES TO SHORT-TERM ADMINISTRATION OF THC.pdf 451.6 kB
  • Response surface optimization of hemp seed oil yield and oxidation stability by supercritical carbon dioxide extraction.pdf 947.9 kB
  • Responses to Oral D9THC in Frequent and Infrequent Marijuana Users.pdf 137.9 kB
  • Retail marijuana purchases in designer and commercial markets in New York city - sales units, weights, and prices per gram.pdf 347.9 kB
  • Reversal of D9THC-induced tolerance by specific kinase inhibitors.pdf 748.3 kB
  • Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by D9THC and other cannabinoids.pdf 284.4 kB
  • Reversible and regionally selective downregulation of brain cannabinoid CB1 recptors in chronic daily cannabis smokers.pdf 399.4 kB
  • Review on clinical studies with cannabis and cannabinoids 2005-2009.pdf 333.7 kB
  • Revival of Industrial Hemp - A systematic analysis of the current global industry to determine limitations and identify future potentials within the concept of sustainability.pdf 663.3 kB
  • Rick Simpson’s directions.pdf 121.0 kB
  • Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.pdf 448.6 kB
  • Role of cannabinoid CB1 receptors and Gi-o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and ▵9-THC.pdf 352.0 kB
  • Role of cannabinoids in multiple sclerosis.pdf 168.7 kB
  • Role of CB2 receptors in neuroprotective effects of cannabinoids.pdf 305.1 kB
  • Role of Cyclic AMP in the Actions of Cannabinoid Receptors.pdf 1.1 MB
  • ROLE OF ENDOCANNABINOIDS IN BRAIN DEVELOPMENT.pdf 1.2 MB
  • Routes of Administration of Cannabis Used for Nonmedical Purposes and Associations With Patterns of Drug Use.pdf 359.7 kB
  • Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent.pdf 1.1 MB
  • Sativex cannabis based medicine maintains improvements in sleep quality in patients with multiple sclerosis and neuropathic pain.pdf 129.6 kB
  • Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease.pdf 2.8 MB
  • Schizophrenia/Association between cannabis use, psychosis, and schizotypal personality disorder- Findings from the National Epidemiological Survey on alcohol and Related Conditions.pdf 305.9 kB
  • Schizophrenia/Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.pdf 985.4 kB
  • Schizophrenia/Cannabidiol monotherapy for treatment-resistant schizophrenia.pdf 108.2 kB
  • Schizophrenia/Cannabis use in young people - The risk for schizophrenia.pdf 353.8 kB
  • Schizophrenia/Does cause/A case of self amputation of penis by cannabis induced psychosis.pdf 326.7 kB
  • Schizophrenia/Does cause/Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.pdf 786.6 kB
  • Schizophrenia/Does cause/Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.pdf 311.5 kB
  • Schizophrenia/Does cause/Alteration to hippocampal shape in cannabis users with and without schizophrenia.pdf 1.1 MB
  • Schizophrenia/Does cause/Are cannabis use disorders associated with an earlier age at onset of psychosis- A study in first episode schizophrenia.pdf 224.2 kB
  • Schizophrenia/Does cause/Assessing evidence for a causal link between cannabis and psychosis- A review of cohort studies.pdf 279.6 kB
  • Schizophrenia/Does cause/Association between aggressiveness, schizotypal personality traits and cannabis use in Swiss psychology students.pdf 93.9 kB
  • Schizophrenia/Does cause/CANNABINOIDS & PSYCHOSIS- EVIDENCE FROM STUDIES WITH I.V THC IN SCHIZOPHRENIC PATIENTS AND CONTROLS.pdf 95.3 kB
  • Schizophrenia/Does cause/Cannabis abuse and risk for psychosis in a prodromal sample.pdf 98.5 kB
  • Schizophrenia/Does cause/Cannabis abuse is associated with better emotional memory in schizophrenia- A functional magnetic resonance imaging study.pdf 1.1 MB
  • Schizophrenia/Does cause/Cannabis and psychometrically-defined schizotypy- Use, problems and treatment considerations.pdf 214.5 kB
  • Schizophrenia/Does cause/Cannabis and psychosis- Have we found the missing links.pdf 464.3 kB
  • Schizophrenia/Does cause/Cannabis and psychosis.pdf 55.5 kB
  • Schizophrenia/Does cause/CANNABIS and schizophrenia - A longitudinal study of Swedish Conscripts.pdf 572.0 kB
  • Schizophrenia/Does cause/Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.pdf 341.7 kB
  • Schizophrenia/Does cause/Cannabis use and brain structural alterations of the cingulate cortex in early psychosis.pdf 422.8 kB
  • Schizophrenia/Does cause/Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia.pdf 1.1 MB
  • Schizophrenia/Does cause/Cannabis use and genetic predisposition for schizophrenia - a case-control study.pdf 64.3 kB
  • Schizophrenia/Does cause/Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.pdf 198.9 kB
  • Schizophrenia/Does cause/Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.pdf 388.1 kB
  • Schizophrenia/Does cause/Cannabis Use and Psychosis - A Longitudinal Population-based Study.pdf 141.7 kB
  • Schizophrenia/Does cause/Cannabis Use And Psychosis - a review of clinical and epidemiological evidence.pdf 41.0 kB
  • Schizophrenia/Does cause/Cannabis use and risk of psychosis in later life.pdf 407.8 kB
  • Schizophrenia/Does cause/Cannabis use and striatal D2 receptor density in untreated first-episode psychosis- An in vivo SPECT study.pdf 148.6 kB
  • Schizophrenia/Does cause/Cannabis use disorders in schizophrenia- Effects on cognition and symptoms.pdf 182.1 kB
  • Schizophrenia/Does cause/Cannabis use in adolescence and risk for adult psychosis longitudinal prospective study.pdf 139.9 kB
  • Schizophrenia/Does cause/Cannabis use in adolescence and risk for adult psychosis- longitudinal prospective study.pdf 210.9 kB
  • Schizophrenia/Does cause/Cannabis use in young people- The risk for schizophrenia.pdf 575.7 kB
  • Schizophrenia/Does cause/Cannabis withdrawal in chronic cannabis users with schizophrenia.pdf 141.8 kB
  • Schizophrenia/Does cause/Cannabis, synthetic cannabinoids, and psychosis risk - What the evidence says.pdf 780.1 kB
  • Schizophrenia/Does cause/Causal association between cannabis and psychosis- Examination of the evidence.pdf 420.9 kB
  • Schizophrenia/Does cause/CHARACTERISTICS OF SCHIZOPHRENIA IN USERS AND NON USERS OF CANNABIS.pdf 30.4 kB
  • Schizophrenia/Does cause/Childhood symptoms of inattention–hyperactivity predict cannabis use in first episode psychosis.pdf 179.9 kB
  • Schizophrenia/Does cause/Current cannabis use and age of psychosis onset- A gender-mediated relationship - Results from an 8-year FEP incidence study in Bologna.pdf 204.5 kB
  • Schizophrenia/Does cause/Delta-9-tetrahydrocannabinol effects in schizophrenia- Implications for cognition, psychosis, and addiction.pdf 536.8 kB
  • Schizophrenia/Does cause/Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.pdf 233.4 kB
  • Schizophrenia/Does cause/Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.pdf 289.0 kB
  • Schizophrenia/Does cause/Does dopamine mediate the psychosis-inducing effects of cannabis- A review and integration of findings across disciplines.pdf 510.9 kB
  • Schizophrenia/Does cause/DOSE-RESPONSE OF THC EFFECTS IN SCHIZOPHRENICS AND HEALTHY CONTROLS.pdf 255.4 kB
  • Schizophrenia/Does cause/Effects of cannabis use on age at onset in schizophrenia and bipolar disorder.pdf 241.9 kB
  • Schizophrenia/Does cause/Effects of cannabis use status on cognitive function, inmales with schizophrenia.pdf 186.2 kB
  • Schizophrenia/Does cause/Feasibility of teaching motivational interviewing to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use.pdf 301.4 kB
  • Schizophrenia/Does cause/Increased gray matter density in patients with schizophrenia and cannabis use- A voxel-based morphometric study using DARTEL.pdf 237.6 kB
  • Schizophrenia/Does cause/Interaction between COMT haplotypes and cannabis in schizophrenia- A case-only study in two samples from Spain.pdf 186.2 kB
  • Schizophrenia/Does cause/LABORATORY STUDIES OF D9THC IN HUMANS- RELEVANCE TO SCHIZOPHRENIA.pdf 100.2 kB
  • Schizophrenia/Does cause/Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.pdf 124.7 kB
  • Schizophrenia/Does cause/Longitudinal Evidence of a Gene X Environment Interaction.pdf 198.8 kB
  • Schizophrenia/Does cause/NEGATIVE ASSOCIATION BETWEEN NEUROLOGICAL SOFT SIGNS AND CANNABIS USE IN TUNISIAN PATIENTS WITH FIRST-EPISODE PSYCHOSIS.pdf 30.0 kB
  • Schizophrenia/Does cause/Neurocognitive functions of heavy cannabis using schizophrenia patients.pdf 219.8 kB
  • Schizophrenia/Does cause/Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.pdf 255.0 kB
  • Schizophrenia/Does cause/Psychosis risk syndrome comorbid with panic attack disorder in a cannabis-abusing patient affected by Arnold–Chiari malformation type I.pdf 244.7 kB
  • Schizophrenia/Does cause/Rehashing the evidence on psychosis and cannabis.pdf 195.8 kB
  • Schizophrenia/Does cause/Substance use and psychosis.pdf 78.6 kB
  • Schizophrenia/Does cause/Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.pdf 218.6 kB
  • Schizophrenia/Does cause/Temporal relationship of first-episode non-affective psychosis with cannabis use- A clinical verification of an epidemiological hypothesis.pdf 246.5 kB
  • Schizophrenia/Does cause/The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia- A systematic review.pdf 401.1 kB
  • Schizophrenia/Does cause/The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia.pdf 301.6 kB
  • Schizophrenia/Does cause/Variability of the COMT gene and modification of the risk of schizophrenia conferred by cannabis consumption.pdf 202.3 kB
  • Schizophrenia/Does cause/What every adolescent needs to know - Cannabis can cause psychosis.pdf 148.6 kB
  • Schizophrenia/Does cause/Why do patients with psychosis use cannabis and are they ready to change their use.pdf 261.6 kB
  • Schizophrenia/Does not cause/A comparison of symptoms and family history in schizophrenia with and without prior cannabis use- Implications for the concept of cannabis psychosis.pdf 175.7 kB
  • Schizophrenia/Does not cause/A controlled family study of cannabis users with and without psychosis.pdf 206.0 kB
  • Schizophrenia/Does not cause/Cannabis policy- Time to move beyond the psychosis debate.pdf 290.5 kB
  • Schizophrenia/Does not cause/Harvard - Marijuana Doesn’t Cause Schizophrenia.pdf 212.7 kB
  • Schizophrenia/Does not cause/New study casts doubt on “cannabis-induced psychosis” claims, pot doesn’t cause schizophrenia.pdf 211.5 kB
  • Schizophrenia/Does not cause/Testing hypotheses about the relationship between cannabis use and psychosis.pdf 457.4 kB
  • Schizophrenia/Does not cause/The Yin and Yang of Cannabis-induced Psychosis - the Actions of THC and CBD in Rodent Models of Schizophrenia.pdf 291.0 kB
  • Schizophrenia/DOSE-RESPONSE OF THC EFFECTS IN SCHIZOPHRENICS AND HEALTHY CONTROLS.pdf 257.5 kB
  • Schizophrenia/ENVIRONMENT-ENVIRONMENT INTERACTIONS IN A SCHIZOPHRENIA RELATED DISEASE MODEL - IMPACT OF POLY IC AND THC ON THE DEVELOPING BRAIN.pdf 60.3 kB
  • Schizophrenia/Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.pdf 168.9 kB
  • Schizophrenia/Role of the endocannabinoid system in brain functions relevant for schizophrenia - An overviewof human challenge studies with cannabis or Δ9-tetrahydrocannabinol (THC).pdf 513.3 kB
  • Schizophrenia/Smoked cannabis for spasticity in multiple sclerosis - a randomized, placebo-controlled trial.pdf 290.7 kB
  • Schizophrenia/Synthetic D9THC (Dronabinol) Can Improve the Symptoms of Schizophrenia.pdf 91.6 kB
  • Schizophrenia/THC can improve symptoms of schizophrenia.pdf 119.5 kB
  • Scientific Evidence Concerning Medical Marijuana Use.pdf 383.3 kB
  • Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts.pdf 200.5 kB
  • SCREENING OF ANTIBACTERIAL ACTIVITY OF MEDICINAL PLANTS.pdf 445.7 kB
  • Seasonal fluctuations in Cannabinoid content of Kansas marijuana.pdf 713.6 kB
  • Secondary metabolism in cannabis.pdf 706.6 kB
  • Secretory Vesicle Formation in the Secretory Cavity of Glandular Trichomes of Cannabis sativa L. (Cannabaceae).pdf 2.0 MB
  • Selective and Potent Analgetics Derived from Cannabinoids.pdf 1.1 MB
  • Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.pdf 5.5 MB
  • Selective processing of cannabis cues in regular cannabis users.pdf 186.7 kB
  • Self-administration of cannabinoids by experimental animals and human marijuana smokers.pdf 345.8 kB
  • Self-administration of D9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys.pdf 191.5 kB
  • Self-Administration of D9THC by Rats.pdf 297.5 kB
  • Self-change - A pathway to cannabis abuse resolution.pdf 113.4 kB
  • Self-control and its relation to joint developmental trajectories of cannabis use and depressive mood symptoms.pdf 201.8 kB
  • Self-reported lifetime marijuana use and interleukin-6 levels inmiddle-aged African Americans.pdf 338.7 kB
  • Self-reported medical use of marijuana - a survey of the general population.pdf 177.8 kB
  • Separate and combined effects of the cannabinoid agonists nabilone and D9THC in humans discriminating D9THC.pdf 246.2 kB
  • Separate and combined effects of the GABA reuptake inhibitor tiagabine and D9THC in humans discriminating D9THC.pdf 409.3 kB
  • Separate and combined effects of the GABA-B agonist baclofen and D9THC in humans discriminating D9THC.pdf 338.5 kB
  • Sequenced Anaerobic-Aerobic Treatment of Hemp Pulping Wastewaters.pdf 4.6 MB
  • Sewer epidemiology mass balances for assessing the illicit use of methamphetamine, amphetamine and tetrahydrocannabinol.pdf 795.1 kB
  • Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of D9THC in the rat.pdf 1.6 MB
  • Sex differences in CB1 vs. CB2 receptor mediation of THC induced antinociception.pdf 36.1 kB
  • Sex differences in CB1 vs. CB2 receptor mediation of THC-induced antinociception.pdf 36.6 kB
  • Sex Hormones Levels as Influenced by Cannabis sativa in Rats and Men.pdf 267.7 kB
  • Sex-specific disturbances of the glutamate-GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure.pdf 1.1 MB
  • Short tandem repeat (STR) DNA markers are hypervariable and informative in Cannabis sativa- implications for forensic investigations.pdf 189.1 kB
  • Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain.pdf 573.7 kB
  • Should Medical Marijuana Be Prescribed to Children- by William Courtney.pdf 88.0 kB
  • Side Chain Methyl Analogues of D8THC.pdf 1.4 MB
  • Signal transduction of the CB1 cannabinoid receptor.pdf 235.2 kB
  • Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge.pdf 563.6 kB
  • Simultaneous cannabis and tobacco use and cannabis-related outcomes in young women.pdf 160.7 kB
  • Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid.pdf 401.9 kB
  • Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD.pdf 361.3 kB
  • Skeletal anabolic activity of cannabinoid receptor agonists.pdf 64.1 kB
  • Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawl.pdf 408.6 kB
  • Smoke Screen - America’s Drug Policy and Medical Marijuana.pdf 76.0 kB
  • Smoke signals - a social history of marijuana - medical, recreational and scientific.pdf 3.4 MB
  • Smoked Marijuana as a Cause of lung injury.pdf 49.2 kB
  • Social anxiety and cannabis use- An analysis from ecological momentary assessment.pdf 598.4 kB
  • Soil washing of Pb, Zn and Cd using biodegradable chelator and permeable barriers and induced phytoextraction by Cannabis sativa.pdf 214.5 kB
  • Solid dispersions based on inulin for the stabilisation and formulation of D9THC.pdf 137.7 kB
  • Solubility of D9THC in supercritical carbon dioxide - Experiments and modeling.pdf 366.6 kB
  • Solubility of non-psychoactive cannabinoids in supercritical carbon dioxide and comparison with psychoactive cannabinoids.pdf 297.7 kB
  • Sourcing Brazilian marijuana by applying IRMS analysis to seized samples.pdf 358.0 kB
  • Sourcing the provenance of cannabis crops using inter-element association patterns 'fingerprinting' and laser ablation inductively coupled plasma mass spectrometry.pdf 310.6 kB
  • Spasms & Spasticity/A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.pdf 203.6 kB
  • Spasms & Spasticity/Atheroma and Coronary Artery Spasm.pdf 481.2 kB
  • Spasms & Spasticity/Cannabinoids control spasticity and tremor in a multiple sclerosis model.pdf 178.6 kB
  • Spasms & Spasticity/Cannabinoids control spasticity and tremor in amultiple sclerosis model.pdf 378.4 kB
  • Spasms & Spasticity/Cannabinoids do not reduce objective measurements in muscle spasticity, but people with multiple sclerosis perceive some benefit.pdf 136.2 kB
  • Spasms & Spasticity/Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study) – multicenter randomised placebo-controlled trial.pdf 125.5 kB
  • Spasms & Spasticity/Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.pdf 333.3 kB
  • Spasms & Spasticity/Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis.pdf 481.3 kB
  • Spasms & Spasticity/Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.pdf 242.0 kB
  • Spasms & Spasticity/Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain - A double-blind placebo-controlled cross-over trial.pdf 93.6 kB
  • Spasms & Spasticity/Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain.pdf 74.0 kB
  • Spasms & Spasticity/Marihuana as a therapeutic agent for muscle spasm or spasticity.pdf 363.3 kB
  • Spasms & Spasticity/Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.pdf 545.1 kB
  • Spasms & Spasticity/Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity.pdf 280.6 kB
  • Spasms & Spasticity/Smoked cannabis for spasticity in multiple sclerosis - a randomized, placebo-controlled trial.pdf 290.7 kB
  • Spasms & Spasticity/THC and CBD oromucosal spray (Sativex) in the management of spasticity associated with multiple sclerosis.pdf 797.2 kB
  • Spasms & Spasticity/The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.pdf 849.6 kB
  • Spasms & Spasticity/The treatment of spasticity with D9-tetrahydrocannabinol in persons with spinal cord injury.pdf 170.3 kB
  • Spasms & Spasticity/Treatment of human spasticity with D9THC.pdf 613.9 kB
  • Spasms & Spasticity/Use of D9-tetrahydrocannabinol in the treatment of spasticity in spinal cord injury patients.pdf 34.5 kB
  • Spasms & Spasticity/Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis - a systematic review.pdf 192.6 kB
  • Speciation, Species, Chemotaxonomy/A CHEMOTAXONOMIC ANALYSIS OF CANNABINOID VARIATION IN CANNABIS (CANNABACEAE).pdf 106.7 kB
  • Speciation, Species, Chemotaxonomy/A chemotaxonomic analysis of terpenoid variation in Cannabis.pdf 229.6 kB
  • Speciation, Species, Chemotaxonomy/A chemotaxonomic analysis of terpenoid.pdf 190.3 kB
  • Speciation, Species, Chemotaxonomy/A Chemotaxonomic Approach to the Fatty Acid and Tocochromanol Content of Cannabis sativa L. (Cannabaceae).pdf 1.2 MB
  • Speciation, Species, Chemotaxonomy/A Numerical Taxonomic Analysis of Cannabis with Special Reference to Species Delimitation.pdf 1.5 MB
  • Speciation, Species, Chemotaxonomy/A Practical and Natural Taxonomy for Cannabis.pdf 4.5 MB
  • Speciation, Species, Chemotaxonomy/A Study of Infraspecific Flavinoid Variation of Cannabis sativa L. (Cannabaceae).pdf 2.9 MB
  • Speciation, Species, Chemotaxonomy/Cannabis - a polytypic genus.pdf 615.5 kB
  • Speciation, Species, Chemotaxonomy/CHEMOTAXONOMY OF CANNABIS 1. CROSSBREEDING BETWEEN CANNABIS SATIVA AND C. RUDERALIS, WITH ANALYSIS OF CANNABINOID CONTENT.pdf 456.9 kB
  • Speciation, Species, Chemotaxonomy/Flavonoid variation in Cannabis L..pdf 524.4 kB
  • Speciation, Species, Chemotaxonomy/Genetic evidence for speciation in Cannabis (Cannabaceae).pdf 568.9 kB
  • Speciation, Species, Chemotaxonomy/Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes.pdf 2.0 MB
  • Speciation, Species, Chemotaxonomy/Morphological variation of achenes of Cannabis.pdf 1.4 MB
  • Speciation, Species, Chemotaxonomy/Patterns of diversity in Cannabis.pdf 1.3 MB
  • Speciation, Species, Chemotaxonomy/The Evolution of Cannabinoid Phenotypes in Cannabis.pdf 2.0 MB
  • Speciation, Species, Chemotaxonomy/The Genus Cannabis and the Correct Use of Taxonomic Categories.pdf 5.7 MB
  • Species Identification of Cannabis sativa Using Real-Time Quantitative PCR (qPCR).pdf 215.7 kB
  • SPECTRAL POWER SHIFTS WITHIN THE EEG ALPHA FREQUENCY BAND ASSOCIATED WITH CHRONIC HEAVY MARIHUANA (THC) USE.pdf 90.6 kB
  • Spice drugs are more than harmless herbal blends- A review of the pharmacology and toxicology of synthetic cannabinoids.pdf 779.4 kB
  • Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.pdf 116.0 kB
  • Spontaneous multivessel coronary artery dissection associated with cannabis use.pdf 750.2 kB
  • Spray freeze drying to produce a stable D9THC containing inulin-based solid dispersion powder suitable for inhalation.pdf 561.8 kB
  • SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice.pdf 308.0 kB
  • SR 141716A prevents D9THC spatial learning deficit in a Morris-type water maze in mice.pdf 139.0 kB
  • Stability of D9THC in oral fluid using the Quantisal collection device.pdf 276.4 kB
  • Stable isotope models to predict geographic origin and cultivation conditions of marijuana.pdf 430.9 kB
  • Stable Isotope Ratios of Marijuana. I. Carbon and Nitrogen stable isotopes describe growth conditions.pdf 340.9 kB
  • STABLE SUPPOSITORY FORMULATIONS OTHER PUBLICATIONS EFFECI‘ING BIOVAVILABILITY OF D9THC.pdf 551.5 kB
  • State MMJ laws - Understanding the laws and their limitations.pdf 2.5 MB
  • Statement by Leukemia & Lymphocyte Society about Medical Marijuana Use and Research.pdf 120.2 kB
  • Statistics on cannabis users skew perceptions of cannabis.pdf 1.5 MB
  • STEREOCHEMICAL EFFECTS OF 1 l-OH-A8-TETRAHYDROCANNABINOL-DIMETHYLHEPTYL TO INHIBIT ADENYLATE CYCLASE AND BIND TO THE CANNABINOID RECEPTOR.pdf 527.8 kB
  • Stereochemical Effects of 11-OH- A 8-THC,-Dimethylheptyl in Mice and Dogs.pdf 528.5 kB
  • Stereochemical Effects of 11-OH- D8THC,-Dimethylheptyl in Mice and Dogs.pdf 528.5 kB
  • Stereospecific cyclizations and isomerizations of cannabichromene and related cannabinoids.pdf 159.0 kB
  • STIMULATION OF ANANDAMIDE BIOSYNTHESIS IN N-18TG2 NEUROBLASTOMA CELLS BY D9THC.pdf 417.9 kB
  • Stimulation of eating in healthy volunteers following acute oromucosal administration of D9THC.pdf 55.3 kB
  • Striatal D2-D3 receptor availability is inversely correlated with cannabis.pdf 440.2 kB
  • Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops.pdf 324.3 kB
  • Structural Adaptations in a Membrane Enzyme That Terminates endocannabinoid signaling.pdf 552.6 kB
  • STRUCTURAL AND FUNCTIONAL IMAGING STUDIES IN CHRONIC CANNABIS USERS- A SYSTEMATIC REVIEW OF ADOLESCENT AND ADULT FINDINGS.pdf 33.5 kB
  • Structural divergence among cannabinoids influences membrane dynamics- A 2H Solid-State NMR analysis.pdf 1.0 MB
  • Structural modifications of the cannabinoid side chain towards C3-aryl and 10,10-cycloalkyl-10-cyano cannabinoids.pdf 129.5 kB
  • Structural MRI Findings in Long-Term Cannabis Users- What Do We Know.pdf 457.9 kB
  • Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor.pdf 225.9 kB
  • STRUCTURAL REQUIREMENTS FOR CANNABINOID ACTIVITY.pdf 613.0 kB
  • Structure Activity Relationship of Four THCs and the pharmacological activity of five semi-purified extracts of Cannabis sativa.pdf 524.8 kB
  • Structure and Function of Δ1THCA synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa.pdf 1.7 MB
  • Structure of a cannabinoid receptor and functional expression of the cloned cDNA.pdf 941.3 kB
  • Structure-Activity Relationships for Cannabinoid Receptor-Binding and Analgesic Activity - Studies of Bicyclic Cannabinoid Analogs.pdf 1.6 MB
  • Structure-activity relationships in man of Cannabis constituents and homologs and metabolites of D9THC.pdf 1.0 MB
  • Structure-Activity Relationships of Indole- and Pyrrole-Derived Cannabinoids.pdf 135.0 kB
  • Structure-Activity relationships of the cannabinoids - National Institute on Drug Abuse (1987).pdf 2.1 MB
  • Structure-Anticonvulsant Activity Relationships of Cannabidiol Analogs.pdf 2.3 MB
  • Studies on Ipomea carnea and Cannabis sativa as an alternative pulp blend for softwood - an optimization of kraft delignification process.pdf 716.4 kB
  • Studies on the Components of the Hemp Plant - part 2 - Isolation and identification of piperidine and several amino acids in the hemp plant.pdf 165.5 kB
  • Study of cannabinoid dependence in animals.pdf 192.8 kB
  • Study on the Chemical Constituents of Fruits of Cannabis Sativa L..pdf 1.3 MB
  • SUBCELLULAR DISTRIBUTION OF D9THC IN RAT BRAIN.pdf 318.7 kB
  • Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration.pdf 269.3 kB
  • Subjective Syndromes, Physiological Changes and After-Effects of the Acute A9-Tetrahydrocannabinol-Intoxication - Two Double-Blind Studies in Volunteers.pdf 433.7 kB
  • Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.pdf 409.7 kB
  • Subjectively Experienced Cannabis Effects in Animals.pdf 569.2 kB
  • Sudden unexpected death under acute influence of cannabis.pdf 338.8 kB
  • Super-Charged - How Outlaws, Hippies, and Scientists Reinvented Marijuana.pdf 1.1 MB
  • Superiority of Nabilone over Prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.pdf 600.6 kB
  • Supplement 1 - Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-THC.xls.pdf 7.0 MB
  • Supplement 2 - Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-THC.pdf 559.9 kB
  • Suppression by of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.pdf 1.6 MB
  • Suppression of experimental autoimmune encephalomyelitis by cannabinoids.pdf 492.0 kB
  • SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY D8THC.pdf 65.2 kB
  • SUPPRESSION OF OUTWARD K+ CURRENTS BY WIN55212-2 IN RAT RETINAL GANGLION CELLS IS INDEPENDENT OF CB1-CB2 RECEPTORS.pdf 1.3 MB
  • Survey of medicinal cannabis use among childbearing women - Patterns of its use in pregnancy and retroactive self-assessment.pdf 144.7 kB
  • Survey on Cannabis Use in Parkinson’s Disease - Subjective Improvement of Motor Symptoms.pdf 104.4 kB
  • Survey on the Medical Use of Cannabis and THC in Germany.pdf 188.4 kB
  • Susceptibility of Naegleria fowleri to THC.pdf 1.5 MB
  • Symptom-relieving and neuroprotective effects of the phytocannabinoid Delta(9)-THCV in animal models of Parkinson's disease.pdf 1.6 MB
  • Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.pdf 171.9 kB
  • Synergistic cytotoxicity of D9THC and butylated hydroxyanisole.pdf 327.2 kB
  • Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice.pdf 142.9 kB
  • Synergistic interactions of endogenous opioids and cannabinoid systems.pdf 223.6 kB
  • Synergy between D9THC and morphine in the arthritic rat.pdf 229.1 kB
  • Syntheses of D2THC and Related Cannabinoids.pdf 918.8 kB
  • Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds.pdf 1.1 MB
  • Synthesis and Antitumor Activity of Cannabigerol.pdf 238.2 kB
  • Synthesis and binding study of certain 6-arylalkanamides as molecular probes for cannabinoid receptor subtypes.pdf 959.8 kB
  • Synthesis and Pharmacological Activity of Some 9-Substituted D8THC Analogues.pdf 419.3 kB
  • SYNTHESIS AND PHARMACOLOGY OF THE I',2'-DIMETHYLHEPTYL D8-THC ISOMERS EXCEPTIONALLY POTENT CANNABINOIDS.pdf 314.9 kB
  • Synthesis and Pharmacology of the Isomeric Methylheptyl-D8THC.pdf 1.4 MB
  • Synthesis and structure–activity relationship of substitutions at the C-1 position of Δ9-tetrahydrocannabinol.pdf 577.0 kB
  • Synthesis of 5’-(2H3)-(-)-11-Nor-9-carboxy-D9THC Methyl Ester Methyl Ether.pdf 948.8 kB
  • Synthesis of a potential photoactivatable anandamide analog.pdf 122.1 kB
  • Synthesis of a Primary Metabolite of Cannabidiol (2).pdf 33.6 kB
  • Synthesis of a Primary Metabolite of Cannabidiol.pdf 31.2 kB
  • Synthesis of a Tetracyclic, Conformationally Constrained Analogue of D8THC.pdf 842.6 kB
  • Synthesis of Cannabidiols via Alkenylation of Cyclohexenyl Monoacetate.pdf 104.5 kB
  • Synthesis of Optically Active ( - )-11-Nor-A9-Tetrahydrocannabinol-9-Carboxylic Acid.pdf 163.6 kB
  • Synthesis of quinoline derivatives of tetrahydrocurcumin and zingerone and evaluation of their antioxidant and antibacterial attributes.pdf 2.6 MB
  • Synthesis of Racemic and Optically Active D9THC Metabolites.pdf 1.1 MB
  • Synthesis of some novel 3,5-disubstituted 1,3,4-oxadiazole derivatives and anticancer activity on EAC animal model.pdf 1.8 MB
  • SYNTHESIS OF THE INDIVIDUAL, PHARNACOLOGICALLY DISTINCT, ENANTIONERS OF A TETRAHYDROCANNABINOL DERIVATIVE.pdf 169.9 kB
  • Synthesis of Δ1 and Δ1(6) tetrahydrocannabinol metabolites.pdf 127.9 kB
  • Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel 3,4-Diarylpyrazolines as Potent and Selective CB1 Cannabinoid Receptor Antagonists.pdf 707.1 kB
  • Synthetic and plant derived cannabinoid receptor antagonists show hypophagic properties in fasted and non‐fasted mice.pdf 630.6 kB
  • Synthetic and plant-derived cannabinoid receptor agonists show hypophagic properties in fasted and non-fasted mice.pdf 631.5 kB
  • Synthetic cannabis- A comparison of patterns of use and effect profile with natural cannabis in a large global sample.pdf 378.8 kB
  • Synthetic THC (Dronabinol) Can Improve the Symptoms of Schizophrenia.pdf 91.6 kB
  • Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.pdf 261.6 kB
  • Systems Biology Analysis of the Endocannabinoid System Reveals a Scale-free Network with Distinct Roles for Anandamide and 2-Arachidonoylglycerol.pdf 389.0 kB
  • Taming THC- potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.pdf 2.3 MB
  • Targeted mutation of Δ12 and Δ15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil.pdf 588.6 kB
  • Targeting cannabinoid receptor CB2 cardiovascular disorders- promises and controversies.pdf 1.1 MB
  • Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.pdf 472.4 kB
  • Targeting the endocannabinoid system with cannabinoid receptor agonists - pharmacological strategies and therapeutic possibilities.pdf 446.6 kB
  • Targets and consequences of protein SUMOylation in neurons.pdf 664.9 kB
  • Terminal elimination plasma half-life of D1THC in heavy users of marijuana.pdf 601.2 kB
  • Terpenoids, ‘minor’ cannabinoids contribute to ‘entourage effect’ of cannabis-based medicines.pdf 7.4 MB
  • Testing bidirectional effects between cannabis use and depressive symptoms - moderation by the serotonin transporter gene.pdf 266.5 kB
  • Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis - a randomised, double-blind crossover trial.pdf 255.3 kB
  • Tetrahydrocannabinol and endocannabinoids in feeding and appetite.pdf 121.1 kB
  • Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.pdf 578.2 kB
  • Tetrahydrocannabinol Inhibition of Macrophage Nitric Oxide Production.pdf 1.2 MB
  • TETRAHYDROCANNABINOL LEVELS IN HEMP (CANNABIS SATIVA) GERMPLASM RESOURCES.pdf 172.1 kB
  • Tetrahydrocannabinolic Acid Synthase, the Enzyme Controlling Marijuana Psychoactivity, is Secreted into the Storage Cavity of the Glandular Trichomes.pdf 294.5 kB
  • Tetrahydrocortisol–apolipoprotein A-I complex specifically interacts with eukaryotic DNA and GCC elements of genes.pdf 182.1 kB
  • THC - moderation during implantation.pdf 649.2 kB
  • THC aggravates rat muricide behavior induced by two levels of magnesium deficiency.pdf 388.7 kB
  • THC Can Be Detected in Brain While absent in blood.pdf 133.5 kB
  • THC induces clinical and biochemical improvement with a steroid sparing effect in active inflammatory bowel disease.pdf 53.6 kB
  • THC inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.pdf 1.7 MB
  • THC may palliate altered chemosensory perception in cancer patients - results of a randomized, double-blind, placebo-controlled pilot trial.pdf 363.6 kB
  • THCA Synthase, the Enzyme Controlling Marijuana Psychoactivity, is Secreted into the Storage Cavity of the Glandular Trichomes.pdf 373.9 kB
  • THCVA-A – A new additional marker for illegal cannabis consumption.pdf 884.3 kB
  • The 2005 NORML Truth Report - Your Government Is Lying To You (Again) About Marijuana - An Updated Refutation Of The Drug Czar’s “Open Letter To America’s prosecutors”.pdf 221.7 kB
  • THE 94-DAY CANNABIS STUDY.pdf 483.7 kB
  • The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain.pdf 373.4 kB
  • THE ACTIVE PRINCIPLES OF CANNABIS INDICA RESIN. I.pdf 623.3 kB
  • The acute effects of cannabinoids on memory in humans - a review.pdf 505.1 kB
  • The acute effects of D9THC on brain activity during working memory.pdf 108.3 kB
  • The adverse health and psychological consequences of Cannabis dependence.pdf 1.2 MB
  • The adverse health effects of cannabis use - What are they, and what are their implications for policy.pdf 370.5 kB
  • The analgesic potential of cannabinoids.pdf 662.0 kB
  • The analgesic properties of D9THC and codeine.pdf 854.5 kB
  • THE ANTICONVULSANT ACTIVITY OF CANNABIDIOL AND CANNABINOL.pdf 152.4 kB
  • The antiemetic interaction of D9THC when combined with tropisetron or dexamethasone in the least shrew.pdf 385.5 kB
  • The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the memvrane lipid raft.pdf 1.0 MB
  • The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.pdf 791.2 kB
  • The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A.pdf 281.8 kB
  • The application of DNA micro-arrays (gene arrays) to the study of herbal medicines.pdf 821.7 kB
  • The Art and Science of Cooking With Cannabis.pdf 2.4 MB
  • The behaviora effects of acute D9THC and heroin (diacetylmorphine) exposure in adult zebrafish.pdf 2.1 MB
  • THE BELIEFS OF TEENAGE MALE CANNABINOID USERS- A QUALITATIVE STUDY.pdf 576.4 kB
  • The bidirectional relationships between alcohol, cannabis, depressive disorder- Results from a national sample.pdf 240.3 kB
  • The Biotechnology of Cannabis sativa 1st edition.pdf 461.8 kB
  • The Biotechnology of Cannabis sativa 2nd edition.pdf 45.2 MB
  • The botany and chemistry of Cannabis.pdf 999.4 kB
  • The Budgetary Implications of Marijuana Prohibition.pdf 230.2 kB
  • The Cannabinoid Acids - Nonpsychoactive Derivatives with Therapeutic Potential.pdf 422.6 kB
  • The cannabinoid CB2 receptor - a good friend in the gut.pdf 457.4 kB
  • The cannabinoid receptor - biochemical, anatomical and behavioral characterization.pdf 1.4 MB
  • The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation.pdf 58.5 kB
  • The cannabinoid receptors.pdf 113.8 kB
  • The Cannabinoid System - A brief Review.pdf 603.9 kB
  • The cannabinoid system and immune modulation.pdf 200.4 kB
  • The Cannabinoid System and Male Reproductive Functions.pdf 54.9 kB
  • The Cannabinoids - an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy in appetite promotion, in multiple sclerosis and in neuroprotection.pdf 210.2 kB
  • The cannabinoids - chemical, pharmacologic, and therapeutic aspects (1984).pdf 25.1 MB
  • The cannabis market - UNDOC.pdf 8.5 MB
  • The Cannabis Withdrawal Scale development- Patterns and predictors of cannabis withdrawal and distress.pdf 545.2 kB
  • The cannabis withdrawal syndrome.pdf 115.1 kB
  • The Cannabis Youth Treatment (CYT) Study - main findings from two randomized trials.pdf 441.7 kB
  • The Carbon Sequestration Potential of Hemp-binder - A study of embodied carbon in hemp-binder compared with dry lining solutions for insulating solid walls.pdf 2.5 MB
  • The cardiac and haemostatic effects of dietary hempseed.pdf 301.9 kB
  • The case for medical marijuana in epilepsy.pdf 111.5 kB
  • The case for small-scale domestic cannabis cultivation.pdf 186.7 kB
  • The CB1 Cannabinoid Receptor Agonist, HU-210, Reduces Levodopa-Induced Rotations in 6-Hydroxydopamine-Lesioned Rats.pdf 127.8 kB
  • The CB1-CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.pdf 1.7 MB
  • The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons.pdf 633.5 kB
  • THE CENTRAL NEUROPHARMACOLOGY OF PSYCHOTROPIC Cannabinoids.pdf 5.4 MB
  • THE COMPARATIV REZULTS OF HEMPSEED PRODUCTION OF MONOECIOUS AND DIOECIOUS CULTIVARS (Cannabis sativa L.).pdf 409.7 kB
  • The Composition of Hemp Seed Oil and Its potential as an important source of nutrition.pdf 143.6 kB
  • THE CONSEQUENCES AND COSTS OF MARIJUANA PROHIBITION.pdf 613.8 kB
  • The Constituents of Cannabis sativa Pollen.pdf 602.5 kB
  • The CPRO Cannabis germplasm collection.pdf 873.4 kB
  • The DEA - Four Decades of Impeding and Rejecting Science.pdf 197.0 kB
  • The DEA Position On Marijuana 2011.pdf 987.9 kB
  • The detection of Cannabis constituents in the mouth and on the fingers of smokers.pdf 261.7 kB
  • The differentiation of fibre- and drug type Cannabis seedlings by gas chromatography-mass spectrometry and chemometric tools.pdf 327.6 kB
  • The Dispensatory of the United States of America.pdf 97.9 kB
  • The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids - THC, CBD and THCV.pdf 232.0 kB
  • The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids- THC, CBD, and tetrahydrocannabivarin.pdf 282.0 kB
  • The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users.pdf 499.5 kB
  • The draft genome and transcriptome of Cannabis sativa.pdf 3.3 MB
  • The DSM Guided Cannabis Screen (DSM-G-CS)- Description, reliability, factor structure and empirical scoring with a clinical sample.pdf 180.5 kB
  • The dual neuroprotective–neurotoxic profile of cannabinoid drugs.pdf 508.3 kB
  • THE ECONOMICS OF MARIJUANA CONSUMPTION.pdf 170.4 kB
  • The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks.pdf 619.5 kB
  • The effect of cannabichromene on adult neural stem-progenitor cells.pdf 965.4 kB
  • The effect of cannabis on urge incontinence in patients with multiple sclerosis - a multicentre, randomized placebo-controlled trial.pdf 282.8 kB
  • The Effect of Cannabis sativa Hydroalcoholic Extract on Sperm Parameters and Testis Histology in Rats.pdf 4.3 MB
  • The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val158Met polymorphism.pdf 586.5 kB
  • THE EFFECT OF CHRONICALLY ADMINISTERED CANNABIS EXTRACT ON the testicular function of mice.pdf 427.2 kB
  • The effect of cultivar and seed density on the production and fibre content of Cannabis sativa in Southern England.pdf 95.2 kB
  • THE EFFECT OF D9-THC ON THE TURNOVER RATE OF BRAIN SEROTONIN OF THE RAT.pdf 499.3 kB
  • THE EFFECT OF D9THC ON 5-HT3 RECEPTORS DEPENDS ON THE CURRENT DENSITY.pdf 859.9 kB
  • The effect of D9THC on sensorimotor gating in socially isolated rats.pdf 286.7 kB
  • The effect of GWP42006, a cannabinoid extract on MCF-7 human breast carcinoma cells.pdf 14.9 kB
  • The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.pdf 234.7 kB
  • THE EFFECTS OF CANNABINOIDS ON THE BRAIN.pdf 1.1 MB
  • The effects of cannabis and alcohol on simulated arterial driving- Influences of driving experience and task demand.pdf 372.3 kB
  • The effects of cannabis and alcohol on simulated driving- Influences of dose and experience.pdf 441.6 kB
  • The effects of cannabis on information-processing speed.pdf 140.8 kB
  • The effects of cannabis use on physical and mental health.pdf 521.3 kB
  • The effects of D9THC on human brain function involved in emotional processing- a pharmacological fMRI study.pdf 64.3 kB
  • The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.pdf 1.3 MB
  • The effects of delta9-tetrahydrocannabinol (THC) on human brain function involved in emotional processing - a pharmacological fMRI study.pdf 54.4 kB
  • The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.pdf 108.9 kB
  • The Effects of Heavy Metal Salts on the Phytohormonal Status and sex expression in marijuana.pdf 126.4 kB
  • The effects of large doses of Cannabis indica.pdf 549.7 kB
  • The effects of nabilone on sleep in fibromyalgia - results of a randomized controlled trial.pdf 34.4 kB
  • The emerging role of cannabinoid neuromodulators in symptom management.pdf 140.9 kB
  • The Emperor Wears No Clothes - The Authoritative Historical Record of Cannabis and the Conspiracy Against Marijuana (2000, 11th edition).pdf 997.3 kB
  • THE END OF THE RED QUEEN’S RACE – MEDICAL MARIJUANA IN THE NEW CENTURY.pdf 892.1 kB
  • The Endocannabinoid System - A Putative Role in Neurodegenerative Diseases.pdf 136.7 kB
  • The Endocannabinoid System - Drug Targets, Lead Compounds, and Potential Therapeutic Applications.pdf 624.6 kB
  • The endocannabinoid system and the treatment of obesity.pdf 183.2 kB
  • The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD).pdf 803.0 kB
  • The Endocannabinoid System as an Emerging Target of Pharmacotherapy.pdf 2.5 MB
  • The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.pdf 675.9 kB
  • The endocannabinoid system- Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.pdf 535.3 kB
  • The endocannabinoids - functional roles and therapeutic opportunities.pdf 50.2 kB
  • The endogenous cannabinoid anandamide shares discriminative stimulus effects with D9THC in fatty acid amide hydrolase knockout mice.pdf 459.7 kB
  • The endogenous cannabinoid system - a newplayer in the brain-gut-adipose axis.pdf 193.3 kB
  • The endogenous cannabinoid system and the basal ganglia- biochemical, pharmacological, and therapeutic aspects.pdf 345.7 kB
  • The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.pdf 545.7 kB
  • The ethics of MMJ - Government restrictions vs. medical necessity.pdf 5.8 MB
  • The Evolution of Cannabinoid Phenotypes in Cannabis.pdf 2.0 MB
  • The expression of the peripheral cannabinoid receptor on cells of the immune system and non-Hodgkin's lymphomas.pdf 3.2 MB
  • The future of endocannabinoid-oriented clinical research after CB1 antagonists.pdf 52.7 kB
  • The Gastrointestinal Pharmacology of Cannabinoids - Focus on Motility.pdf 447.2 kB
  • The good and the bad effects of (-) trans-D9-THC on humans.pdf 124.9 kB
  • The growth of cannabis cultivation - Explanations for import substitution in the UK.pdf 103.6 kB
  • The health and psychological effects of Cannabis use.pdf 558.5 kB
  • The hexanoyl-CoA precursor for cannabinoid biosynthesis is formed by an acyl-activating enzyme in Cannabis sativa trichomes.pdf 1.5 MB
  • The highs and lows of cannabinoid receptor expression in disease- mechanisms and their therapeutic implications..pdf 232.9 kB
  • The impact of cannabis use in adolescence on psychotic transition in adult patients.pdf 200.7 kB
  • The impact of comorbid cannabis use disorders on the clinical presentation of social anxiety disorder.pdf 159.9 kB
  • The impact of early-onset cannabis use on functional brain correlates of working memory.pdf 643.4 kB
  • THE IMPACT OF MARIJUANA USE ON GLUCOSE, INSULIN, AND INSULIN RESISTANCE AMONG U.S. ADULTS.pdf 30.7 kB
  • THE IN VITRO AND IN VIVO METABOLISM OF TETRAHYDROCANNABINOL (THC).pdf 636.8 kB
  • The incidence of drugs of impairment in oral fluid from random roadside testing.pdf 171.9 kB
  • THE INFLUENCE OF A 9 –TETRAHYDROCANNABINOL ON INTRAOCULAR PRESSURE IN THE ANAESTHETIZED CAT.pdf 326.0 kB
  • The influence of cannabis on driving.pdf 1.5 MB
  • The Influence of Different Seeding Space and Organic Fertilization Level Upon Production and Mass of 1000 Seeds, Recorded in Some Hemp Varieties.pdf 374.5 kB
  • The Influence of Socioeconomic Status on Cannabis Use Among French Adolescents.pdf 1.2 MB
  • The inheritance of chemical phenotype in Cannabis sativa L. (II)- Cannabigerol predominant plants.pdf 479.1 kB
  • The inheritance of chemical phenotype in Cannabis sativa L. (III)- variation in Cannabichromene proportion.pdf 713.1 kB
  • The inheritance of chemical phenotype in Cannabis sativa L. (IV)- cannabinoid-free plants.pdf 427.5 kB
  • The inheritance of chemical phenotype in Cannabis sativa L..pdf 182.2 kB
  • The interaction of cannabinoid receptor agonists, CP55940 and WIN55212-2 with membranes using solid state 2H NMR.pdf 917.6 kB
  • The interactive effects of emotional clarity and cognitive reappraisal on problematic cannabis use among medical cannabis users.pdf 231.8 kB
  • The Lack of an Effect of D9THC on Pulmonary Smooth Muscle Function in the Guinea Pig.pdf 1.3 MB
  • THE MARIHUANA TAX ACT OF 1937.pdf 190.7 kB
  • The mediation role of licit drugs in the influence of socializing on cannabis use among adolescents- A quantitative approach.pdf 308.1 kB
  • The Medical Cannabis Advocate’s Handbook - PATIENT CULTIVATION - The Seed of Safe Access.pdf 62.4 kB
  • The Medical Marijuana Problem.pdf 379.0 kB
  • The Medicinal Use of Cannabis and Cannabinoids – An International Cross-Sectional Survey on Administration forms.pdf 398.4 kB
  • The medicinal use of cannabis in the UK - results of a nationwide survey.pdf 101.7 kB
  • The Medicinal Uses of Cannabis and Cannabinoids - A review of cannabis and driving skills.pdf 204.3 kB
  • The Medicinal Uses of Cannabis and its constituents.pdf 1.5 MB
  • THE MOLECULAR BASIS OF CANNABINOID ACTIVITY.pdf 820.7 kB
  • THE MOLECULAR LOGIC OF ENDOCANNABINOID SIGNALLING.pdf 413.4 kB
  • The Multiplicity of Action of Cannabinoids- Implications for treating neurodegeneration.pdf 571.0 kB
  • The National Industrial Hemp Strategy.pdf 6.8 MB
  • The neurobiology and evolution of cannabinoid signalling.pdf 2.6 MB
  • THE NEUROBIOLOGY OF CANNABINOID DEPENDENCE- SEX DIFFERENCES AND POTENTIAL INTERACTIONS BETWEEN CANNABINOID AND OPIOID SYSTEMS.pdf 665.5 kB
  • THE OCULAR EFFECTS OF CANNABINOIDS.pdf 524.4 kB
  • The Ontogeny of Cannabinoid Receptors in the Brain of Postnatal and Aging Rats.pdf 723.7 kB
  • THE OPTIMIZATION OF THE SEPARATION CONDITIONS FOR CANNABINOIDS ... AND APPLICATION OF THE METHOD TO DETERMINE THE CONTENT OF THC IN PLANT MATERIAL.pdf 133.1 kB
  • The Origins of Cannabis Prohibition in California.pdf 447.4 kB
  • THE OXIDATION OF THE ENDOGENOUS CANNABINOID ANANDAMIDE AND THE SYNTHETIC CANNABINOID JWH-018, A drug of abuse, by human cytochrome P450 2J2.pdf 2.0 MB
  • The perceived effects of marijuana on spinal cord injured males.pdf 57.9 kB
  • The peripheral cannabinoid receptor - adenylate cyclase inhibition and G protein coupling.pdf 450.6 kB
  • The pharmacokinetics of THC in fat and brain - resulting functional responses to marihuana smoking.pdf 224.6 kB
  • The Pharmacologic and Clinical Effects of Medical Cannabis.pdf 315.1 kB
  • The pharmacological activity of inhalation exposure to marijuana smoke in mice.pdf 183.1 kB
  • The pharmacology of cannabinoid receptors and their ligands- an overview.pdf 90.5 kB
  • The Pharmacology of Cannabis Indica.pdf 317.5 kB
  • The phytocannabinoid D9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum.pdf 793.9 kB
  • The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum.pdf 809.1 kB
  • The possible pathological role of endogenous cannabinoid system in heart failure syndrome.pdf 171.0 kB
  • The potency of cannabis in New Zealand from 1976 to 1996.pdf 2.1 MB
  • The Potential for Clinical Use of Cannabinoids in Treatment of Cardiovascular Disease.pdf 111.9 kB
  • The potential of hemp (Cannabis sativa L.) for sustainable fibre production - a crop physiological appraisal.pdf 1.1 MB
  • The potential of hemp buildings in different climates - A comparison between a common passive house and the hempcrete building system.pdf 2.8 MB
  • The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part I.pdf 90.4 kB
  • The prevalence of cannabis-involved driving in California.pdf 229.7 kB
  • The prevalence of drugs in injured drivers.pdf 176.8 kB
  • The Procoagulatory Effects of THC in human platelets.pdf 200.5 kB
  • The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action.pdf 667.2 kB
  • The psychoactive plant cannabinoid, D9THC, is antagonized by D8- and D9THCV in mice in vivo.pdf 165.8 kB
  • The Psychotomimetic States Inventory (PSI)- Measuring psychotic-type experiences from ketamine and cannabis.pdf 130.1 kB
  • The Public Health Consequences of Marijuana Legalization (Government Propaganda).pdf 70.1 kB
  • The quest for a vascular endothelial cannabinoid receptor.pdf 168.0 kB
  • The RasGrf family of mammalian guanine nucleotide exchange factors.pdf 1.3 MB
  • The relationship between non-acute adolescent cannabis use and cognition.pdf 123.5 kB
  • The relationship between performance on the standardised field sobriety tests, driving performance and the level of D9THC in blood.pdf 167.9 kB
  • The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program.pdf 138.0 kB
  • The relationship of stem and seed yields to flowering phenology and sex expression in monoecious hemp (Cannabis sativa L.).pdf 638.4 kB
  • The religious and medicinal uses of Cannabis in China, India and Tibet.pdf 80.7 kB
  • The Role of Cannabinoids and Cannabinoid Receptors in Enteric Neuronal Survival.pdf 951.4 kB
  • The role of CB1 in immune modulation by cannabinoids.pdf 482.0 kB
  • The role of child protection in cannabis grow-operations.pdf 238.6 kB
  • The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice.pdf 793.2 kB
  • The role of temperament in the relationship between early onset of tobacco and cannabis use- The TRAILS study.pdf 233.4 kB
  • The role of the CB1 receptor in the regulation of sleep.pdf 660.5 kB
  • The safety of modafinil in combination with oral D9THC in humans.pdf 920.8 kB
  • The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories.pdf 200.7 kB
  • The Science of Marijuana, 2nd edition.pdf 11.6 MB
  • The Science of Marijuana.pdf 4.3 MB
  • The seed and the soil - Effect of dosage, personality and starting state on the response to D9THC in man.pdf 2.5 MB
  • The Selective Cannabinoid Antagonist SR 141716A Blocks Cannabinoid-Induced Antinociception in Rats.pdf 167.6 kB
  • The sexual differentiation of Cannabis sativa L.- A morphological and molecular study.pdf 489.3 kB
  • The Shafer Commission Report (1972).doc 136.6 kB
  • The Shafer Commission Report (1972).pdf 382.6 kB
  • The Stable Isotope Ratios of Marijuana. II. Strontium isotope relate to geographic origin.pdf 402.5 kB
  • The synthetic cannabinoid WIN 55212-2 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animals.pdf 201.5 kB
  • The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies.pdf 109.3 kB
  • The THC content of cannabis in Australia - evidence and implications.pdf 49.5 kB
  • The therapeutic potential of cannabis- review.pdf 586.3 kB
  • The therapeutic potential of G-protein coupled receptors in Huntington's disease.pdf 873.9 kB
  • The Therapeutic Potential Of Marihuana.pdf 14.9 MB
  • The therapeutic potential of novel cannabinoid receptors.pdf 608.6 kB
  • The Therapeutic Use of Cannabis sativa (L.) in Arabic Medicine.pdf 69.3 kB
  • The Toxicology of Cannabis and Cannabis Prohibition.pdf 151.7 kB
  • The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder - Anecdotal Evidence and the Need for Clinical Research.pdf 660.0 kB
  • The Use of Marijuana or Synthetic Cannabinoids for the Treatment of Headache.pdf 66.8 kB
  • The validation of a 15 STR multiplex PCR for Cannabis species.pdf 287.4 kB
  • The Volatile Oil Composition of Fresh and Air-Dried Buds of Cannabis sativa.pdf 381.8 kB
  • The “flexible” response of cannabis markets to enforcement and interdiction policy - An international review of market transformations and elasticities.pdf 157.7 kB
  • The_Biotechnology_of_Cannabis_sativa_1st_edition.pdf 578.1 kB
  • The_Biotechnology_of_Cannabis_sativa_2nd_edition.pdf 45.2 MB
  • Theoretical analysis of the NMR and electronic structure of novel D8-THC derivatives.pdf 404.2 kB
  • Therapeutic aspects of cannabis and cannabinoids.pdf 450.2 kB
  • Therapeutic effects of D9THC and modafinil in a marmoset Parkinson model.pdf 348.1 kB
  • Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model.pdf 319.8 kB
  • Therapeutic interventions for symptomatic treatment in Huntington’s disease (Review).pdf 570.7 kB
  • THERAPEUTIC POTENTIAL OF A NOVEL CANNABINOID AGENT CB52 IN THE MOUSE MODEL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS.pdf 2.8 MB
  • Therapeutic potential of cannabinoid medicines.pdf 149.6 kB
  • Therapeutic Potential of Cannabinoid-Based Drugs (page 395).pdf 7.8 MB
  • Therapeutic Potential of Cannabinoids - Perspectives for the Future.pdf 394.5 kB
  • Therapeutic Potential of Cannabinoids - Retrospective and Historical Developments.pdf 345.1 kB
  • Therapeutic Potential of Cannabinoids in CNS Disease.pdf 271.2 kB
  • Thidiazuron-induced high-frequency direct shoot organogenesis of Cannabis sativa L..pdf 259.5 kB
  • THIRD TIME THE CHARM - State Laws on Medical Cannabis Distribution and Department of Justice Guidance on Enforcement.pdf 5.6 MB
  • Time course for the induction and maintenance of tolerance to D9THC in mice.pdf 134.5 kB
  • Time course of cannabinoid accumulation and chemotype development during the growth of Cannabis sativa L..pdf 515.7 kB
  • Time-dependent alterations of the endocannabinoid system and synaptic markers following adolescent delta-9-tetrahydrocannabinol (THC) administration in female rats.pdf 42.1 kB
  • Time-dependent vascular actions of cannabidiol in the rat aorta.pdf 1.1 MB
  • Tissue Culture & Micropropagation/A MICROPROPAGATION SYSTEM FOR CLONING OF HEMP BY SHOOT TIP CULTURE (Tissue Culture).pdf 121.0 kB
  • Tissue Culture & Micropropagation/Assessment of the Genetic Stability of Micropropagated plants of Cannabis sativa by ISSR Markers.pdf 139.3 kB
  • Tissue Culture & Micropropagation/Estimation of Cannabis sativa L. Tissue Culture Conditions Essential for Callus Induction and Plant Regeneration.pdf 178.5 kB
  • Tissue Culture & Micropropagation/Thidiazuron-Induced High-Frequency Direct Shoot Organogenesis of Cannabis (Tissue Culture).pdf 259.5 kB
  • Tissue Culture & Micropropagation/TISSUE CULTURE AND AGROBACTERIUM-MEDIATED TRANSFORMATION OF HEMP (CANNABIS SATIVA L.).pdf 312.0 kB
  • Tissue Engineering of Cartilage- Can Cannabinoids Help.pdf 2.4 MB
  • Tolerability and effects of oral D9THC in older adolescents with marijuana use disorders.pdf 252.7 kB
  • Tolerance to Chronic Administration of Cannabis sativa (Marihuana) in Rats.pdf 814.4 kB
  • Tolerance to the disruptive effects of D9THC on learning in rats.pdf 542.0 kB
  • Tolerance to the reinforcing effects of morphine in D9THC treated mice.pdf 265.3 kB
  • Topographic quantitative EEG sequelae of chronic marihuana use- a replication using medically and psychiatrically screened normal subjects.pdf 842.6 kB
  • Total exposure duration and proximity of cessation of cannabis use predict severity of sub-clinical psychotic symptoms among former users.pdf 139.0 kB
  • Tourette's Syndrome/Cannabinoids - possible role in patho-physiology and therapy of Gilles de la Tourette syndrome.pdf 480.2 kB
  • Tourette's Syndrome/Cannabinoids for Tourette's syndrome.pdf 186.2 kB
  • Tourette's Syndrome/Cannabinoids for Tourette’s Syndrome (Review).pdf 186.2 kB
  • Tourette's Syndrome/Cannabinoids improve driving ability in a Tourette's patient.pdf 98.7 kB
  • Tourette's Syndrome/Cannabinoids reduce symptoms of Tourette's syndrome.pdf 138.6 kB
  • Tourette's Syndrome/D9THC is Effective in the Treatment of Tics in Tourette Syndrome - a 6-Week Randomized Trial.pdf 58.7 kB
  • Tourette's Syndrome/Oral THC Improved Refractory Gilles de la Tourette Syndrome in an Adolescent by Increasing Intracortical Inhibition.pdf 167.0 kB
  • Tourette's Syndrome/Treatment of Tourette syndrome with Cannabinoids.pdf 1.2 MB
  • Tourette's Syndrome/Treatment of Tourette Syndrome with Delta-9- Tetrahydrocannabinol (D9-THC) - No Influence on Neuropsychological Performance.pdf 92.5 kB
  • Tourette's Syndrome/Treatment of Tourette's syndrome with D9THC - A randomized crossover trial.pdf 76.5 kB
  • Toward Drugs Derived from Cannabis.pdf 565.2 kB
  • Towards the use of cannabinoids as antitumour agents.pdf 918.7 kB
  • Toxic Effects of Marijuana on the Cardiovascular System.pdf 240.2 kB
  • Toxicological investigations for drugs of abuse in arrested drivers- A 2-year retrospective study (2005–2006) in Strasbourg, France.pdf 151.8 kB
  • Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor CB1.pdf 366.0 kB
  • TOXICOLOGY AND PHARMACOLOGY OF MARIJUANA.pdf 503.7 kB
  • Tracing retail cannabis in the United States - Geographic origin and cultivation patterns.pdf 1.1 MB
  • Traditional Cannabis Cultivation in Darchula District, Nepal - Seed, Resin and Textiles.pdf 1.3 MB
  • Trajectory of adolescent cannabis use on addiction vulnerability.pdf 1.5 MB
  • Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder.pdf 1.1 MB
  • Transitions between tobacco and cannabis use among adolescents- A multi-state modeling of progression from onset to daily use.pdf 388.8 kB
  • Treatment for cramps in amyotrophic lateral sclerosis-motor neuron disease (Review).pdf 630.4 kB
  • Treatment of a hyperkinetic movement disorder during pregnancy with dronabinol.pdf 83.2 kB
  • Treatment of Crohn's disease with cannabis - an observational study.pdf 1.7 MB
  • TRENDS AND ACHIEVEMENTS IN INDUSTRIAL HEMP (Cannabis sativa L.) BREEDING.pdf 1.6 MB
  • Trichomes of Cannabis sativa L. (Cannabaceae).pdf 4.7 MB
  • Triggering Myocardial Infarction by Marijuana.pdf 155.4 kB
  • Trypanocidal Effect of Cannabis sativa on Experimental Camel Trypansomosis.pdf 335.6 kB
  • Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neuronal Stem Cells. Compagnucci et al 2013.pdf 2.0 MB
  • UMHS Information for Clinicians on the Michigan Medical Marijuana Program.pdf 51.8 kB
  • UMHS Information for Clinicians on the Michigan MMJ program.pdf 49.9 kB
  • Uncertain Action Of Cannabis Indica.pdf 335.7 kB
  • Understanding Marijuana - A New Look at the Scientific Evidence.pdf 1.1 MB
  • Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay.pdf 180.1 kB
  • Unexpected interference of baby wash products with a cannabinoid THC immunoassay.pdf 196.1 kB
  • Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.pdf 700.0 kB
  • United Nations Bulletin on Narcotics - Review of the World Cannabis Situation.pdf 8.7 MB
  • US20080112895A1 ... Aqueous Drobinol Formulations.pdf 470.1 kB
  • Use of cannabis among 139 cluster headache sufferers.pdf 212.9 kB
  • Use of cannabis enhances attentional inhibition.pdf 155.5 kB
  • Use of dronabinol (delta-9-THC) in autism – A prospective single-case-study with an early infantile autistic child.pdf 224.9 kB
  • Use of dronabinol for cannabis dependence - two case reports and review.pdf 31.5 kB
  • Using a political ecology framework to examine extra-legal livlihood strategies - a lesotho-based case study of cultivation of and trade in cannabis.pdf 474.1 kB
  • Validation of Large White Pig as an animal model for the study of cannabinoids metabolism - Application to the study of THC distribution in tissues.pdf 151.6 kB
  • Validation of Large White Pig as an animal model for the study of cannabinoids metabolism- Application to the study of THC distribution in tissues.pdf 172.2 kB
  • Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.pdf 252.2 kB
  • Vaporization as a Smokeless Cannabis Delivery System - A Pilot Study.pdf 286.6 kB
  • VARIATION OF THE ALKYL SIDE CHAIN IN D8THC.pdf 260.8 kB
  • Variations and origin of the atmospheric pollen of Cannabis detected in the province of Tetouan (NW Morocco) 2008–2010.pdf 542.8 kB
  • Variations of D9THC content in single plants of hemp varieties.pdf 80.9 kB
  • Vascular effects of D9THC, anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.pdf 575.8 kB
  • Vascular effects of THC, anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.pdf 551.1 kB
  • Very low doses of D8THC increase food consumption and alter neurotransmitter levels following weight loss.pdf 648.1 kB
  • Videos, Audio, other stuff/Administering lipophilic drug through mucous membranes - Patent Application US20030021752.pdf 2.5 MB
  • Videos, Audio, other stuff/American_Drug_War_The_Last_White_Hope_2007.3gp 72.5 MB
  • Videos, Audio, other stuff/American_Drug_War_The_Last_White_Hope_2007.flv 303.6 MB
  • Videos, Audio, other stuff/Arthritis and Marijuana - How marijuana, diet, and exercise can heal arthritis.pdf 7.9 MB
  • Videos, Audio, other stuff/Audio, Interviews, Transcripts, Nixon, Shafer Commission Report/Gary Webb May 11, 1998 interview on Democracy Now CIA Crack Connection Reporter Releases New Book.mp3 36.6 MB
  • Videos, Audio, other stuff/Audio, Interviews, Transcripts, Nixon, Shafer Commission Report/Nixon tapes and Shafer Commission Report/Nixon_audio_Schafer_Report_1.mp3 4.5 MB
  • Videos, Audio, other stuff/Audio, Interviews, Transcripts, Nixon, Shafer Commission Report/Nixon tapes and Shafer Commission Report/Nixon_audio_Schafer_Report_2.mp3 3.5 MB
  • Videos, Audio, other stuff/Audio, Interviews, Transcripts, Nixon, Shafer Commission Report/Nixon tapes and Shafer Commission Report/Nixon_audio_Schafer_Report_3.mp3 5.4 MB
  • Videos, Audio, other stuff/Audio, Interviews, Transcripts, Nixon, Shafer Commission Report/Nixon tapes and Shafer Commission Report/Nixon_Transcript_1.pdf 102.2 kB
  • Videos, Audio, other stuff/Audio, Interviews, Transcripts, Nixon, Shafer Commission Report/Nixon tapes and Shafer Commission Report/Nixon_Transcript_2.pdf 150.9 kB
  • Videos, Audio, other stuff/Biology of Marijuana - from Gene to Behavior.pdf 7.7 MB
  • Videos, Audio, other stuff/CANNABIS - PHILOSOPHY FOR EVERYONE - What Were We Just Talking About.pdf 2.8 MB
  • Videos, Audio, other stuff/Cannabis Cures Cancer.pdf 8.0 MB
  • Videos, Audio, other stuff/Drug War Facts - Factbook 2007.pdf 1.4 MB
  • Videos, Audio, other stuff/Heart of Dankness - Underground Botanists, Outlaw Farmers, and the Race for the Cannabis Cup.pdf 940.8 kB
  • Videos, Audio, other stuff/Hemp - Industrial Production and Uses.pdf 5.1 MB
  • Videos, Audio, other stuff/Hemp for Health.pdf 45.0 MB
  • Videos, Audio, other stuff/How Marijuana Cures Cancer.pdf 21.9 MB
  • Videos, Audio, other stuff/Marijuana - The First Twelve Thousand Years.pdf 1.2 MB
  • Videos, Audio, other stuff/MARIJUANA LESS DANGEROUS THAN TOBACCO.pdf 48.8 kB
  • Videos, Audio, other stuff/Marijuana Medicine - A world tour of the visionary and healing powers of Cannabis.pdf 58.2 MB
  • Videos, Audio, other stuff/Medicinal Plant Biotechnology.pdf 4.2 MB
  • Videos, Audio, other stuff/Other Stuff/arrest_table_arrests_for_drug_abuse_violations_percent_distribution_by_regions_2012.xls 24.6 kB
  • Videos, Audio, other stuff/Other Stuff/arrest_table_arrests_for_drug_abuse_violations_percent_distribution_by_regions_2012.xlt 25.1 kB
  • Videos, Audio, other stuff/Other Stuff/Democracy Now Friday, May 15, 1998 CIA Involvement with the War On Drugs Michael Levine (DEA) interview.mp3 28.7 MB
  • Videos, Audio, other stuff/Other Stuff/FBI_table_69_arrest_by_state_2012.xls 55.8 kB
  • Videos, Audio, other stuff/Other Stuff/FBI_table_69_arrest_by_state_2012.xlt 55.8 kB
  • Videos, Audio, other stuff/Other Stuff/FBI_table_69_arrest_by_state_2012_.xls 55.8 kB
  • Videos, Audio, other stuff/Other Stuff/Gary Webb May 11, 1998 interview on Democracy Now CIA Crack Connection Reporter Releases New Book.mp3 36.6 MB
  • Videos, Audio, other stuff/Other Stuff/Is there a Drug War.docx 15.4 kB
  • Videos, Audio, other stuff/Other Stuff/Is there a Drug War.pdf 99.7 kB
  • Videos, Audio, other stuff/Other Stuff/marijuana arrests chart 1965 - 2012.gif 30.3 kB
  • Videos, Audio, other stuff/Other Stuff/media coverage of THC and CBD oil both curing.docx 10.0 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/diag08.jpg 29.7 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/Nutrient Uptake pH Chart - Soil and Soilless.jpg 62.0 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH11.jpg 70.4 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH12.jpg 24.9 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH13.jpg 91.8 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH14.jpg 92.9 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH15.gif 16.4 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH17.jpg 146.9 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH18.jpg 42.1 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH19.jpg 106.2 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/ph20.jpg 24.6 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH21.jpg 31.6 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH22.jpg 22.2 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH23.jpg 19.0 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH24.jpg 164.5 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH25.jpg 21.7 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH26.jpg 21.3 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH27.jpg 101.1 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH7.jpg 19.1 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH8.jpg 25.5 kB
  • Videos, Audio, other stuff/Other Stuff/pH nutrient uptake charts/pH9.jpg 30.3 kB
  • Videos, Audio, other stuff/Other Stuff/Powderburns - Cocaine, Contras & the Drug War.pdf 7.0 MB
  • Videos, Audio, other stuff/Otherwise Law-Abiding Citizens - A scientific and moral assessment of Cannabis use.pdf 1.2 MB
  • Videos, Audio, other stuff/The 15 Ounce Pound - Big Pharma's Plan to Patent Pot.pdf 24.3 MB
  • Videos, Audio, other stuff/The Benefits of Marijuana - Physical, Psychological and Spiritual.pdf 35.1 MB
  • Videos, Audio, other stuff/The Book Of Grass - An Anthology on Indian Hemp.pdf 1.0 MB
  • Videos, Audio, other stuff/The Gospel of Hemp; How Hemp Can Save Our World.pdf 4.9 MB
  • Videos, Audio, other stuff/The Great Book of Hemp.pdf 47.3 MB
  • Videos, Audio, other stuff/The Hemp Manifesto - 101 Ways That Hemp Can Save Our World.pdf 7.9 MB
  • Videos, Audio, other stuff/The Pot Book.pdf 110.9 MB
  • Videos, Audio, other stuff/The State of Legal Marijuana Markets 2nd Edition - Executive Summary.pdf 9.4 MB
  • Videos, Audio, other stuff/Videos/American_Drug_War_The_Last_White_Hope_2007.3gp 72.5 MB
  • Videos, Audio, other stuff/Videos/American_Drug_War_The_Last_White_Hope_2007.flv 303.6 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Assassin_Of_Youth_1937.3gp 44.9 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Assassin_Of_Youth_1937.mp4 195.8 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Devil_s_Harvest.3gp 31.7 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Devil_s_Harvest.mp4 166.1 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Marihuana_1936_Complete_Film_-_ANTI_MARIJUANA_propaganda.3gp 34.5 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Marihuana_1936_Complete_Film_-_ANTI_MARIJUANA_propaganda.mp4 187.1 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Reefer_Madness_1937.3gp 41.7 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/Reefer_Madness_1937.mp4 184.8 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/She_Shoulda_Said_No_1949_Wild_Weed.3gp 42.2 MB
  • Videos, Audio, other stuff/Videos/Anti-Cannabis Propaganda/She_Shoulda_Said_No_1949_Wild_Weed.mp4 219.6 MB
  • Videos, Audio, other stuff/Videos/Cannabinoids_And_The_Reason_Why_The_Establishment_Hates_Them_Dr_Bob_Melamede_30Aug2013.3gp 56.4 MB
  • Videos, Audio, other stuff/Videos/Cannabinoids_And_The_Reason_Why_The_Establishment_Hates_Them_Dr_Bob_Melamede_30Aug2013.flv 244.6 MB
  • Videos, Audio, other stuff/Videos/Cannabinoids_And_The_Reason_Why_The_Establishment_Hates_Them_Dr_Bob_Melamede_30Aug2013.mp4 255.9 MB
  • Videos, Audio, other stuff/Videos/Cannabis_Rising_The_Key_In_The_Lock._Your_Health_Your_Future.3gp 75.8 MB
  • Videos, Audio, other stuff/Videos/Cannabis_Rising_The_Key_In_The_Lock._Your_Health_Your_Future.flv 277.0 MB
  • Videos, Audio, other stuff/Videos/Cannabis_Rising_The_Key_In_The_Lock._Your_Health_Your_Future.mp4 356.9 MB
  • Videos, Audio, other stuff/Videos/Ethan_Nadelmann_Plenary_Speech_at_Bioneers_Conference_2012.3gp 19.0 MB
  • Videos, Audio, other stuff/Videos/Ethan_Nadelmann_Plenary_Speech_at_Bioneers_Conference_2012.flv 80.1 MB
  • Videos, Audio, other stuff/Videos/Ethan_Nadelmann_Plenary_Speech_at_Bioneers_Conference_2012.mp4 113.8 MB
  • Videos, Audio, other stuff/Videos/How to Make Money Selling Drugs 2013 Blu-Ray 720p x264 AAC Dolby FLiCKSiCK.mp4 1.2 GB
  • Videos, Audio, other stuff/Videos/Jack_Herer_-_Emperor_of_Hemp_Full.3gp 35.5 MB
  • Videos, Audio, other stuff/Videos/Jack_Herer_-_Emperor_of_Hemp_Full.flv 149.7 MB
  • Videos, Audio, other stuff/Videos/Jack_Herer_-_Emperor_of_Hemp_Full.mp4 246.3 MB
  • Videos, Audio, other stuff/Videos/Message_to_Canadian_Medical_Association_-_CANNABINOIDS_KILL_CANCER_CELLS.flv 203.9 MB
  • Videos, Audio, other stuff/Videos/Message_to_Canadian_Medical_Association_-_CANNABINOIDS_KILL_CANCER_CELLS.mp4 257.0 MB
  • Videos, Audio, other stuff/Videos/Natural_Cure_for_Cancer_Discovered_-_Run_From_the_Cure_2nd_Edition_Full_Version.flv 144.1 MB
  • Videos, Audio, other stuff/Videos/Natural_Cure_for_Cancer_Discovered_-_Run_From_the_Cure_2nd_Edition_Full_Version.mp4 200.1 MB
  • Videos, Audio, other stuff/Videos/Phytocannabinoids_in_the_Treatment_of_Breast_Cancer_Cristina_Sanchez_PhD_-_NORML_Live_Show.3gp 15.9 MB
  • Videos, Audio, other stuff/Videos/Phytocannabinoids_in_the_Treatment_of_Breast_Cancer_Cristina_Sanchez_PhD_-_NORML_Live_Show.flv 71.9 MB
  • Videos, Audio, other stuff/Videos/Phytocannabinoids_in_the_Treatment_of_Breast_Cancer_Cristina_Sanchez_PhD_-_NORML_Live_Show.mp4 87.0 MB
  • Videos, Audio, other stuff/Videos/Reefer_Madness_2_-_The_Nature_of_Things_with_David_Suzuki-1.3gp 76.4 MB
  • Videos, Audio, other stuff/Videos/Reefer_Madness_2_-_The_Nature_of_Things_with_David_Suzuki.3gp 27.5 MB
  • Videos, Audio, other stuff/Videos/Reefer_Madness_2_-_The_Nature_of_Things_with_David_Suzuki.flv 114.6 MB
  • Videos, Audio, other stuff/Videos/Should_Grandma_Smoke_Pot_2013.3gp 17.7 MB
  • Videos, Audio, other stuff/Videos/Should_Grandma_Smoke_Pot_2013.flv 70.9 MB
  • Videos, Audio, other stuff/Videos/Smoking_Weed_with_the_President_of_Uruguay_Full_Length.3gp 4.4 MB
  • Videos, Audio, other stuff/Videos/Smoking_Weed_with_the_President_of_Uruguay_Full_Length.flv 73.8 MB
  • Videos, Audio, other stuff/Videos/Smoking_Weed_with_the_President_of_Uruguay_Full_Length.mp4 124.3 MB
  • Videos, Audio, other stuff/Videos/Stoned_Kids.3gp 9.4 MB
  • Videos, Audio, other stuff/Videos/Stoned_Kids.flv 40.3 MB
  • Videos, Audio, other stuff/Videos/Stoned_Kids.mp4 68.2 MB
  • Videos, Audio, other stuff/Videos/The_Best_Marijuana_Documentary_Canadian.3gp 63.6 MB
  • Videos, Audio, other stuff/Videos/The_Best_Marijuana_Documentary_Canadian.flv 265.0 MB
  • Videos, Audio, other stuff/Videos/the_nature_of_things_david_suzuki_reefer_madness_-_Bing_Vide.flv 346.8 kB
  • Videos, Audio, other stuff/Videos/This_is_your_body_on_weed.flv 4.7 MB
  • Videos, Audio, other stuff/Videos/This_is_your_body_on_weed.mp4 8.2 MB
  • Videos, Audio, other stuff/Videos/True_History_of_Marijuana_Full_Movie.3gp 47.4 MB
  • Videos, Audio, other stuff/Videos/True_History_of_Marijuana_Full_Movie.flv 199.7 MB
  • Videos, Audio, other stuff/Videos/True_History_of_Marijuana_Full_Movie.mp4 238.8 MB
  • Videos, Audio, other stuff/Videos/Weed_-_CNN_Special_Dr_Sanjay_Gupta_2013_Documentary_Full_English_1080p_HD.flv 113.2 MB
  • Videos, Audio, other stuff/Videos/Weed_-_CNN_Special_Dr_Sanjay_Gupta_2013_Documentary_Full_English_1080p_HD.mp4 189.0 MB
  • Videos, Audio, other stuff/Videos/WEED_2_-_Cannabis_Madness_-_Dr._Sanjay_Gupta_Reports_Full_HD_1080p_-_2014_CNN_Documentary.3gp 26.5 MB
  • Videos, Audio, other stuff/Videos/WEED_2_-_Cannabis_Madness_-_Dr._Sanjay_Gupta_Reports_Full_HD_1080p_-_2014_CNN_Documentary.flv 113.2 MB
  • Videos, Audio, other stuff/Videos/WEED_2_-_Cannabis_Madness_-_Dr._Sanjay_Gupta_Reports_Full_HD_1080p_-_2014_CNN_Documentary.mp4 216.6 MB
  • Videos, Audio, other stuff/Waiting for the Opportune Moment - The Tobacco Industry and Marijuana Legalization.pdf 177.8 kB
  • Videos, Audio, other stuff/Weed Land - INSIDE AMERICA’S MARIJUANA EPICENTER AND HOW POT WENT LEGIT.pdf 976.1 kB
  • Videos, Audio, other stuff/Why Is Marijuana Illegal.pdf 75.8 MB
  • Voltammetric determination of D9THC in glassy carbon electrode- An important contribution to forensic electroanalysis.pdf 324.5 kB
  • War on People - Reframing the War on Drugs by Addressing Racism within American Drug Policy through Restorative Justice and Community Collaboration.pdf 1.2 MB
  • What Can We Learn from the Dutch Cannabis Coffeeshop Experience.pdf 595.9 kB
  • What You Need to Know About Cannabis Understanding the Facts.pdf 677.6 kB
  • What’s the co$t – The Federal War on Patients – A report on the casualties of the war on medical Cannabis.pdf 11.4 MB
  • White matter integrity in adolescents with histories of marijuana use and binge drinking.pdf 274.5 kB
  • Whither Medical Marijuana.pdf 127.1 kB
  • Why Changes in Price Matter When Thinking About Marijuana Policy - A review of the literature on the elasticity of demand.pdf 836.8 kB
  • Why do cannabinoid receptors have more than one endogenous ligand.pdf 639.9 kB
  • WHY DO FIRST-EPISODE PSYCHOSIS PATIENTS USE CANNABIS- CASE CONTROL STUDY.pdf 30.9 kB
  • WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-v pathway.pdf 1.4 MB
  • Witches Broom and Phyllody like symptoms of disease in Acalypha indica L. and Cannabis sativa L.- A New Report from Champaran, North Bihar.pdf 728.8 kB
  • Withdrawal from THC during adolescence. Sex differences in locomotor activity and anxiety.pdf 1.1 MB
  • World Wide Weed - Global Trends in Cannabis Cultivation and its control.pdf 7.1 MB
  • Yield and quality of fibre and oil of fourteen hemp cultivars in Northern Germany at two harvest dates.pdf 981.4 kB
  • Yield and turnover of illicit indoor cannabis (Cannabis spp.) plantations in Belgium.pdf 387.7 kB
  • Yield of Illicit Indoor Cannabis Cultivation in The Netherlands.pdf 71.7 kB
  • Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use.pdf 511.2 kB
  • δ9 THC content in illicit cannabis products over the period 1997-2004 (1st 4 months).pdf 56.9 kB
  • ‘WEED, NEED AND GREED - A study of domestic Cannabis cultivation'.pdf 169.0 kB
  • ‘‘SPICE’’ GIRLS- SYNTHETIC CANNABINOID INTOXICATION.pdf 531.3 kB
  • “But my Doctor Recommended Pot” - Medical Marijuana and the Patient–Physician Relationship.pdf 132.2 kB
  • “Herbal incense”. Designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.pdf 861.3 kB
  • “THE GOOD, THE BAD, THE UGLY” - EXPERIMENTAL HUMAN STUDIES OF CBD, THC, AND THCV.pdf 81.6 kB
  • “Youthful epidemic” or diagnostic bias- Differential item functioning of DSM-IV cannabis use criteria in an Australian general population survey.pdf 284.3 kB

随机展示

相关说明

本站不存储任何资源内容，只收集BT种子元数据(例如文件名和文件大小)和磁力链接(BT种子标识符)，并提供查询服务，是一个完全合法的搜索引擎系统。 网站不提供种子下载服务，用户可以通过第三方链接或磁力链接获取到相关的种子资源。本站也不对BT种子真实性及合法性负责，请用户注意甄别！
>